<SEC-DOCUMENT>0000355019-23-000054.txt : 20231114
<SEC-HEADER>0000355019-23-000054.hdr.sgml : 20231114
<ACCEPTANCE-DATETIME>20231114143522
ACCESSION NUMBER:		0000355019-23-000054
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		60
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231114
DATE AS OF CHANGE:		20231114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		231404529

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar_10-q.htm
<DESCRIPTION>FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2023
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:FONR="http://fonar.com/20230930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_FONR_fonar.com_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20230701_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DDocumentFiscalYearFocus_2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:DocumentFiscalYearFocus">2024</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2023-06-30" id="xdx2ixbrl0068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParty" contextRef="AsOf2023-06-30" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember" id="xdx2ixbrl0191" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" id="xdx2ixbrl0193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0213" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0253" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0271" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-07-01to2023-09-30" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0438" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0486" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-07-012022-09-30" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0697" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0701" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0747" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl0863" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl0865" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2023-09-30" id="xdx2ixbrl0944" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl0987" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1017" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20230930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-07-01to2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_CommonStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CommonStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember1033083781">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember1033083828">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">MFORM
<span id="xdx_90B_edei--DocumentType_c20230701__20230930_znsd3MlSIG6g"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_edei--DocumentQuarterlyReport_c20230701__20230930_zzVdVnWoxPAb" title="Document Quarterly Report"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">[X]</ix:nonNumeric></span>
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_edei--DocumentTransitionReport_c20230701__20230930_zQfZUWKZThK2" title="Document Transition Report" style="display: none"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">[
]</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 31.5pt; text-align: center; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;For
the quarterly period ended <span id="xdx_908_edei--DocumentPeriodEndDate_c20230701__20230930_zN718Tf4HS44"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">SEPTEMBER 30, 2023</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commission
file number <span id="xdx_901_edei--EntityFileNumber_c20230701__20230930_zlNuFIm3xNb"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityFileNumber">000-10248</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<img src="fonar_logo.jpg" alt="" style="height: 30px; width: 200px" /></span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_edei--EntityRegistrantName_c20230701__20230930_znsOet2W94E4"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20230701__20230930_zjdqKoM5qnw8" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20230701__20230930_zo4OgcJlGGD2"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(State
    or other jurisdiction of <br />
    incorporation or organization)</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(I.R.S.
    Employer <br />
    Identification No.)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_edei--EntityAddressAddressLine1_c20230701__20230930_zAImPM3aEhF9" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>&#160;&#160;<span id="xdx_903_edei--EntityAddressCityOrTown_c20230701__20230930_zGnq0mok0nJ1" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20230701__20230930_ztHD4eWyxj22" title="Entity Address, State or Province"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
    <td style="width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20230701__20230930_z1fnJ3vntR79" title="Entity Address, Postal Zip Code"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Address
    of principal executive offices)</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Zip
    Code)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Registrant's
telephone number, including area code: <span id="xdx_909_edei--CityAreaCode_c20230701__20230930_zcjxp0eckjbb"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20230701__20230930_zMSJMF0Ier5l"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes _X_ No ___.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90E_edei--EntityCurrentReportingStatus_c20230701__20230930_zFNKH5HSVCk9" title="Entity Current Reporting Status"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> _X_ No ___</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was required
to submit such files <span id="xdx_903_edei--EntityInteractiveDataCurrent_c20230701__20230930_zhxHM1eKy9Vj"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">_X_
No ___</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See definition of accelerated filer, large accelerated filer, smaller reporting company and emerging growth
company in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer___ Accelerated filer ___ <span id="xdx_90B_edei--EntityFilerCategory_c20230701__20230930_z0X0Xw42P3je" title="Entity Filer Category"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> _X_, Smaller
reporting company _<span id="xdx_90C_edei--EntitySmallBusiness_c20230701__20230930_zRajSDxuCtY8" title="Entity Small Business"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">X</ix:nonNumeric></span>_ Emerging growth company ___<span id="xdx_904_edei--EntityEmergingGrowthCompany_c20230701__20230930_zgaWUPOc28C" style="display: none"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ___ <span id="xdx_908_edei--EntityShellCompany_c20230701__20230930_zOTIkvrzk1Rg" title="Entity Shell Company"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> _X_</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Securities
registered pursuant to Section 12(b) of the Act:&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; width: 30%; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Title
    of each class</span></td>
    <td style="width: 7%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 28%; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Trading
    symbol</span></td>
    <td style="width: 7%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 28%; padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_edei--Security12bTitle_c20230701__20230930_zVNuxLSHwFHa"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:Security12bTitle">Common
    Stock, $.0001 par value</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_edei--TradingSymbol_c20230701__20230930_z4KowHRLEEGe"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_edei--SecurityExchangeName_c20230701__20230930_z5G4DKotV5rh"><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
the number of shares outstanding of each of the issuer's classes of common stock, as of the close of the latest practicable date.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 50%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class</span></td>
    <td style="width: 11%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 39%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Outstanding
    at November 7, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common Stock,
    par value $.0001</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_edei--EntityCommonStockSharesOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRkvaJc1lpE" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-11-07_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class B Common
    Stock, par value $.0001</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: -0.1pt; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zxXW7XZEDTT2" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-11-07_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class C Common
    Stock, par value $.0001</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: -0.1pt; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_edei--EntityCommonStockSharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zBRkMTIbtUci" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-11-07_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class A Preferred
    Stock, par value $.0001</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: -0.1pt; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_edei--EntityCommonStockSharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zMLVPgFN6Cuk" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-11-07_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span></span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">INDEX</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
    I - FINANCIAL INFORMATION</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PAGE</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    1. Financial Statements</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="height: 30pt; vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt; width: 82%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#BalanceSheet">Condensed Consolidated Balance Sheets - September 30, 2023 (Unaudited) and June 30, 2023</a></span></td>
    <td style="width: 9%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; width: 9%; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span></td>
    </tr>
  <tr style="height: 30pt; vertical-align: bottom">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#IncomeStatement">Condensed Consolidated Statements of Income for the Three Months Ended September 30, 2023 and September 30, 2022 (Unaudited)</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;6</span></td>
    </tr>
  <tr style="height: 30pt; vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#ChangesInEquity">Condensed Consolidated Statements of Changes in Equity for the Three Months Ended September 30, 2023 and September 30, 2022 (Unaudited)</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;7</span></td>
    </tr>
  <tr style="height: 30pt; vertical-align: bottom">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#CashFlow">Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2023 and September 30, 2022 (Unaudited)</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;8</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#NotesToFinancialStatements">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;9</span></td>
    </tr>
  <tr style="height: 33pt; vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#MDA">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;20</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Disclosures">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;26</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#ControlsAndProcedures">Item 4. Controls and Procedures</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;26</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
    II - OTHER INFORMATION</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;26</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#LegalProceedings">Item 1. Legal Proceedings</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;26</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#RiskFactors">Item 1A. Risk Factors</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;26</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#UseOfProceeds">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;29</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Defaults">Item 3. Defaults Upon Senior Securities</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;29</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#MineSafety">Item 4. Mine Safety Disclosures</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#MoreInformation">Item 5. Other Information</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;29</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Exhibits">Item 6. Exhibits</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29&#160;</span></td>
    </tr>
  <tr style="height: 23pt; vertical-align: bottom">
    <td style="text-decoration: underline; padding-left: 10pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Signatures">Signatures</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; padding-left: 10pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></td>
    <td>&#160;</td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  </table>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="BalanceSheet"></span>CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASSETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_111_pn3n3_zUSMPyaeIUr" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_496_20230930_zD2wIV3kax9d" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49C_20230630_zuU6uDU1QC04" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30,</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023*</span></td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    Assets:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_pn3n3_maACzFRv_zW6jIqy3Tbwl" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    and cash equivalents</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,693</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,280</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ShortTermInvestments_i01I_pn3n3_maACzFRv_zFRmS0ZsUV66" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term
    investments</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--AccountsReceivableServiceAndRepairFees_i01I_pn3n3_maACzFRv_z3x9u0JfXwc4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,092</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,861</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--AccountReceivableRelatedParties_i01I_pn3n3_maACzFRv_zpvlpVQQoXt8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0068">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--MedicalReceivable_i01I_pn3n3_maACzFRv_zOEJdEmVx0Z7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable - net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,924</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,259</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ManagementAndOtherFees_i01I_pn3n3_maACzFRv_z8dbJgo4g3p2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,118</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,888</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_pn3n3_maACzFRv_zJaGUGoZbF0h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices - net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,063</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,162</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_pn3n3_maACzFRv_zCy1r488FZ07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,824</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,570</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_pn3n3_maACzFRv_zwz1MqWH4hig" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,310</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,608</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrent_i01TI_pn3n3_mtACzFRv_maAzzcg_zLaAD86U3wGg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Current Assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129,147</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125,661</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--AccountsReceivableNetLongTerm_i01I_pn3n3_maAzzcg_zP92F1UF94hh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - long term</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">710</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pn3n3_maAzzcg_zwp0rzjKiNA1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax asset</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,042</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzzcg_zifp6970Dyz4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment - net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,107</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,146</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pn3n3_maAzzcg_zYalM9P3GfCb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    Asset - operating lease</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,203</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,069</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_pn3n3_maAzzcg_ziaIeryDB1bf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    Asset - financing lease</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">680</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">729</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_i01I_pn3n3_maAzzcg_zHDIX5ElLIL3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_pn3n3_maAzzcg_zAfobpIi7Z2l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    intangible assets - net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,355</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,432</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherAssets_i01I_pn3n3_maAzzcg_zyiL5f7XDMRe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">495</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">524</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Assets_i01TI_pn3n3_mtAzzcg_zG4EXwgKMoee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Assets</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201,556</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200,582</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.2in; text-indent: -4.5pt"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September 30,</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June 30,</span></td></tr>
<tr style="vertical-align: bottom">
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td>
<td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023*</span></td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current Liabilities:</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtCurrent_i01I_pn3n3_maLCz94A_zXkpKPnGDXze" style="vertical-align: bottom; background-color: White">
<td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current portion of long-term debt</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--AccountsPayableCurrent_i01I_pn3n3_maLCz94A_zjgGI2xbJwci" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts payable</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,040</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,579</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_i01I_pn3n3_maLCz94A_zUgHG99yoOqa" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other current liabilities</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,984</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,444</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--DeferredRevenueCurrent_i01I_pn3n3_maLCz94A_zhTAFqMZPsm9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned revenue on service contracts</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,944</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,832</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--UnearnedRevenueOnServiceContractsRelatedParty_i01I_pn3n3_maLCz94A_zeemcgVSDLLe" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned revenue on service contracts &#8211; related party</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParty" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0131">&#8212;</span>&#160;&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pn3n3_maLCz94A_zfBs7QPZJFT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating lease liability - current portion</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,295</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,905</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_pn3n3_maLCz94A_zJGKhO4JbvAj" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing lease liability - current portion</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">219</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_ecustom--CustomerDeposits_i01I_pn3n3_maLCz94A_zKlFMi2WmCck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer deposits</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">623</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">602</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i01TI_pn3n3_mtLCz94A_maLzI5x_zo84c2K62obe" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total Current Liabilities</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,232</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,624</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesNoncurrentAbstract_iB" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Term Liabilities:</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredRevenueNoncurrent_i01I_pn3n3_maLNzlqN_zYwHuuqOGOd6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned revenue on service contracts</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">562</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">760</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_pn3n3_maLNzlqN_zD7H8zkBJpS9" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred income tax liability</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--AccountsPayableRelatedPartyNoncurrent_i01I_pn3n3_maLNzlqN_z01QFz0wFnkg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Due to related medical practices</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pn3n3_maLNzlqN_zr0a8pzUeu88" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating <span style="font-variant: normal">lease liability &#8211; net of current portion</span></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,503</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,105</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_pn3n3_maLNzlqN_z5IVomXVxnFj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing lease liability &#8211; net of current portion</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">565</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">620</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtNoncurrent_i01I_pn3n3_maLNzlqN_znFIY3zbuVQh" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term debt, less current portion</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OtherLiabilities_i01I_pn3n3_maLNzlqN_zEDCEuAUPPui" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -9pt; padding-left: 17.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other liabilities</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--LiabilitiesNoncurrent_i01TI_pn3n3_mtLNzlqN_maLzI5x_zLzEu5c9CGi5" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total Long-Term Liabilities</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,251</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,130</ix:nonFraction></span></td>
<td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--Liabilities_i01TI_pn3n3_mtLzI5x_maLASEzvU8_zPMgUN60fO8c" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total Liabilities</span></td>
<td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,483</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,754</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY (Continued)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">STOCKHOLDERS'
    EQUITY:</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2023 *</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A non-voting preferred stock $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20230930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zZbrHT1oh332" title="Preferred stock, par value"><span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z3IP6ZputXv9" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zPJ8NfeOEMA8" title="Preferred stock, shares authorized"><span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zDrSqj1uy1Bg" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">453</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2023 and June 30, 2023, <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z3G7opEv7gvh" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zd0JDGu53fhj" title="Preferred stock, shares outstanding"><span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z2pxcIcVBMta" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zGR5SdDTSfkb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding
    at September 30, 2023 and June 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PreferredStockValue_iI_pn3n3_maSEzHmb_c20230930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zfA81kfxXL12" title="Preferred stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0191">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PreferredStockValue_iI_pn3n3_maSEzHmb_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zI7QJKwMYtg8" title="Preferred stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0193">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Preferred
    stock $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zy4I4x9f5All" title="Preferred stock, par value"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zK7sSWJ8IeFa" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zZl3FkkqbBr8" title="Preferred stock, shares authorized"><span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zfn66KeRds1l" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2023 and June 30, 2023, issued and outstanding &#8211; <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z9foFo7Xt8Ya" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zFQNfSaPcnhk" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zGaPuCKkCTah" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zbDHavfwVLnj" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--PreferredStockValue_iI_pn3n3_maSEzHmb_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zb2H9GoIyjre" title="Preferred stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0211">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--PreferredStockValue_iI_pn3n3_maSEzHmb_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zB3WrHT2tvI1" title="Preferred stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0213">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgbr5oojFTyj" title="Common stock, par value"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zjumYuz8RkV3" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zUynJnUegcQ6" title="Common stock, shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0PJ2hO3AHv" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,500</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2023 and June 30, 2023, <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrm1OwIBCjXf" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,506</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYqsbeXQ5IR4" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,462</ix:nonFraction></span> issued at September 30,
    2023 and June 30, 2023, respectively, <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zN9Iyy8bQI15" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,451</ix:nonFraction></span> and <span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8NdvD37TkD6" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,451</ix:nonFraction></span> outstanding at September 30, 2023 and June 30, 2023 respectively</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--CommonStockValue_iI_pn3n3_maSEzHmb_c20230930__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zaZmRTiOsfh2" title="Common stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30_custom_CommonStocksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--CommonStockValue_iI_pn3n3_maSEzHmb_c20230630__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zdv3sKLLk3si" title="Common stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_custom_CommonStocksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B Common Stock (10 votes per share) $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z0cOlBpjEEei" title="Common stock, par value"><span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zFeIqxxg9217" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjUTUXfxpS27" title="Common stock, shares authorized"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zf5Wd7pw4ACj" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">227</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2023 and June 30, 2023; .<span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pp0p0_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zaHzXDvwGBUk" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zoNrWH8t1zFg" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pp0p0_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zIrXuQbkBgnk" title="Common stock, shares outstanding"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjSaWAeDRy31" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued
    and outstanding at September 30, 2023 and June 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--CommonStockValue_iI_pn3n3_maSEzHmb_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9syeaOSRkr9" title="Common stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0251">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--CommonStockValue_iI_pn3n3_maSEzHmb_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwjWQnY3Mtsa" title="Common stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0253">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock (25 votes per share) $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zDVTaXFaJ3d4" title="Common stock, par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7ObFf0Q2hie" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEqkLjXMc9Sc" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxlcjMKxpF2d" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2023 and June 30, 2023, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUgks4R2Adw7" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znUcvhTrjmWc" title="Common stock, shares outstanding"><span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zSeERlZMG2Q6" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zx7TG0u8o97h" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and
    outstanding at September 30, 2023 and June 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--CommonStockValue_iI_pn3n3_maSEzHmb_c20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzmpx4Qr5vKc" title="Common stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0271">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--CommonStockValue_iI_pn3n3_maSEzHmb_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zq2cxKKkaCSf" title="Common stock value" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0273">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AdditionalPaidInCapital_iI_pn3n3_maSEzHmb_zbTo9zIhmI4j" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid-in
    capital in excess of par value</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,613</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,613</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_maSEzHmb_z2gzegWkY1Wh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    deficit</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,085</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,191</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--TreasuryStockValue_iNI_pn3n3_di_msSEzHmb_zXmbbX3rVLW" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    stock, at cost &#8211; <span id="xdx_90C_eus-gaap--TreasuryStockCommonShares_iI_pn3n3_c20230930_z5COxQ8PHIk8" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">55</ix:nonFraction></span> shares of common stock at September 30, 2023 and <span id="xdx_900_eus-gaap--TreasuryStockCommonShares_iI_pn3n3_c20230630_zzc8GfsiCju1" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">11</ix:nonFraction></span> shares of common stock at June 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,230</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">516</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_iTI_pn3n3_mtSEzHmb_maSEIPAzXM8_zhw9iR4tjY12" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Fonar Corporation&#8217;s Stockholders&#8217; Equity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">161,299</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157,907</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterest_iI_pn3n3_maSEIPAzXM8_zlUHVfogGPqd" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Noncontrolling
    interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,226</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,079</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iTI_pn3n3_mtSEIPAzXM8_maLASEzvU8_zxcxA9BZ5bf3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Stockholders' Equity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">154,073</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,828</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pn3n3_mtLASEzvU8_zr3XNzZAUQQe" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Liabilities and Stockholders' Equity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201,556</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200,582</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="IncomeStatement"></span>CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_pn3n3_zbCCGkTIKbL" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_495_20230701__20230930_zqwsGJfni0d1" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49B_20220701__20220930_zcm7TpvJ8bMb" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FOR
    THE THREE MONTHS ENDED SEPTEMBER 30,</span></td></tr>
  <tr id="xdx_40F_eus-gaap--RevenuesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">REVENUES</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_400_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_pn3n3_maRzL5a_zvV7kctGBIhf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,676</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,076</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ProductSalesNet_i01_pn3n3_maRzL5a_zUNz530VsZqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Product
    sales &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--ServiceAndRepairFeesNet_i01_pn3n3_maRzL5a_ztz8g4pji3Bh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,864</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,820</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_pn3n3_maRzL5a_zoS0FKmv3e48" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
    and repair fees - related parties &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagementAndOtherFeesNet_i01_pn3n3_maRzL5a_z9pcox0emFz4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; net</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,119</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_pn3n3_maRzL5a_zpvsWaGO24Vg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees - related medical practices &#8211; net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--Revenues_iT_pn3n3_mtRzL5a_maILFCOzrhL_zqzs2fBCmatd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,838</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,191</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CostsAndExpensesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">COSTS
    AND EXPENSES</span></td><td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherCostOfOperatingRevenue_i01_pn3n3_maCAEzUHe_z9kSIyOB7JEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to patient fee revenue</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,427</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--CostsRelatedToProductSales_i01_pn3n3_maCAEzUHe_zjuZl4boyVNc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to product sales</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--CostsRelatedToServiceAndRepairFees_i01_pn3n3_maCAEzUHe_z2oUxrJENgXh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">848</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">718</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_pn3n3_maCAEzUHe_zWqP81vMyFYe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees - related parties</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--CostsRelatedToManagementAndOtherFees_i01_pn3n3_maCAEzUHe_z5EnxLvHPFB4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,024</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,501</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_pn3n3_maCAEzUHe_zsK58o9YhDC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees &#8211; related medical practices</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,519</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,398</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_i01_pn3n3_maCAEzUHe_zQkhPLG6j9rk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
    and development</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">349</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_pn3n3_maCAEzUHe_zKADpsASYTx6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Selling,
    general and administrative</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,866</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,334</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CostsAndExpenses_i01T_pn3n3_mtCAEzUHe_msILFCOzrhL_z7dYqD5npHVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,267</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,280</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_pn3n3_mtILFCOzrhL_maILFCOzbHM_zjOncBHtQCe8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    From Operations</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,571</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,911</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--OtherNonoperatingIncomeExpense_maILFCOzbHM_z5FrsREKt4Z5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Income</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#8212;</span>&#160;&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InterestExpense_iN_pn3n3_di_msILFCOzbHM_zHczHB8KXo1f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    Expense</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--InvestmentIncomeNet_maILFCOzbHM_zQnt77z2HPI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Investment
    Income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">507</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzbHM_maPLzTAe_zLUDgfhT4Ttj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    Before Provision for Income Taxes and Noncontrolling Interests</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,030</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,059</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iN_pn3n3_di_msPLzTAe_z1ROcHXxLu98" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    for Income Taxes</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,670</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,409</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--ProfitLoss_iT_pn3n3_mtPLzTAe_maNILznER_zaK7s5ViJR8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,360</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,650</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msNILznER_zv3H3cP4Imod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income - Noncontrolling Interests</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,254</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_iT_mtNILznER_zyo5yemVkfNk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,106</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--NetIncomeLoss_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zYPsoM1EgVHd"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,855</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zCeG6fMgxdDj"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,923</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--SupplementalIncomeStatementElementsAbstract_iB_zgjMmkMYhHK8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 18.4pt"><b style="display: none">Supplemental Income Statement Elements</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_eus-gaap--NetIncomeLoss_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zJ2lDi71ztwl"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_ClassANonVotingPreferredStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">187</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zyIorpcxkkI4"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_custom_ClassANonVotingPreferredStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class C Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--NetIncomeLoss_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zvXNI2Ql0sz3"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLvM23tpUbxj"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_ztLipbH1Zhje" title="Basic Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.60</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zsWVduEnWgRl" title="Basic Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zBQwU1AEhi2j" title="Diluted Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.59</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zPdFa2WxiUm" title="Diluted Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    and Diluted Income Per Share &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zZwB0Kdalum6" title="Basic Net Income Per Common Share Available to Common Stockholders"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zF27rsDQ3xHi" title="Diluted Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.17</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKwWH0R8Znp5" title="Basic Net Income Per Common Share Available to Common Stockholders"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPShELpgmari" title="Diluted Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z74hYAFXSP21"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,408</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zjRVJnR0tEsj"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Diluted Shares Outstanding - Common Stockholders</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z3vkQ8xM3qfe" title="Weighted Average Diluted Shares Outstanding - Common Stockholders"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,536</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z0VoUoxiIKwk" title="Weighted Average Diluted Shares Outstanding - Common Stockholders"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,673</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic and Diluted Shares Outstanding &#8211; Class C Common</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zngdH3l39gId" title="Weighted Average Basic Shares Outstanding"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zGTLOpwU6ND5" title="Weighted Average Diluted Shares Outstanding - Common Stockholders"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zjQM1psS3tBk" title="Weighted Average Basic Shares Outstanding"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKmhysp0qwwe" title="Weighted Average Diluted Shares Outstanding - Common Stockholders"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;</span></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br />
FONAR CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="ChangesInEquity"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the Three Months Ending September 30, 2023</span></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_114_pn3n3_zr8z9V383k9k" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td title="Net income" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zftMfNcmnMG5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zDulO4VoIKWd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zDqRos59TKc7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_zgmiTWV7M6rc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zDk6IqM2cQE6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B2_z6JlUHIQXnEf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid
    in capital in excess of par value</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non
    Controlling Interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr id="xdx_43D_c20230701__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zAoybuAJIPXj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; padding-left: 0.05in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; June 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember1033083781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,613</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,191</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">516</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,079</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,828</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zv9VIFHBnWE6" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0427">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,106</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0430">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0431">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,106</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_z8Gb3i5ocu37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of Treasury stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0434">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0435">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0436">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">714</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0438">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">714</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zsN4l1dGrXm5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    - Non controlling</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0441">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0443">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0444">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,401</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,401</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zeO7DfnTF9u3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.05in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    - Non controlling interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0449">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0451">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,254</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,254</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_436_c20230701__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zw5TiEyssp9j" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; padding-left: 0.05in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; September 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember1033083828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,613</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,085</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,230</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,226</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">154,073</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the Three Months Ending September 30, 2022</span></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid
    in capital in excess of par value</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non
    Controlling Interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr id="xdx_43E_c20220701__20220930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zUJwmKy0plEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    - June 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,567</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,054</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146,236</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zKE18J9EKMfe" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0472">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zySORSmAPi57" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of Treasury Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0478">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zMCWtwFENN42" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    - Non controlling</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0483">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0485">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0486">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,634</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,634</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zBBZCW3sQYUa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    - Non controlling interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0492">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0493">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20220701__20220930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zYzP05fqdqa9" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; September 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,520</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">797</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,085</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,130</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="CashFlow"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_112_pn3n3_zBU8UCBx7LJ8" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 26.1pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20230701__20230930_zHzJ0Xp2Io2b" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20220701__20220930_zqQVWwRtFCV4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FOR
    THE THREE MONTHS <br />ENDED SEPTEMBER 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -22.5pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    Flows from Operating Activities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_maNCPBUzyBN_zjKhgprrhFBk" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Net
    income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,360</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,650</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Adjustments
    to reconcile net income to net cash provided by operating activities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherDepreciationAndAmortization_i01_pn3n3_maNCPBUzyBN_zGXqCC2mCsxh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,195</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_pn3n3_maNCPBUzyBN_zeIjbRoSrJnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
    of right-of-use assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,024</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,061</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProvisionForBadDebts_i01_pn3n3_maNCPBUzyBN_zLC7Hvmmaisa" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Recovery)
    Provision for bad debts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">68</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,398</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_pn3n3_maNCPBUzyBN_zmn7WoEbzJmc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,242</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,146</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Increase)
    decrease in operating assets, net:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_pn3n3_di_msNCPBUzyBN_zEB9k0oS3NR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts,
    medical and management fee receivable(s)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,837</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,407</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--IncreaseDecreaseInNotesReceivable_i01_pn3n3_maNCPBUzyBN_zW2hBYk0XXbf" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInInventories_i01N_pn3n3_di_msNCPBUzyBN_zp0CORMsE3Tj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">255</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i01N_pn3n3_di_msNCPBUzyBN_zbU4rEAqmBJj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">293</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_pn3n3_di_msNCPBUzyBN_z4NQKQYSrSh7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0541">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -22.5pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Increase
    (decrease) in operating liabilities, net:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_pn3n3_maNCPBUzyBN_zl9khu0UCek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">539</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">779</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_pn3n3_maNCPBUzyBN_zHB7X0WE0Aif" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,463</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,580</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_ecustom--IncreaseDecreaseInOperatingLeaseLiabilities_i01_pn3n3_maNCPBUzyBN_z5o0CemqcV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,322</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">912</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_pn3n3_di_msNCPBUzyBN_zL0Mka7Gjljk" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInCustomerAdvance_i01_pn3n3_maNCPBUzyBN_zIV3HwAt6Mgh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_pn3n3_maNCPBUzyBN_z0Nb2SYFbfDa" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pn3n3_maCCERCzkWi_mtNCPBUzyBN_zMrFO5m5WoG" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -22.5pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    cash provided by operating activities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,618</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,697</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Cash
    Flows from Investing Activities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pn3n3_di_msNCPBUzwHm_zw2uaxbZryM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchases
    of property and equipment</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">939</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_pn3n3_di_msNCPBUzwHm_z0f1c4MQswXg" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cost
    of patents</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pn3n3_mtNCPBUzwHm_maCCERCzkWi_zEifQho4o9Mk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    cash used in investing activities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">79</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">963</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Cash
    Flows from Financing Activities:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RepaymentsOfNotesPayable_i01N_pn3n3_di_msNCPBUzwdX_zailJpMPkyBl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Repayment
    of borrowings and capital lease obligations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_i01N_pn3n3_di_msNCPBUzwdX_zYqGT84LDX07" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of treasury stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">714</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_pn3n3_di_msNCPBUzwdX_zJt5g6qpHWpf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,401</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,634</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pn3n3_mtNCPBUzwdX_maCCERCzkWi_zqRvrAF1g327" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 26.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    cash used in financing activities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,126</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,761</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_pn3n3_mtCCERCzkWi_z1Z1x1Y3o947" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Net
    Increase (Decrease) in Cash and Cash Equivalents</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">413</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">27</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9.9pt; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    and Cash Equivalents - Beginning of Period</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,280</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,723</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9.9pt; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    and Cash Equivalents - End of Period</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51,693</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,696</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="NotesToFinancialStatements"></span>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zLcZBGEk3M46" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
1 &#8211; <span id="xdx_82B_zylxQw7N43Vd">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_90B_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zpKfxXpuE70c" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span>% interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_901_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_z9lHTzIDwOI8" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span>% in HDM, and the original
investors in HDM retained a <span id="xdx_90F_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z4G1MlJ27d2e" title="The ownership interest of the original investors of HDM"><ix:nonFraction name="FONR:OwnershipInterestOfOriginalInvestorsOfHdm" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span>% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $<span id="xdx_903_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3n3_c20210701__20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zaFkCicpZPF4" title="Direct purchase of Noncontrolling Interests"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">546,000</ix:nonFraction></span>. Currently the Company has a direct ownership interest
of <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zIE7y2yZfyXf" title="Direct ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; have a <span id="xdx_900_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zyATQEzNmYEi" title="Investors ownership interest percentage"><ix:nonFraction name="FONR:InvestorsOwnershipInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2023, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2024. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2023 for the fiscal
year ended June 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. The Company must now take into account the severity, duration and recurrence
of new strains of the COVID-19 virus which adds a new dimension to the challenges and uncertainty facing our business and the world economy
in general. Although we are unable to predict if there will be additional consequences on our operations from the continuing global pandemic
of COVID-19, the Company believes with positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_231_zenOEISJmP4" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_zfnmNDJFI77" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zoYngIxee6kf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zQ7YTh6zbtJ3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zEvB658qCkU9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zzspqxrxJ8Ig" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zd94OfdwumUd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zI9YF1tjm3ug" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zmsT9kCVBQQc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z01UzdraZ3Ba" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zIMRMcyDwndc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_82B_z0Ur9KezDTSd">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zf8USUG2pr2i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_86B_zF4k5lZYbahl">Principles
of Consolidation</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zjFRWqaa4ppj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_862_ztp9bSST0AKg">Revenues</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zRu8GtWVUwmi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_864_zXRbla5Qq5p4">BUSINESS
COMBINATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_231_zvJNSWlQK2rb" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23A_z1mfYQ4Mbnsh" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zENv0HjHOpYh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zYuQqa37qiC9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zG332gzofJE3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zeeBVnZbfYUh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z61UAUlbeFPj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zWXJecMfF08f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zhzWPBcsZcpg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zpnrnwtUm6aj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zYQia1nWzBB" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zq4HuRIz7vxc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zrStdWNG0D9j" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zotopoVYLNgf">Earnings
Per Share</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2023 and 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2023 and 2022, diluted EPS for
common shareholders includes <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20230930_z0iGwqA2jRg2" title="Shares included upon conversion of Class C Common"><span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zJxPWRVB75Rf" title="Shares included upon conversion of Class C Common"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></ix:nonFraction></span></span> shares upon conversion of Class C Common.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br /> September 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br /> September 30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br /> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,106</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,855</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" title="Common Stock and Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,923</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,408</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,408</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.64</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.60</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.17</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.31</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:
    <br /> Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,408</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0701">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,536</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,673</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.59</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.17</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zBwEnJBHhAF1">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_236_zAXA2rjkBGMi" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_zvUgcWHoTXgj" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zSLKr9tLGk4i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zyNCwh0eDcg7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zhO0YsKDgU5l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zhRxAPrI28l1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zBVZyJkqGtMg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zTHRrCh0uxDe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z64DnIweKcnb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zcHKZJmwPd22" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_809_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z76b1jhlAlJh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; <span id="xdx_824_zx2kIfGqNB84">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at September 30, 2023, and June 30, 2023:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zWq5k09emNHc" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"><span id="xdx_8BE_z1y9InVJZbHi" style="display: none">Financing receivable noncurrent allowance for credit loss</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zFuUZjzFtPhl" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,291</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zNt4CVaWg8uc" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230930_zV0qVg2Q5OP7" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,092</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLJMgdSNYhQ5" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zDJnEYNqFq6k" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0741">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_pn3n3_c20230930_zwpZI3T8dKE9" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z5MRda6Hk1f4" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,924</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zP0Gg20G2nNl" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0747">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_pn3n3_c20230930_zn3Vo9lVCVqk" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,924</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zNDKUJgkeZfl" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,882</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zes9eJCCR1E" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,764</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930_zVTo0kSdD6d3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,118</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztkuFc3YR5I6" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,829</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zuZGc3LF5kWh" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,766</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930_zKfe0RZTt3Pg" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,063</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zfIh7ricclI6" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,060</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrJISdlL9DPk" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630_zQrzXF3FHBC3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,861</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--MedicalReceivable_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zVWjq2dHhyR3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,259</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--MedicalReceivable_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zUHpP8oSxGEa" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0771">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--MedicalReceivable_pn3n3_c20230630_z3W0m3yBcSL" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,259</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zD1yvS2JZcK1" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,497</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z0bNuUhF6M4g" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,609</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630_zhr3HcVHF1pf" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,888</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLw7TfaAm5yl" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,152</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zmjvqmqOy8fa" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,990</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630_zW0ICFokgpxd" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,162</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_z8ll0KVc0Rx3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_23D_zCPBRsgnjPl5" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_zMQaduFKkCik" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zx3UwHyYGnXb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zfzg21MmyKD" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zRV1YySate7d" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z0AYyn6MmHjg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zHTreOQOhedk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zAhIeYfKblDe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zx4i04YGUBB7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zDEMxjVNhY7l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zLXi9I95wK75" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zk0eCUYia2c2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
term accounts receivable balances at September 30, 2023 and June 30, 2023 amounted to approximately $<span id="xdx_90E_ecustom--AccountsReceivableNetLongTerm_iI_pn3n3_c20230930_zTIdAXXYEsa7" title="Accounts receivable - long term"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></span> and $<span id="xdx_90D_ecustom--AccountsReceivableNetLongTerm_iI_pn3n3_c20230630_z7Dt5zVHCTu5" title="Accounts receivable - long term"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">710</ix:nonFraction></span>, respectively. The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following two years as of September 30, 2023 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zq88Lpxv1I8h" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 30%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_8B8_zkBh6jN57Y09" style="display: none">Schedule of facilities owned or managed</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="width: 17%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 12%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230930_zQBvQXslH9Ll" title="2025" style="vertical-align: top; width: 25%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueOneToTwoYears" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">450</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230930_zUxelnUBC2W1" title="2026" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20230930_zROFV8ZVydvk" title="Total" style="border-bottom: Black 2.5pt double; vertical-align: top; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">562</ix:nonFraction></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zDv3uF5HYa87" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Receivables</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third-party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230701__20230930_zVDje3lOgAP9" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.8</ix:nonFraction></span>%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20220930_zBZQfnw072wc" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.0</ix:nonFraction></span>% of the PCs&#8217; net revenues for the three months ended September 30, 2023 and 2022, respectively, were derived from no-fault
and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance
for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with
the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230701__20230930_zq6fKDG6c1ec" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.6</ix:nonFraction></span>% and <span id="xdx_907_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20220930_zqBgOeai7T1e" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.9</ix:nonFraction></span>% of the consolidated net
revenues for the three months ended September 30, 2023 and 2022, respectively.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_239_zd6HygFUHdFa" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zP6O5j6OTxKj" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zUkcZwstEmag" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z52pTjBpZaRl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zTh5Z1UO42g3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zwuRReFPQZz" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zJs0Q6y4QDQ3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zZnxN7xrPtRe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zXvCOIc0uS25" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zQVMxu1twqti" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_z4VUw5AwDCXi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zDBGsmz6zij7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zA6ytODr2ple" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zA30mVbxrX03" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, Inc., Stand Up MRI of Boca Raton, Inc., and Stand Up MRI &amp; Diagnostic Center, Inc. (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2023 and 2022
are summarized in the following table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="FONR:ScheduleOfPatientFeeRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_zxVyQdCFSCBa" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BE_zJenYjEJlLPa" style="display: none">Schedule of patient fee revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Three Months Ended <br />September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 67%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zYeGyRqOocj7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-07-012023-09-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,173</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zgURSWDMaDFl" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">911</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zBYKRJlFSg2e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-07-012023-09-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zoWD1QQb7Bga" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zAn1jjs8Ebh2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-07-012023-09-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,138</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zpPXMG2Mnv1b" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,235</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z3iwOoMfpTC6" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-07-012023-09-30_custom_OtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,094</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z0fPfWvpZmTj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_OtherMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">692</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930_za6njTiOltb5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,676</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930_zikFvFnPoQ07" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,076</ix:nonFraction></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_z4fnd87NzEkl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_804_eus-gaap--LesseeOperatingLeasesTextBlock_zuqeqDXcJ7q1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; <span id="xdx_824_zcZbW4D6Jmwj">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, &#8220;Leases&#8221; (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date, and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: -9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (ASC) 842 &#8211;
&#8220;Leases,&#8221; as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_239_zI4bVsedVlE8" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23E_zYZ0Db1XdVyd" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zwVFBxo1TbYb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zkswNyukuYh4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zD1JP8oP3636" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z95UAFaWXdv3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zO7pjUPKn1Yh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zjeLtidpiV0j" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zaIbUmBI8p8l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zSJUYH9e3D6g" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zr1jsnSMa5pe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; OPERATING &amp; FINANCING LEASES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z7QqeBxgxRp1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2023 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zJtpM52l2JI5" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_8B9_zI7SinKVL1D3" style="display: none">Lessee operating leases liability maturity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Twelve
                                            Months Ending<span style="font-variant: normal">&#160;<br />September 30,</span></span></p></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
                                            Lease<span style="font-variant: normal">&#160;<br />Payments</span></span></p></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
                                            Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payments</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 38%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBsqOcqp9ayk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,009</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zSBOfBlekqQ8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zk9MaZaYLVd9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,768</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTqB86RbVXl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zJ0BR2KdKIgj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,320</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlDKhUCwXbZ4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfLiGxKcAHg6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,865</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zq9FxaePDfKi" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zjOelamJoSKc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,526</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBmgPRARCHJe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfRrsrBua6H3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,471</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlo4KDWyauAe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--PresentValueDiscount_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zUYfxOlSm8Dh" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,161</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zjPsvMQdJS28" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">50</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zhs4OGrg9VGg" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,798</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FinanceLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zQqljvyyjNze" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiability" contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">784</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zpnXhbCxq30b" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
5 - <span id="xdx_82F_zUouiDw6VBu8">INVENTORIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zElUGVYXOTee" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8BA_zAgah6TZlXw5" style="display: none">Schedule of inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_498_20230930_zk2cYdJ9i9n5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_499_20230630_zDwr2Agh67Rj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br />2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br />2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zpdRKa70pRvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,346</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_z14ihIR1LQz4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">293</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">224</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_mtIFGAWzdt0_zVgkMzY2k4l6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,824</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,570</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zqYp6X1Avn79" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_82C_zbba5GkoqrTl">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zFOiTzJPcLF5" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8BE_z87CRPHw7aga" style="display: none">Schedule of other intangible assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br />2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br />2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,468</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,452</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-compete</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930_pn3n3" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,523</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630_zYISEkB4ydgf" title="Gross other intangible assets" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,507</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230930_pn3n3" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,168</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630_z7UXWt5IJTH3" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,075</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230930_pn3n3" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,355</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20230630_zoNV9uoHDR95" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,432</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_232_zHb7M98EZYr6" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23C_z75MExtmKsbi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zOqquOQrd3Y8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z6Xje9tuYzpk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zovMjIw8cd5d" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zjQaKSjxZLk8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zCtGsiMrpc5e" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zsbSdst0qzC2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zz0SktU0DgU3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zuG2oUBhHfr3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z84jNkcw6gti" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; OTHER INTANGIBLE ASSETS (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zigaXT19akj6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended September 30, 2023 and 2022 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012023-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_z7ADYezpgPo3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended September 30, 2023 and 2022 amounted to $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012023-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsBMcHYK45Oa" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_809_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z7X5ojiVoag1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; <span id="xdx_82C_zWsjdpbUbFqd">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zAF61ffQMGIc" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span id="xdx_8BF_zOwmCgSmkskk" style="display: none">Schedule of other current liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_495_20230930_zLsxxZM3Espa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_490_20230630_zCZd4nMJg6ri" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br />2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br />2023</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zwUd3VTiwrlk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,827</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,413</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_z2m3DlJiBVGb" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">193</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzdop_z0ZU62Qz69Ej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0944">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzdop_zNqgGXEPBiva" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzdop_z5jN17Rzvpc1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzdop_zU755oafvnpl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">176</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzdop_zDMp3n3Elbag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_z36j2r9xAkb5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    general and administrative expenses</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">694</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">574</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zZ4FA4ElM3t" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,984</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,444</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zPzG0VQHf7W3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_822_z7fw4MW3tzOf">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2023. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_230_zEpOAYHfbq6a" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zcS0ZW8yoboi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zwIhR88xBVuf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zQ1JDRIef5y2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z6CtJ8ojOHSd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zNAPhtxfDjNd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zFvmWart5uwj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zp3ccq18xcih" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zYYsY8Q0Y9n5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zVm3S1tL1oO8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zRkwCCYVMREe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - SEGMENT AND RELATED INFORMATION (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zjfSehXUwSMf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zZIG65ctMVI3" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zEhaEFWdpf75" style="display: none">Schedule
    of summarized segment financial information</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    <br /> Equipment</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    <br /> of Diagnostic <br /> Imaging <br /> Centers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 55%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHJJUM3abEY5" title="Net revenues from external customers" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,056</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpNMaRqUO2uh" title="Net revenues from external customers" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,782</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20230930_zSYOLDvCoXP" title="Net revenues from external customers" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,838</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zQ2f6WTnmENj" title="Inter-segment net revenues" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyb499xmpPJ3" title="Inter-segment net revenues" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0987">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930_z4kbCKcoIzh8" title="Inter-segment net revenues" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zV7AeR6lAC77" title="(Loss) Income from operations" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">738</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zcJauCxccFab" title="(Loss) Income from operations" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,309</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930_zLyvhvaBxAFd" title="(Loss) Income from operations" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,571</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zzXioLSXFVQ6" title="Depreciation and amortization" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">61</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPJOLg1o3BNb" title="Depreciation and amortization" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,134</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930_z3YkNiVMql26" title="Depreciation and amortization" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,195</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_z6NPxTdabOi5" title="Capital expenditures" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrWJgRRPSpo4" title="Capital expenditures" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930_zEamsH9Hkezl" title="Capital expenditures" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Total Revenues - Net" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zRjbxIAP9QTj" title="Net revenues from external customers" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,878</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zfc8GkVvSDF8" title="Net revenues from external customers" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,313</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20220701__20220930_zALiXFlYl3R2" title="Net revenues from external customers" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,191</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_ziN2lGCyRkge" title="Inter-segment net revenues" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zBbNgJRrkSyd" title="Inter-segment net revenues" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1017">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930_zMnJn1rIrynj" title="Inter-segment net revenues" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zJsyqubEYeT4" title="(Loss) Income from operations" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">802</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zsD8es7WMqYa" title="(Loss) Income from operations" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,713</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930_ztYbWRPzu2V8" title="(Loss) Income from operations" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,911</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zxDdIdvRDVA3" title="Depreciation and amortization" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zVv2Q9YVWwX3" title="Depreciation and amortization" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,046</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930_z8hX23re9786" title="Depreciation and amortization" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHB8D3KsxTCj" title="Capital expenditures" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zeWHM6Zkznl4" title="Capital expenditures" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">939</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930_zwg5Y5HbKbHd" title="Capital expenditures" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">963</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_809_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zscdwkucfBW8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_82A_zJacSpFcxF8e">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2023 and September 30, 2022, the Company paid $<span id="xdx_90A_eus-gaap--InterestPaidNet_pn3n3_c20230701__20230930_zN5BgU8b4D0d" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--InterestPaidNet_pn3n3_c20220701__20220930_z6wr6sgGQz14" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span> for interest, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2023 and September 30, 2022, the Company paid $<span id="xdx_90B_eus-gaap--IncomeTaxesPaid_pn3n3_c20230701__20230930_z4vrgJW1fUlj" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_pn3n3_c20220701__20220930_zlotCbguAbs6" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span> for income taxes, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zg3BCHiCbgUh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; <span id="xdx_822_zlNQqUvQAwj5">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_23F_zkx4r0OM0vnc" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23A_z7qd0XcB2LN2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_ztTUN21ODni2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zjxsAHx9rLsb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zhTrwQ02Vjg1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zCleZmzsIEKc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z5mDuXNMFF7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zyla7UFftS25" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zIvyQeH7rpRh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zjiqrNYKnFfk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; COMMITMENTS AND CONTINGENCIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zoWnQKtOFKa9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_906_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn6n6_c20220926_zvNvX6GYAOZ3" title="Stock purchase plan"><ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="AsOf2022-09-26" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">9</ix:nonFraction></span> million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the three months ended September 30, 2023 and
2022, the Company repurchased <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20230930_zBDlEazuNdHd" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">43</ix:nonFraction></span> and <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20220930_zyJqUgzP7RV7" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">9</ix:nonFraction></span> shares at a cost of $<span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230701__20230930_zZlklHRUa9Q6" title="Number of shares repurchased, value"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">714</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20220701__20220930_zhMehpQdQVBf" title="Number of shares repurchased, value"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_900_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pn3n3_c20230701__20230930_zR4zl0QyZvre" title="Liability for individual claims"><ix:nonFraction name="FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span> per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of September 30, 2023 and June 30, 2023, the Company had approximately $<span id="xdx_90A_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_iI_pn3n3_c20230930_z2HYkHqzGkEg" title="Reserve for self-funded"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">176</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_iI_pn3n3_c20230630_z675cYmLioef" title="Reserve for self-funded"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></span>, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the
condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zmIr6y0AlSi7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - <span id="xdx_827_zyet9be3q4K9">INCOME TAXES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740-270, &#8220;Income Taxes &#8211; Interim Reporting,&#8221; the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2023 and 2022, the Company recorded income tax expense of $<span id="xdx_90F_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20230701__20230930_zCAX1OUUoFGb" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,670</ix:nonFraction></span> in 2023 as compared
to $<span id="xdx_902_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20220701__20220930_zPLWglrOBq49" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,409</ix:nonFraction></span> in 2022. The 2023 provision is comprised of a current income tax component of $<span id="xdx_907_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_c20230701__20230930_zvgAdvdZjx8f" title="Income tax component - current"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">428</ix:nonFraction></span> and a deferred income tax component of $<span id="xdx_90E_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zag9knJmBkIg" title="Income tax component - deferred"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,242</ix:nonFraction></span>.
Obligations for any liability associated with the current income tax provision has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC Topic 740. The Company believes there are no uncertain tax positions in prior year tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_23E_z70j1eAQesed" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_233_zwBHbQogT0F7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zT0ihKu54cd3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zRFmYGB7S7kf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zoekY9HAqK6g" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zPHqIvRAmKo" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zLfYPxQsgFy7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zLCGRJOJqSg7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zNusqAa62xxl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zS9RyH28yUKe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zbk5OQt9YkTd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zPInA4wj1W4f" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC Topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2018.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company recorded a deferred tax asset of $<span id="xdx_902_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20230930_zEF2FWUVPxX8" title="Deferred tax asset"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,800</ix:nonFraction></span>
and a deferred tax liability of $<span id="xdx_906_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20230930_ze3Cp7syDcac" title="Deferred tax liability"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span>
as of September 30, 2023, primarily relating to Federal operating loss carryforwards, allowance for doubtful accounts and tax
credits. There is approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230930_zG6dbdffUY3b" title="Federal operating loss carryforwards"><span id="xdx_905_ecustom--FederalOperatingLosses_pn3n3_c20230701__20230930_zV95le90BkTl" title="Federal operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="FONR:FederalOperatingLosses" contextRef="From2023-07-01to2023-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,198</ix:nonFraction></ix:nonFraction></span></span>
of Federal operating losses available to offset future taxable income through 2031. The net operating losses begin to expire in 2028
for federal tax and state income tax purposes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September, 2023, no such changes in ownership have occurred.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share
repurchases that occur after December 31, 2022 and introduces a 15% corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company is expecting
the IRA not to have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-07-01to2023-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zTwiyT02uMoe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 &#8211; <span id="xdx_821_zl0CPIjTreQc">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to September 30, 2023 and through the date the condensed consolidated financial
statements were issued.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of October 31, 2023, the Company repurchased </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20231031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHkHVWivZNzj" title="Stock repurchase plan, shares"><ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" contextRef="AsOf2023-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">33</ix:nonFraction></span>
shares of common stock at a cost of $<span id="xdx_90A_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20231031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTBvDEoxzEQb" title="Stock repurchase plan"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2023-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">471</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which
was authorized under the stock repurchase plan adopted in September 2022.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_812_zHPIfqDGG1Dg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="MDA"></span>Item
2. &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited
condensed financial statements and notes thereto included in Part I, item 1 of the Quarterly Report on Form 10-Q and with our audited
consolidated financial statements and notes thereto for the year ended June 30, 2023 included in our Annual Report on Form 10-K for the
fiscal year ended June 30, 2023 filed with the U.S. Securities and Exchange Commission (SEC) on September 28, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the three month period ended September 30, 2023, we reported a net income of $5.4 million on revenues of $25.8 million as compared to
net income of $2.7 million on revenues of $23.2 million for the three month period ended September 30, 2022. Operating income increased
from $3.9 million for the three month period ended September 30, 2022 to $6.6 million for the three month period ended September 30,
2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
revenue increase, from $23.2 million for the first three months of fiscal 2023 to $25.8 million for the first three months of fiscal
2024, was primarily due to increases in patient fee revenue of $2.6 million, from $6.1 million for the first three months of fiscal 2023
to $8.7 million for the first three months of fiscal 2024. Revenues from product sales and service and repair fees increased by 9.5%
from $1.9 million for the first three months of fiscal 2023 to $2.1 million for the first three months of fiscal 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">While
our revenues increased, our costs and expenses remained constant resulting in our operating income increasing to $6.6 million for the
three months ended September 30, 2023 as compared to $3.9 million for the three months ended September 30, 2022. In terms of percentages,
costs and expenses remained constant at $19.3 million for the first three months of fiscal 2023 and for the first three months of fiscal
2024, while revenues increased 11.4%, from $23.2 million for the first three months of fiscal 2023 to $25.8 million for the first three
months of fiscal 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fonar&#8217;s
wholly owned subsidiary, Health Management Corporation of America (&#8220;HMCA&#8221;), has the controlling interest in Health Diagnostics
Management, LLC (&#8220;HDM&#8221;). HMCA presently has a direct ownership interest of 70.8% in HDM, and the investors in HDM have a
29.2% ownership interest. The management of the diagnostic imaging centers business segment is being conducted by HDM, operating under
the name &#8220;Health Management Company of America&#8221;. For the sake of simplicity, HMCA, and HDM are referred to as &#8220;HMCA&#8221;,
unless otherwise indicated.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
most significant adverse impact on our Company in fiscal 2023 and the first quarter of fiscal 2024 has been the lingering COVID-19 pandemic.
Although it had seemed the worst had passed, subsequent events have shown a spike in new cases and the emergence of new strains of the
virus. This is by no means a problem confined to our Company, but despite our best efforts and improved ability to cope with the pandemic
and the availability of new vaccines, the impact on our results of operations and financial condition is potentially volatile and severe.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
have adversely affected our workforce, liquidity, financial condition, revenues, profitability and business operations The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. Although we are unable to predict if there will be additional consequences
on our operations from the continuing global pandemic of COVID-19, the Company believes with its positive cash flows, low debt and cash
on hand, it will be able to continue operations going forward.&#160;</span></p>


<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the first quarter of fiscal 2024, the aggregate number of scans performed by the sites we manage or own increased to 50,744 scans from
44,471 scans in the first quarter of fiscal 2023. This increase was due to the opening of new stand-alone facility in Florida along with
our return to a full operating schedule after addressing our technologist staffing shortfall.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Forward
Looking Statements</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Certain
statements made in this Quarterly Report on Form 10-Q are &#34;forward-looking statements&#34; (within the meaning of the Private Securities
Litigation Reform Act of 1995) regarding the plans and objectives of Management for future operations. Such statements involve known
and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements
included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based,
in part, on assumptions involving the expansion of business. Assumptions relating to the foregoing involve judgments with respect to,
among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible
to predict accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking
statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this Report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking
statement included herein, the inclusion of such information should not be regarded as a representation by us or any other person that
our objectives and plans will be achieved.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Results
of Operations</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
operate in two industry segments: the manufacture and servicing of medical (MRI) equipment, which is conducted by Fonar, and diagnostic
facilities management services, which is conducted through HMCA.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
and Service of MRI Equipment</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues
from MRI product sales increased to $164,000 for the first three months of fiscal 2024 from $30,000 for the first three months of fiscal
2023. Costs related to product sales decreased from $169,000 for the three month period ended September 30, 2022 to $103,000 for the
three month period ended September 30, 2023. Economic uncertainty and lower reimbursement rates for MRI scans, have depressed the market
for our MRI scanner products, notwithstanding our scanners&#8217; unique technological capabilities (e.g. multi positional scanning).
Due to the low sales volumes of our MRI product, period to period comparisons are not necessarily indicative of any trends.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
revenues increased to $1.9 million for the three month period ended September 30, 2023 as compared to $1.8 million for the three month
period ended September 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
relating to providing service were $729,000 in the first three months of fiscal 2023 and $861,000 in the first three months of fiscal
2024. Because of our ability to monitor the performance of customers&#8217; scanners from our facilities in Melville, New York on a daily
basis and to detect and repair any irregularities before more serious and costly problems develop, we have been able to contain our costs
of providing service.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
were approximately $138,000 in foreign revenues for the first three months of fiscal 2024 as compared to approximately $99,000 in foreign
revenues for the first three months of fiscal 2023, representing an increase in foreign revenues of 39.4%. We do not regard this as a
material trend, but as part of a normal although sometimes volatile variation resulting from low volumes of foreign sales.</span></p>


<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
recognize MRI scanner sales revenues on the &#8220;percentage of completion&#8221; basis, which means the revenues are recognized as
the scanner is manufactured. Revenues recognized in a particular quarter do not necessarily reflect new orders or progress payments made
by customers in that quarter. We build the scanner as the customer meets certain benchmarks in site preparation and our installation
of the scanner, in order to minimize the time lag between incurring costs of manufacturing and our receipt of the cash progress payments
from the customer which are due upon delivery. Consequently, there can be a disparity between the revenues recognized in a fiscal period
and the number of product sales. Generally, the revenues from a scanner sale are recognized in a fiscal quarter or quarters following
the quarter in which the sale was made.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues
for the medical equipment segment increased to $2.1 million for the first three months of fiscal 2024 from $1.9 million for the first
three months of fiscal 2023. Operating losses for our medical equipment segment decreased to an operating loss of $738,000, for the first
three months of fiscal 2024 as compared to an operating loss of $802,000 for the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
Facilities Management Services</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
revenues increased in the first three months of fiscal 2024 by 11.6% to $23.8 million from $21.3 million for the first three months
of fiscal 2023. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage
of our total revenues increased slightly to 92.0% for the first three months of fiscal
2024, from 91.9% for the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
current strategy is to counter the effects of lower reimbursement rates by increasing the scan volume of the facilities it owns or manages
by adding additional scanners at current centers and increasing our marketing efforts. As a result of the COVID-19 virus, however, the
Company had seen decreases in its scan volume. Nevertheless, the Company continued its program of adding additional scanners and due
to this the scan volume increased in the first quarter of 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
number of scans performed at our centers and at our clients&#8217; centers has recovered to pre-COVID-19 levels and has increased from
approximately 44,000 in the first three months of fiscal 2023 to approximately 51,000 in the first three months of fiscal 2024. The increase
in scans was due to the addition of two new stand-alone facilities which opened in Florida and another one in New York</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
now manage or own a total of 42 MRI scanners. Twenty-five (25) MRI scanners are located in New York and seventeen (17) are located in
Florida. HMCA experienced an operating income of $7.3 million for the first three months of fiscal 2024 compared to operating income
of $4.7 million for the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ability of HMCA to maintain its profitability is principally due to HMCA&#8217;s success in marketing the scanning services of the facilities
managed or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government.
The reductions in reimbursement rates are not unique to HMCA or HMCA&#8217;s clients but are being experienced by the industry in general.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
cost of revenues for the first three months of fiscal 2024 increased to $12.9 million as compared to $11.7 million for the first
three months of fiscal 2023.</span></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the first three months of fiscal 2024, our consolidated net revenues increased by 11.4% to $25.8 million from $23.2 million for the
first three months of fiscal 2023, and total costs and expenses remained constant at $19.3 million for the first three months of
fiscal 2024 and for the first three months of fiscal 2023 respectively. As a result, our operating income increased to $6.6 million
in the first three months of fiscal 2024 as compared to $3.9 million in the first three months of fiscal 2023. A decrease in
selling, general and other administrative costs in particular resulted in costs and expenses remaining constant as
compared to the increase in net revenues.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Selling,
general and administrative expenses decreased to $4.9 million in the first three months of fiscal 2024 from $6.3 million in the first
three months of fiscal 2023. This decrease in selling, general and administrative expenses was due mainly to less reserves taken on management
fees. Some of these reserves had been taken in the ordinary course of business and some in connection with the impact of the COVID-19
virus.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development expenses increased by 33.8% to $467,000 for the first three months of fiscal 2024 from $349,000 for the first three months
of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
expense in the first three months of fiscal 2024 increased by 242.9% to $48,000 from $14,000 in the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
increased to $2.8 million at September 30, 2023 as compared to $2.6 million at June 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
management fee and medical receivables increased by 4.2% to $69.1 million at September 30, 2023 from $66.3 million at June 30, 2023 as
a result of slower collections and increased scan volume. The slower collections were primarily due to an increase in no-fault and workers&#8217;
compensation revenue, which typically takes longer to collect.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
results of operations for the first three months of fiscal 2024 reflect a increase in revenues from management, patient and other fees,
as compared to the first three months of fiscal 2023 ($23.8 million for the first three months of fiscal 2024 as compared to $21.3 million
for the first three months of fiscal 2023), and an increase in the MRI equipment segment revenues ($2.1 million for the first three months
of fiscal 2024 as compared to $1.9 million for the first three months of fiscal 2023). Revenues were 8.0% from the MRI equipment segment
and 92.0% from HMCA, for the first three months of fiscal 2024, as compared to 8.1% from the MRI equipment segment and 91.9% from HMCA
for the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
a result of the Patient Protection and Affordable Care Act (PPACA) we have experienced a reduction of reimbursement rates and less interest
in our MRI equipment. Any changes to the PPACA may result in further changes in the healthcare industry and our business.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements. Nevertheless,
factors beyond our control, such as the COVID-19 virus, the timing and rate of market growth, economic conditions, the availability of
credit and payor reimbursement rates, or unexpected expenditures and the timing of such expenditures, make it difficult to forecast future
operating results.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
mentioned, one of the effects of the PPACA on our business has been the reduction in Medicare reimbursement rates for MRI scans. This
also has resulted in a reduction in the reimbursement rates by commercial insurers and government programs which tie their reimbursement
rates to the Medicare rates. Nevertheless, the patient volume of the scanning centers we manage or own has enabled us to maintain healthy
operating results in spite of these challenges. We believe we are pursuing the correct policies to cope with these problems and to improve
the Company&#8217;s operating results.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
Upright&#174; MRI (also referred to as the Stand-Up&#174; MRI), together with our works-in-progress, are intended to significantly improve
our competitive position.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting,
reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in
some positions and not others. This enables surgical corrections that heretofore would not have been addressable for lack of visualizing
the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better treatment outcome for
his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built multi-position
adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the MRI technologist to
ask the patient to position himself/herself in the exact position that generates his/her pain so that images of the patient in the position
that explicitly generates the patient&#8217;s pain can be nailed down. Full-range-of-motion studies of the joints in virtually any direction
are possible, a particularly promising feature for sports injuries.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Liquidity
and Capital Resources</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents, and short term investments increased from $51.3 million at June 30, 2023 to $51.7 million at September 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
provided by operating activities for the first three months of fiscal 2024 was $2.6 million. Cash provided by operating activities was
attributable principally to net income of $5.4 million, depreciation and amortization of $1.2 million, amortization on right-to-use assets
of $1.0 million, and deferred income tax of $1.2 million, offset by an increase in accounts, management fee receivables and medical receivables
of $2.8 million, a decrease of operating lease liabilities of $1.3 million and a decrease in other current liabilities of $1.5 million.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
used in investing activities for the first three months of fiscal 2024 was $79,000. Cash used in investing activities during the first
three months of fiscal 2024 consisted of patent costs of $16,000 and the purchase of property and equipment of $63,000.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
used in financing activities for the first three months of fiscal 2024 was $2.1 million. The principal uses of cash in financing activities
during the first three months of fiscal 2024 were the repayment of principal on long-term debt and capital lease obligations of $11,000,
the purchase of treasury stock of $714,000 and distributions to non-controlling interests of $1.4 million.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
liabilities decreased by 4.6% to $47.5 million at September 30, 2023 from $49.8 million at June 30, 2023. &#8220;Other&#8221; current
liabilities decreased by 26.8% to $4.0 million at September 30, 2023 from $5.4 million at June 30, 2023. The current portion of our service
contract liabilities increased by 5.0% to $4.0 million at September 30, 2023 as compared to $3.8 million at June 30, 2023. Customer deposits
increased from $602,000 at June 30, 2023 to $623,000 at September 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of September 30, 2023, the total of $4.0 million in &#8220;other&#8221; current liabilities included accrued salaries and payroll taxes
of $2.8 million, sales taxes payable of $225,000 and other general and administrative expenses of 694,000.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
working capital increased to $114.9 million at September 30, 2023 from $110.0 million at June 30, 2023. This resulted from an increase
in current assets ($125.7 million at June 30, 2023 as compared to $129.1 million at September 30, 2023), and a decrease in current liabilities
from $15.6 million at June 30, 2023 to $14.2 million at September 30, 2023.</span></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry, and tax planning strategies in making this assessment. At the present, the Company
believes that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized.
In recognition of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, (principally
related to research and development tax credits and allowance for doubtful accounts). A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of any portion or all of the valuation allowance.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s effective income tax rate is based on expected income, statutory rates and tax planning opportunities available in the
various jurisdictions in which it operates. For interim financial reporting, the Company estimates the annual income tax rate based on
projected taxable income for the full year and records a quarterly income tax provision or benefit in accordance with the anticipated
annual rate. The Company refines the estimates of the year&#8217;s taxable income on a periodic basis as new information becomes available,
including actual year-to-date financial results. This continual estimation process often results in a change to the expected effective
income tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in
estimate occurs so that the year-to-date provision reflects the expected income tax rate. Significant judgment is required in determining
the effective tax rate and in evaluating tax positions.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fonar
is not committed to making any significant capital expenditures for the remainder of the 2024 fiscal year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Critical
to our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number of scans
performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers with enhanced
equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment and upgrades at
competitive prices.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
pursuit of those goals, Fonar has entered into an agreement with AIRS Medical to install its SwiftMR&#8482;
product on all Fonar Upright&#174; scanners operating at the facilities HMCA owns or manages. Fonar will also make the AIRS
SwiftMR&#8482; product available to the installed base of Fonar scanners operating in the United States. The AIRS SwiftMR&#8482;
product enhances image quality using AI-powered denoising and sharpening. Management believes this product will improve the
quality of the images produced by Fonar equipment, including the scanners operated by HMCA facilities.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
is seeking to promote wider market recognition of Fonar&#8217;s scanner products, and to increase demand for Upright&#174; scanning at
the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, the uncertainty resulting from the Patient
Protection and Affordable Care Act or its repeal or modification, and the impact of the COVID-19 virus on the economy in general, the
sale of medical equipment has and may continue to suffer.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company believes that its business plan has been responsible for its profitability in the past nine consecutive fiscal years and first
fiscal quarter of fiscal 2024, and that its capital resources will be adequate to support operations through at least November 14, 2024.
The future effects on our business of healthcare legislation, the 2.3% excise tax on sales of medical equipment, reimbursement rates,
public health conditions and the general economic and business climate are not known at the present time. Nevertheless, there is a possibility
of adverse consequences to our business operations from these causes. Although the Company cannot predict the full effect of COVID-19
for the first fiscal quarter or any later period, the Company believes that it has adequate revenues, cash reserves and other assets
that will enable it to continue to operate until at least November 14, 2024.</span></p>


<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Disclosures"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="ControlsAndProcedures"></span>Item
4. Controls and Procedures.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Disclosure
Controls and Procedures</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
carried out an evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, under the supervision and with the
participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design
and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act
of 1934, as amended (the &#8216;&#8216;Exchange Act&#8217;&#8217;). Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under
the Exchange Act is accumulated and communicated to the issuer&#8217;s management, including its principal executive and principal financial
officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based upon
our evaluation, our chief executive officer and chief financial officer have concluded that the Company&#8217;s disclosure controls and
procedures were effective as of September 30, 2023, in ensuring that material information that we are required to disclose in reports
that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the same time periods specified
in the Securities and Exchange Commission rules and forms.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Changes
in Internal Control over Financial Reporting</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
were no changes in our system of internal control over financial reporting during our most recently completed fiscal quarter that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
II &#8211; OTHER INFORMATION</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="LegalProceedings"></span>Item
    1 &#8211; Legal Proceedings:&#9;There were no material changes in litigation from that reported in our Form 10-K for the fiscal year
    ended June 30, 2023 and Form 10-Q for the fiscal quarter ended September 30, 2023. </span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="RiskFactors"></span>Item
1A &#8211; Risk Factors: An investment in the securities of the Company is subject to various risks, the most significant of which are
summarized below.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.
Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning center
clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government programs
and private insurance companies. To the extent possible, we counter these reductions by increasing scanning volume and controlling operating
expenses. Inflation in the cost of both materials and labor have limited our ability to control our costs, negatively impacting our ability
to maintain profitability in this business segment.</span></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.
Inflation and Increasing Interest Rates. Inflation has drastically increased our costs for both materials and labor. The Federal Reserve
has increased interest rates substantially in an attempt to control inflation, which in turn has increased the coast of capital. Diagnostic
imaging facilities require significant amounts of capital to operate, particularly in the context of opening new diagnostic imaging centers.
These increased costs make it more difficult to achieve organic growth and extend the time that a new center takes to achieve profitability.
Continued costs increases, coupled with reduced reimbursement rates may threaten the profitability of our current operations and cause
the cost of expansion to become prohibitively high.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.
Demand for MRI Scanners. The reduced reimbursement rates have a negative effect on our sales of MRI scanners. With lower revenue projections,
prospective customers would demand lower prices for scanners. Although the reduced reimbursements may not affect foreign demand, a lower
number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.
Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources, production
capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although Fonar
is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be convinced
that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective will be reached, particularly with
customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing
positions.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.
Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic
imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties
to the facilities we manage or own for the services we perform. If these physicians and other third parties were to reduce the number
of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net revenue and operating
margins.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.
Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations
is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic
imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting
has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed care
organizations in New York or Florida could have a negative impact on the utilization and pricing of services performed at the facilities
HMCA manages or owns to the extent these organizations exert control over patients&#8217; access to diagnostic imaging services, selections
of the provider of such services and reimbursement rates for those services.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7.
Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete
for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established
hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.&#160;</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8.
Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the number
of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will continue to increase
the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift
in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients may result
in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding
decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand for MRI scans as they
become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions
on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase
patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events could have a material
adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9.
Current and future changes in Florida Insurance Law. On March 24, 2023, Florida Governor Ron DeSantis signed into law House Bill 837.
Dubbed the Tort Reform Act, the bill makes sweeping changes to Florida&#8217;s negligence laws, including reducing the statute of limitations,
barring recovery for plaintiffs who are found to be 50% or greater at fault, and changing the rule of evidence regarding admissibility
of the costs of prior and future medical treatment. The bill is viewed as a boon to insurance companies, and is largely aimed at reducing
the cost of personal injury lawsuits to insurers operating in Florida&#8217;s motor vehicle and general liability markets. The full impact
of the bill remains to be seen. Certain provisions of the bill are expected to negatively impact our reimbursement percentage and/or
reimbursement rates. We expect that some percentage of our patients who are seeking treatment following motor vehicle accidents will
not meet the new 51% threshold, and as a result we expect an increase in the percentage of uncollectible billings from those patients.
We are unable to estimate what that percentage might be.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Further,
changes to the evidentiary admissibility rules may lead to a higher percentage of our billings being paid at commercial rates instead
of at the presently prevailing PIP schedule, a reduction in reimbursement of approximately 60%. These changes will negatively impact
our Florida diagnostic imaging facilities (both those we own and those we manage) with more unpaid bills, and lower reimbursement rates.
The full extent of those reductions are unclear at this time.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10.
Federal and state privacy and information security laws. We must comply with numerous federal and state laws and regulations governing
the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations,
as amended by the federal HITECH Act. If we fail to comply with applicable privacy and security laws, regulations and standards, properly
maintain the integrity of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, our business,
reputation, results of operations, financial position and cash flows could be materially and adversely affected.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
security risks have significantly increased in recent years because of the proliferation of new technologies, the use of the internet
and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers,
terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission and
storage of confidential, proprietary and other information in our computer systems and networks.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11.
Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic
and global economic and other conditions, including recessions or economic slowdowns, disruptions of credit markets and military conflicts.
Turbulence and uncertainty in the United States and international markets and economies may adversely affect our workforce, liquidity,
financial condition, revenues, profitability and business operations generally.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="UseOfProceeds"></span>Item
2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds: None</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Defaults"></span>Item
3 - Defaults Upon Senior Securities: None</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="MineSafety"></span>Item
4 - Mine Safety Disclosure: Not Applicable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="MoreInformation"></span>Item
5 - Other Information: None</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Exhibits"></span>Item
6 - Exhibits and Reports on Form 8-K:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 9%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">a)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 9%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 82%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-31.htm">Exhibit 31.1 Certification. See Exhibits</a></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">b)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-32.htm">Exhibit 32.1 Certification. See Exhibits</a></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">c)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501923000048/fonar_8-k.htm" style="-sec-extract: exhibit">Report on Form 8-K filed on September 29, 2022, Item 2.02: Results of Operations and Financial Condition for the fiscal year ended June 30, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Signatures"></span>SIGNATURES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Registrant)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">____________________</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">By:
/s/ Timothy Damadian</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
of the Board of Directors, President, Principal Executive Officer and Treasurer</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">____________________</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/
Luciano Bonanni</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
Bonanni</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 3.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
Vice President, Chief Operating Officer, Acting Principal Financial Officer</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dated:
November 14, 2023&#160;</span></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
Damadian and Luciano Bonanni each certify that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            have reviewed this report on Form 10-Q of Fonar Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, this report does not contain any untrue statement of a material fact or
                                            omit to state a material fact necessary to make the statements made, in light of the circumstances
                                            under which such statements were made, not misleading with respect to the period covered
                                            by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, the financial statements, and other financial information included in this
                                            report, fairly present in all material respects the financial condition, results of operations
                                            and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            am responsible for establishing and maintaining disclosure controls and procedures (as defined
                                            in Exchange Act Rules 13a-15(e) and 15(e)) and internal control over financial reporting
                                            (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">designed
                                            such disclosure controls and procedures or caused such disclosure controls over procedures
                                            to be designed under my supervision to ensure that material information relating to the registrant,
                                            including its consolidated subsidiaries, is made known to us by others within those entities,
                                            particularly during the period in which this report is being prepared;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">designed
                                            such internal control over financial reporting, or caused such internal control over financial
                                            reporting to be designed under my supervision, to provide reasonable assurance regarding
                                            the reliability of financial reporting and the preparation of financial statements for external
                                            purposes in accordance with generally accepted accounting principles;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">evaluated
                                            the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented
                                            in this report my conclusions about the effectiveness of the disclosure controls and procedures
                                            as of the end of the period covered by this report; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">disclosed
                                            in this report any change in the registrant&rsquo;s internal control over financial reporting
                                            that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
                                            fourth fiscal quarter in the case of an annual report) that has materially affected, or is
                                            reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
                                            reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            have disclosed, based on my most recent evaluation of internal control over financial reporting,
                                            to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board
                                            of directors (or persons performing the equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">all
                                            significant deficiencies and material weaknesses in the design or operation of internal control
                                            over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
                                            ability to record, process, summarize and report financial information; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Any
                                            fraud, whether or not material, that involves management or other employees who have a significant
                                            role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">November
    14, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 50%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Timothy Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Luciano
Bonanni,</FONT></P>

<P STYLE="margin-bottom: 0pt"></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Acting
Principal Financial Officer&nbsp;</FONT></P>
<FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
connection with the Quarterly Report of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10-Q for the fiscal
quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;),
I, Timothy Damadian, Principal Executive Officer, and I, Luciano Bonanni, Acting Principal Financial Officer of the Company,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal
    Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Luciano
                                            Bonanni&nbsp;</FONT></P>
                                                                                                 <P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Acting
                                            Principal Financial Officer&nbsp;</FONT></P>
<FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;November
14, 2023</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
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MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
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M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
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M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
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H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fonr-20230930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOaWN2aP9wZ93KekhsGR4bWm6zyMsRcP/BCDlbZgGEaUA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:FONR="http://fonar.com/20230930" elementFormDefault="qualified" targetNamespace="http://fonar.com/20230930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" id="CondensedConsolidatedStatementsOfIncome">
          <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" id="CondensedConsolidatedStatementsOfIncomeParenthetical">
          <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" id="CondensedConsolidatedStatementsOfChangesInEquity">
          <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
          <link:definition>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
          <link:definition>00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
          <link:definition>00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases" id="OperatingFinancingLeases">
          <link:definition>00000011 - Disclosure - OPERATING &amp; FINANCING LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
          <link:definition>00000012 - Disclosure - INVENTORIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
          <link:definition>00000013 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
          <link:definition>00000014 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
          <link:definition>00000015 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
          <link:definition>00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000018 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000019 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
          <link:definition>00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" id="OperatingFinancingLeasesTables">
          <link:definition>00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
          <link:definition>00000024 - Disclosure - INVENTORIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
          <link:definition>00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
          <link:definition>00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
          <link:definition>00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
          <link:definition>00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
          <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
          <link:definition>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1">
          <link:definition>00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
          <link:definition>00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
          <link:definition>00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
          <link:definition>00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
          <link:definition>00000036 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
          <link:definition>00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
          <link:definition>00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
          <link:definition>00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" id="SegmentAndRelatedInformation-SumarizedSegments-Details">
          <link:definition>00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
          <link:definition>00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000043 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommonStocksMember" name="CommonStocksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommonStockholdersMember" name="CommonStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredStockholdersMember" name="ClassANonVotingPreferredStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ControllingInterestMember" name="ControllingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalEquipmentMember" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_UnearnedRevenueOnServiceContractsRelatedParty" name="UnearnedRevenueOnServiceContractsRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsPayableRelatedPartyNoncurrent" name="AccountsPayableRelatedPartyNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInNotesReceivable" name="IncreaseDecreaseInNotesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingFinancingLeasesAbstract" name="DisclosureOperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" name="ScheduleOfPatientFeeRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" name="OwnershipInterestOfOriginalInvestorsOfHdm" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestorsOwnershipInterest" name="InvestorsOwnershipInterest" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeLossAvailableToCommonStockholderBasic" name="NetIncomeLossAvailableToCommonStockholderBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConvertibleClassCStock" name="ConvertibleClassCStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNonRelatedParties" name="ManagementAndOtherFeesNonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StateIncomeTaxesPayable" name="StateIncomeTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" name="StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FederalOperatingLosses" name="FederalOperatingLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeAvailableToClassCCommonStockholders" name="NetIncomeAvailableToClassCCommonStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>fonr-20230930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20230930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230930.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230930.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230930.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230930.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230930.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230930.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230930.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230930.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230930.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_FONRIncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000011 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000036 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>fonr-20230930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20230930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230930.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230930.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230930.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230930.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230930.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230930.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230930.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230930.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230930.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommonStocksMember" xlink:label="loc_FONRCommonStocksMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStocksMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountReceivableRelatedParties_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagementAndOtherFees_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="48" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000011 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FONRControllingInterestMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="loc_FONRManagementAndOtherFeesNonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFeesNonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OtherMember" xlink:label="loc_FONROtherMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000036 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>fonr-20230930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommonStocksMember" xlink:label="FONR_CommonStocksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommonStocksMember" xlink:to="FONR_CommonStocksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_CommonStocksMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommonStockholdersMember" xlink:label="FONR_CommonStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommonStockholdersMember" xlink:to="FONR_CommonStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommonStockholdersMember_lbl" xml:lang="en-US">Common Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockholdersMember" xlink:to="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ControllingInterestMember" xlink:label="FONR_ControllingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ControllingInterestMember" xlink:to="FONR_ControllingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ControllingInterestMember_lbl" xml:lang="en-US">Controlling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DoubtfulMember" xlink:label="us-gaap_DoubtfulMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DoubtfulMember" xlink:to="us-gaap_DoubtfulMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DoubtfulMember_lbl" xml:lang="en-US">Doubtful [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OtherMember" xlink:label="FONR_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherMember" xlink:to="FONR_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalEquipmentMember" xlink:label="FONR_MedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalEquipmentMember_lbl" xml:lang="en-US">Medical Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">Accounts receivable - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivable - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">Management and other fees receivable - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable - related medical practices - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable - long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use Asset - operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use Asset - financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:to="FONR_UnearnedRevenueOnServiceContractsRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty_lbl" xml:lang="en-US">Unearned revenue on service contracts &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsPayableRelatedPartyNoncurrent" xlink:to="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xml:lang="en-US">Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 55 shares of common stock at September 30, 2023 and 11 shares of common stock at June 30, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">&#160;Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue &#8211; net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees - related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees - related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income From Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income - Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:label="us-gaap_SupplementalIncomeStatementElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:to="us-gaap_SupplementalIncomeStatementElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalIncomeStatementElementsAbstract_lbl" xml:lang="en-US">Supplemental Income Statement Elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding - Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance - June 30, 2022</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Purchase of Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions - Non controlling</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income - Non controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Balance &#8211; September 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">&#160;Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">(Recovery) Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="FONR_IncreaseDecreaseInNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInNotesReceivable" xlink:to="FONR_IncreaseDecreaseInNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInNotesReceivable_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="FONR_IncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="FONR_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">&#160;Net Increase (Decrease) in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">BUSINESS COMBINATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earning per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Financing receivable noncurrent allowance for credit loss</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Schedule of facilities owned or managed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:to="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee operating leases liability maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of summarized segment financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Direct purchase of Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Direct ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_InvestorsOwnershipInterest" xlink:label="FONR_InvestorsOwnershipInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestorsOwnershipInterest_lbl" xml:lang="en-US">Investors ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:to="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic Denominator: Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic income per common share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Diluted Denominator: Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ConvertibleClassCStock" xlink:label="FONR_ConvertibleClassCStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConvertibleClassCStock_lbl" xml:lang="en-US">Convertible Class C Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">Total Denominator for Diluted Earnings Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Income per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - Related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_MedicalReceivable_2_lbl" xml:lang="en-US">Medical Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="FONR_ManagementAndOtherFeesNonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNonRelatedParties" xlink:to="FONR_ManagementAndOtherFeesNonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices ("PC's")</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueOneToTwoYears" xlink:to="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xml:lang="en-US">[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Percentage of net revenue derived from no-fault and personal injury protection claim</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage of consolidated net revenue from management fees charged to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">[custom:PresentValueDiscount-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">[custom:PresentValueDiscountFinancingLease-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xml:lang="en-US">Finance Lease, Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Total Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets-net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="FONR_StateIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StateIncomeTaxesPayable_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other general and administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Stock purchase plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Number of shares repurchased, value</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xml:lang="en-US">Liability for individual claims</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xml:lang="en-US">Reserve for self-funded</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Federal operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_FederalOperatingLosses" xlink:label="FONR_FederalOperatingLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FederalOperatingLosses" xlink:to="FONR_FederalOperatingLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FederalOperatingLosses_lbl" xml:lang="en-US">Federal operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US">Stock repurchase plan, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Stock repurchase plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A Non Voting Preferred Stock Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_doc" xml:lang="en-US">It represents the amount of accounts receivable service and repair fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountReceivableRelatedParties_doc" xml:lang="en-US">It represents the amount of accounts receivable service related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalReceivable_doc" xml:lang="en-US">This represents the amount of medical receivable during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFees_doc" xml:lang="en-US">This represents the amount of management and other fees during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xml:lang="en-US">This represents the amount of management and other fees receivable related medical practices net allowances during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetLongTerm_doc" xml:lang="en-US">This represents the amount of accounts receivable net long term during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:to="FONR_UnearnedRevenueOnServiceContractsRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty_doc" xml:lang="en-US">This represents the amount of unearned revenue on service contracts related party during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CustomerDeposits_doc" xml:lang="en-US">This represents the amount of customer deposits during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsPayableRelatedPartyNoncurrent" xlink:to="FONR_AccountsPayableRelatedPartyNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent_doc" xml:lang="en-US">This represents the amount of accounts payable related party noncurrent during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_doc" xml:lang="en-US">This represents the amount of patient fee revenue net of contractual allowances and discounts during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProductSalesNet_doc" xml:lang="en-US">This represents the amount of product sales net during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ServiceAndRepairFeesNet_doc" xml:lang="en-US">This represents the amount of service and repair fees net during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xml:lang="en-US">This represents the amount of service and repair fees related parties net during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesNet_doc" xml:lang="en-US">This represents the value of management and other fees net during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xml:lang="en-US">This represents the value of management and other fees related medical practices net during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToProductSales_doc" xml:lang="en-US">This represents the value of costs related to product sales during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_doc" xml:lang="en-US">This represents the amount of costs related to service and repair fees during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xml:lang="en-US">This represents the amount of costs related to service and repair fees related parties during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_doc" xml:lang="en-US">This represents the amount of costs related to management and other fees during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xml:lang="en-US">This represents the amount of costs related to management and other fees related medical practices during period.</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_NetIncomeAvailableToClassCCommonStockholders" xlink:label="FONR_NetIncomeAvailableToClassCCommonStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeAvailableToClassCCommonStockholders" xlink:to="FONR_NetIncomeAvailableToClassCCommonStockholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetIncomeAvailableToClassCCommonStockholders_doc" xml:lang="en-US">This represents the amount of netIncome available to class c common stockholders during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProvisionForBadDebts_doc" xml:lang="en-US">This represents the amount of provision for bad debts during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_doc" xml:lang="en-US">This represents the amount of increase decrease in financing liabilities during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_doc" xml:lang="en-US">This represents the amount of increase decrease in customer advance during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StateIncomeTaxesPayable_doc" xml:lang="en-US">the value of state income taxes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">This represents the rate of hmca ownership size of imperial management services percent during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">This represents the rate of ownership interest after reorganization for health management corporation of America of newly expanded hdm percent during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_doc" xml:lang="en-US">This represents the rate of ownership interest of original investors of hdm during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_doc" xml:lang="en-US">This represents the amount of direct purchase of noncontrolling interests during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_InvestorsOwnershipInterest_doc" xml:lang="en-US">This represents the rate of investors ownership interest during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:to="FONR_NetIncomeLossAvailableToCommonStockholderBasic_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic_doc" xml:lang="en-US">This represents the amount of net income loss available to common stockholder basic during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ConvertibleClassCStock_doc" xml:lang="en-US">This represents the shares of convertible class c stock during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_doc" xml:lang="en-US">Weighted average number of diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetRelatedParty_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_doc" xml:lang="en-US">Total Facilities Owned Or Managed Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:to="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_doc" xml:lang="en-US">Schedule Of Patient Fee Revenue Table Text Block</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_doc" xml:lang="en-US">This represents the amount of patient fee revenue net of contractual allowances and discounts during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscount_doc" xml:lang="en-US">This represents the amount of present value discount during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscountFinancingLease_doc" xml:lang="en-US">This represents the amount of present value discount financing lease during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management of Diagnostic Imaging Centers - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xml:lang="en-US">This represents the amount of stop loss umbrella policy with 3 rd paryinsurer to limit maximum potential liability for individual claims during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">This represents the amount of intersegment net revenues during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommonStocksMember" xlink:to="FONR_CommonStocksMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommonStocksMember_2_lbl" xml:lang="en-US">Common Stock [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_3_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_3_lbl" xml:lang="en-US">IncreaseDecreaseInCustomerAdvance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>fonr-20230930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20230930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230930.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230930.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230930.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230930.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230930.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230930.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230930.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230930.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230930.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230930.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230930.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommonStocksMember" xlink:label="loc_FONRCommonStocksMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStocksMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:label="loc_us-gaapSupplementalIncomeStatementElementsAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSupplementalIncomeStatementElementsAbstract" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_FONRIncreaseDecreaseInOperatingLeaseLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000011 - Disclosure - OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FONRControllingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="loc_FONRManagementAndOtherFeesNonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFeesNonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OtherMember" xlink:label="loc_FONROtherMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000036 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230930.xsd#FONR_FederalOperatingLosses" xlink:label="loc_FONRFederalOperatingLosses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRFederalOperatingLosses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754785158352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783655888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 51,693<span></span>
</td>
<td class="nump">$ 51,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable - net</a></td>
<td class="nump">4,092<span></span>
</td>
<td class="nump">3,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">Accounts receivable - related party</a></td>
<td class="nump">90<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivable - net</a></td>
<td class="nump">21,924<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">Management and other fees receivable - net</a></td>
<td class="nump">38,118<span></span>
</td>
<td class="nump">35,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable - related medical practices - net</a></td>
<td class="nump">9,063<span></span>
</td>
<td class="nump">9,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">2,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,608<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">129,147<span></span>
</td>
<td class="nump">125,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable - long term</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">8,800<span></span>
</td>
<td class="nump">10,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">21,107<span></span>
</td>
<td class="nump">22,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use Asset - operating lease</a></td>
<td class="nump">33,203<span></span>
</td>
<td class="nump">33,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use Asset - financing lease</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">3,355<span></span>
</td>
<td class="nump">3,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">201,556<span></span>
</td>
<td class="nump">200,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,040<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,984<span></span>
</td>
<td class="nump">5,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">3,944<span></span>
</td>
<td class="nump">3,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_UnearnedRevenueOnServiceContractsRelatedParty', window );">Unearned revenue on service contracts &#8211; related party</a></td>
<td class="nump">82<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability - current portion</a></td>
<td class="nump">4,295<span></span>
</td>
<td class="nump">3,905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability - current portion</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">14,232<span></span>
</td>
<td class="nump">15,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">562<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsPayableRelatedPartyNoncurrent', window );">Due to related medical practices</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">31,503<span></span>
</td>
<td class="nump">32,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">33,251<span></span>
</td>
<td class="nump">34,130<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">47,483<span></span>
</td>
<td class="nump">49,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">182,613<span></span>
</td>
<td class="nump">182,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(20,085)<span></span>
</td>
<td class="num">(24,191)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 55 shares of common stock at September 30, 2023 and 11 shares of common stock at June 30, 2023</a></td>
<td class="num">(1,230)<span></span>
</td>
<td class="num">(516)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">161,299<span></span>
</td>
<td class="nump">157,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">&#160;Noncontrolling interests</a></td>
<td class="num">(7,226)<span></span>
</td>
<td class="num">(7,079)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders' Equity</a></td>
<td class="nump">154,073<span></span>
</td>
<td class="nump">150,828<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">201,556<span></span>
</td>
<td class="nump">200,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStocksMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of accounts receivable service related parties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsPayableRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of accounts payable related party noncurrent during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsPayableRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of accounts receivable net long term during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of accounts receivable service and repair fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of customer deposits during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of management and other fees during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of management and other fees receivable related medical practices net allowances during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of medical receivable during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_UnearnedRevenueOnServiceContractsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of unearned revenue on service contracts related party during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_UnearnedRevenueOnServiceContractsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_CommonStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754784023120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">453,000<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">6,506,000<span></span>
</td>
<td class="nump">6,462,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,451,000<span></span>
</td>
<td class="nump">6,451,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754784158112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue &#8211; net of contractual allowances and discounts</a></td>
<td class="nump">$ 8,676<span></span>
</td>
<td class="nump">$ 6,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees - related parties &#8211; net</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">12,119<span></span>
</td>
<td class="nump">12,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees - related medical practices &#8211; net</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">25,838<span></span>
</td>
<td class="nump">23,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">4,427<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">848<span></span>
</td>
<td class="nump">718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees - related parties</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">7,024<span></span>
</td>
<td class="nump">6,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related medical practices</a></td>
<td class="nump">1,519<span></span>
</td>
<td class="nump">1,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">4,866<span></span>
</td>
<td class="nump">6,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">19,267<span></span>
</td>
<td class="nump">19,280<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income From Operations</a></td>
<td class="nump">6,571<span></span>
</td>
<td class="nump">3,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">7,030<span></span>
</td>
<td class="nump">4,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(1,670)<span></span>
</td>
<td class="num">(1,409)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">5,360<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income - Noncontrolling Interests</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(603)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 4,106<span></span>
</td>
<td class="nump">$ 2,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to management and other fees during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to management and other fees related medical practices during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the value of costs related to product sales during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to service and repair fees during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to service and repair fees related parties during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the value of management and other fees net during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the value of management and other fees related medical practices net during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of patient fee revenue net of contractual allowances and discounts during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of product sales net during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of service and repair fees net during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of service and repair fees related parties net during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781458848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 4,106<span></span>
</td>
<td class="nump">$ 2,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,408<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember', window );">Common Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 3,855<span></span>
</td>
<td class="nump">$ 1,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.60<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,408<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,536<span></span>
</td>
<td class="nump">6,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember', window );">Class A Non Voting Preferred Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781490144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance - June 30, 2022 at Jun. 30, 2022</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 184,531<span></span>
</td>
<td class="num">$ (33,567)<span></span>
</td>
<td class="num">$ (675)<span></span>
</td>
<td class="num">$ (4,054)<span></span>
</td>
<td class="nump">$ 146,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,047<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,634)<span></span>
</td>
<td class="num">(1,634)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; September 30, 2022 at Sep. 30, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
<td class="num">(31,520)<span></span>
</td>
<td class="num">(797)<span></span>
</td>
<td class="num">(5,085)<span></span>
</td>
<td class="nump">147,130<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance - June 30, 2022 at Jun. 30, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">182,613<span></span>
</td>
<td class="num">(24,191)<span></span>
</td>
<td class="num">(516)<span></span>
</td>
<td class="num">(7,079)<span></span>
</td>
<td class="nump">150,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,106<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(714)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,401)<span></span>
</td>
<td class="num">(1,401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,254<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; September 30, 2022 at Sep. 30, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 182,613<span></span>
</td>
<td class="num">$ (20,085)<span></span>
</td>
<td class="num">$ (1,230)<span></span>
</td>
<td class="num">$ (7,226)<span></span>
</td>
<td class="nump">$ 154,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783993136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">&#160;Net income</a></td>
<td class="nump">$ 5,360<span></span>
</td>
<td class="nump">$ 2,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>&#160;Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">(Recovery) Provision for bad debts</a></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">1,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax &#8211; net</a></td>
<td class="nump">1,242<span></span>
</td>
<td class="nump">1,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">(2,837)<span></span>
</td>
<td class="num">(1,407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInNotesReceivable', window );">Notes receivable</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(255)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">293<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(539)<span></span>
</td>
<td class="num">(779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(1,463)<span></span>
</td>
<td class="num">(1,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(1,322)<span></span>
</td>
<td class="num">(912)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer deposits</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,618<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>&#160;Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(963)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>&#160;Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">Purchase of treasury stock</a></td>
<td class="num">(714)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(1,401)<span></span>
</td>
<td class="num">(1,634)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,126)<span></span>
</td>
<td class="num">(1,761)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">&#160;Net Increase (Decrease) in Cash and Cash Equivalents</a></td>
<td class="nump">413<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">51,280<span></span>
</td>
<td class="nump">48,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 51,693<span></span>
</td>
<td class="nump">$ 48,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in customer advance during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in financing liabilities during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of provision for bad debts during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754878634128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zLcZBGEk3M46" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
1 &#8211; <span id="xdx_82B_zylxQw7N43Vd">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_90B_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zpKfxXpuE70c" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM">24.2</span>% interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_901_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_z9lHTzIDwOI8" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM">45.8</span>% in HDM, and the original
investors in HDM retained a <span id="xdx_90F_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z4G1MlJ27d2e" title="The ownership interest of the original investors of HDM">30.0</span>% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $<span id="xdx_903_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3n3_c20210701__20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zaFkCicpZPF4" title="Direct purchase of Noncontrolling Interests">546,000</span>. Currently the Company has a direct ownership interest
of <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zIE7y2yZfyXf" title="Direct ownership interest percentage">70.8</span>% and the investors&#8217; have a <span id="xdx_900_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zyATQEzNmYEi" title="Investors ownership interest percentage">29.2</span>% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2023, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2024. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2023 for the fiscal
year ended June 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. The Company must now take into account the severity, duration and recurrence
of new strains of the COVID-19 virus which adds a new dimension to the challenges and uncertainty facing our business and the world economy
in general. Although we are unable to predict if there will be additional consequences on our operations from the continuing global pandemic
of COVID-19, the Company believes with positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754790601760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zIMRMcyDwndc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_82B_z0Ur9KezDTSd">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zf8USUG2pr2i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_86B_zF4k5lZYbahl">Principles
of Consolidation</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zjFRWqaa4ppj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_862_ztp9bSST0AKg">Revenues</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zRu8GtWVUwmi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_864_zXRbla5Qq5p4">BUSINESS
COMBINATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zrStdWNG0D9j" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zotopoVYLNgf">Earnings
Per Share</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2023 and 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2023 and 2022, diluted EPS for
common shareholders includes <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20230930_z0iGwqA2jRg2" title="Shares included upon conversion of Class C Common"><span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zJxPWRVB75Rf" title="Shares included upon conversion of Class C Common">128</span></span> shares upon conversion of Class C Common.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,106</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,855</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,047</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,923</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share">0.64</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share">0.60</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share">0.17</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share">0.31</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share">0.29</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share">0.08</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock">128</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock">128</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0701">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share">6,536</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share">6,673</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share">0.59</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share">0.17</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share">0.29</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share">0.08</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zBwEnJBHhAF1">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754784053008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z76b1jhlAlJh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; <span id="xdx_824_zx2kIfGqNB84">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at September 30, 2023, and June 30, 2023:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zWq5k09emNHc" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"><span id="xdx_8BE_z1y9InVJZbHi" style="display: none">Financing receivable noncurrent allowance for credit loss</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zFuUZjzFtPhl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,291</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zNt4CVaWg8uc" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">199</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230930_zV0qVg2Q5OP7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,092</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLJMgdSNYhQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zDJnEYNqFq6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0741">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_pn3n3_c20230930_zwpZI3T8dKE9" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z5MRda6Hk1f4" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,924</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zP0Gg20G2nNl" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0747">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_pn3n3_c20230930_zn3Vo9lVCVqk" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,924</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zNDKUJgkeZfl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">49,882</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zes9eJCCR1E" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,764</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930_zVTo0kSdD6d3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,118</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztkuFc3YR5I6" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,829</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zuZGc3LF5kWh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,766</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930_zKfe0RZTt3Pg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,063</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zfIh7ricclI6" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,060</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrJISdlL9DPk" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">199</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630_zQrzXF3FHBC3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,861</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--MedicalReceivable_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zVWjq2dHhyR3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--MedicalReceivable_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zUHpP8oSxGEa" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0771">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--MedicalReceivable_pn3n3_c20230630_z3W0m3yBcSL" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zD1yvS2JZcK1" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z0bNuUhF6M4g" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,609</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630_zhr3HcVHF1pf" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,888</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLw7TfaAm5yl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,152</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zmjvqmqOy8fa" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630_zW0ICFokgpxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,162</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_z8ll0KVc0Rx3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
term accounts receivable balances at September 30, 2023 and June 30, 2023 amounted to approximately $<span id="xdx_90E_ecustom--AccountsReceivableNetLongTerm_iI_pn3n3_c20230930_zTIdAXXYEsa7" title="Accounts receivable - long term">500</span> and $<span id="xdx_90D_ecustom--AccountsReceivableNetLongTerm_iI_pn3n3_c20230630_z7Dt5zVHCTu5" title="Accounts receivable - long term">710</span>, respectively. The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following two years as of September 30, 2023 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zq88Lpxv1I8h" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 30%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_8B8_zkBh6jN57Y09" style="display: none">Schedule of facilities owned or managed</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="width: 17%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 12%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230930_zQBvQXslH9Ll" style="vertical-align: top; width: 25%; text-align: left" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">450</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230930_zUxelnUBC2W1" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">112</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20230930_zROFV8ZVydvk" style="border-bottom: Black 2.5pt double; vertical-align: top; text-align: left" title="Total"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">562</span></td></tr>
  </table>

<p id="xdx_8AA_zDv3uF5HYa87" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Receivables</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third-party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230701__20230930_zVDje3lOgAP9" title="Percentage of net revenue derived from no-fault and personal injury protection claim">67.8</span>%
and <span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20220930_zBZQfnw072wc" title="Percentage of net revenue derived from no-fault and personal injury protection claim">69.0</span>% of the PCs&#8217; net revenues for the three months ended September 30, 2023 and 2022, respectively, were derived from no-fault
and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance
for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with
the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230701__20230930_zq6fKDG6c1ec" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">11.6</span>% and <span id="xdx_907_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20220930_zqBgOeai7T1e" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">12.9</span>% of the consolidated net
revenues for the three months ended September 30, 2023 and 2022, respectively.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, Inc., Stand Up MRI of Boca Raton, Inc., and Stand Up MRI &amp; Diagnostic Center, Inc. (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2023 and 2022
are summarized in the following table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_zxVyQdCFSCBa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BE_zJenYjEJlLPa" style="display: none">Schedule of patient fee revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Three Months Ended <br/>September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 67%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zYeGyRqOocj7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,173</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zgURSWDMaDFl" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">911</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zBYKRJlFSg2e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">271</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zoWD1QQb7Bga" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">238</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zAn1jjs8Ebh2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,138</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zpPXMG2Mnv1b" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,235</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z3iwOoMfpTC6" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,094</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z0fPfWvpZmTj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">692</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930_za6njTiOltb5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,676</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930_zikFvFnPoQ07" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,076</span></td></tr>
  </table>

<p id="xdx_8A1_z4fnd87NzEkl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//310-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754886772368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_804_eus-gaap--LesseeOperatingLeasesTextBlock_zuqeqDXcJ7q1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; <span id="xdx_824_zcZbW4D6Jmwj">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, &#8220;Leases&#8221; (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date, and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: -9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (ASC) 842 &#8211;
&#8220;Leases,&#8221; as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2023 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zJtpM52l2JI5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_8B9_zI7SinKVL1D3" style="display: none">Lessee operating leases liability maturity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Twelve
                                            Months Ending<span style="font-variant: normal">&#160;<br/>September 30,</span></span></p></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
                                            Lease<span style="font-variant: normal">&#160;<br/>Payments</span></span></p></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
                                            Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payments</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 38%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBsqOcqp9ayk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,009</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zSBOfBlekqQ8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zk9MaZaYLVd9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,768</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTqB86RbVXl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zJ0BR2KdKIgj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,320</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlDKhUCwXbZ4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfLiGxKcAHg6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,865</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zq9FxaePDfKi" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">102</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zjOelamJoSKc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,526</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBmgPRARCHJe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfRrsrBua6H3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,471</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlo4KDWyauAe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--PresentValueDiscount_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zUYfxOlSm8Dh" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(10,161</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zjPsvMQdJS28" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(50</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zhs4OGrg9VGg" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,798</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FinanceLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zQqljvyyjNze" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">784</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754878579440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zpnXhbCxq30b" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
5 - <span id="xdx_82F_zUouiDw6VBu8">INVENTORIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zElUGVYXOTee" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8BA_zAgah6TZlXw5" style="display: none">Schedule of inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_498_20230930_zk2cYdJ9i9n5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_499_20230630_zDwr2Agh67Rj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zpdRKa70pRvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,531</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,346</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_z14ihIR1LQz4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">293</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">224</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_mtIFGAWzdt0_zVgkMzY2k4l6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,824</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,570</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754878848912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zqYp6X1Avn79" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_82C_zbba5GkoqrTl">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zFOiTzJPcLF5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8BE_z87CRPHw7aga" style="display: none">Schedule of other intangible assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,468</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,452</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-compete</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,523</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630_zYISEkB4ydgf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,507</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230930_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,168</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630_z7UXWt5IJTH3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,075</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,355</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20230630_zoNV9uoHDR95" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,432</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended September 30, 2023 and 2022 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Amortization of Intangible Assets">43</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_z7ADYezpgPo3" title="Amortization of Intangible Assets">54</span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended September 30, 2023 and 2022 amounted to $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets">50</span> and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsBMcHYK45Oa" title="Amortization of Intangible Assets">50</span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754878893040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z7X5ojiVoag1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; <span id="xdx_82C_zWsjdpbUbFqd">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zAF61ffQMGIc" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span id="xdx_8BF_zOwmCgSmkskk" style="display: none">Schedule of other current liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_495_20230930_zLsxxZM3Espa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_490_20230630_zCZd4nMJg6ri" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2023</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zwUd3VTiwrlk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,827</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,413</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_z2m3DlJiBVGb" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">225</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">193</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzdop_z0ZU62Qz69Ej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0944">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzdop_zNqgGXEPBiva" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzdop_z5jN17Rzvpc1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzdop_zU755oafvnpl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">176</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">101</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzdop_zDMp3n3Elbag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_z36j2r9xAkb5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    general and administrative expenses</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">694</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">574</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zZ4FA4ElM3t" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,984</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,444</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754786969984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zPzG0VQHf7W3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_822_z7fw4MW3tzOf">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2023. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zZIG65ctMVI3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zEhaEFWdpf75" style="display: none">Schedule
    of summarized segment financial information</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    <br/> Equipment</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    <br/> of Diagnostic <br/> Imaging <br/> Centers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 55%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHJJUM3abEY5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,056</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpNMaRqUO2uh" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,782</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20230930_zSYOLDvCoXP" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">25,838</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zQ2f6WTnmENj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">254</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyb499xmpPJ3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0987">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930_z4kbCKcoIzh8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">254</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zV7AeR6lAC77" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(738</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zcJauCxccFab" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,309</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930_zLyvhvaBxAFd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,571</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zzXioLSXFVQ6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">61</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPJOLg1o3BNb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,134</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930_z3YkNiVMql26" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,195</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_z6NPxTdabOi5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrWJgRRPSpo4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">63</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930_zEamsH9Hkezl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">79</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zRjbxIAP9QTj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,878</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zfc8GkVvSDF8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,313</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20220701__20220930_zALiXFlYl3R2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,191</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_ziN2lGCyRkge" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zBbNgJRrkSyd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1017">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930_zMnJn1rIrynj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zJsyqubEYeT4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(802</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zsD8es7WMqYa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,713</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930_ztYbWRPzu2V8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,911</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zxDdIdvRDVA3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zVv2Q9YVWwX3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,046</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930_z8hX23re9786" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,118</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHB8D3KsxTCj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zeWHM6Zkznl4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930_zwg5Y5HbKbHd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">963</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754790629744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_809_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zscdwkucfBW8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_82A_zJacSpFcxF8e">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2023 and September 30, 2022, the Company paid $<span id="xdx_90A_eus-gaap--InterestPaidNet_pn3n3_c20230701__20230930_zN5BgU8b4D0d" title="Interest paid">48</span> and $<span id="xdx_907_eus-gaap--InterestPaidNet_pn3n3_c20220701__20220930_z6wr6sgGQz14" title="Interest paid">15</span> for interest, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2023 and September 30, 2022, the Company paid $<span id="xdx_90B_eus-gaap--IncomeTaxesPaid_pn3n3_c20230701__20230930_z4vrgJW1fUlj" title="Income taxes paid">150</span> and $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_pn3n3_c20220701__20220930_zlotCbguAbs6" title="Income taxes paid">395</span> for income taxes, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754787183520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zg3BCHiCbgUh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; <span id="xdx_822_zlNQqUvQAwj5">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_906_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn6n6_c20220926_zvNvX6GYAOZ3" title="Stock purchase plan">9</span> million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the three months ended September 30, 2023 and
2022, the Company repurchased <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20230930_zBDlEazuNdHd" title="Number of shares repurchased">43</span> and <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20220930_zyJqUgzP7RV7" title="Number of shares repurchased">9</span> shares at a cost of $<span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230701__20230930_zZlklHRUa9Q6" title="Number of shares repurchased, value">714</span> and $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20220701__20220930_zhMehpQdQVBf" title="Number of shares repurchased, value">122</span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_900_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pn3n3_c20230701__20230930_zR4zl0QyZvre" title="Liability for individual claims">150</span> per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of September 30, 2023 and June 30, 2023, the Company had approximately $<span id="xdx_90A_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_iI_pn3n3_c20230930_z2HYkHqzGkEg" title="Reserve for self-funded">176</span> and $<span id="xdx_903_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_iI_pn3n3_c20230630_z675cYmLioef" title="Reserve for self-funded">101</span>, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the
condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783988768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zmIr6y0AlSi7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - <span id="xdx_827_zyet9be3q4K9">INCOME TAXES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740-270, &#8220;Income Taxes &#8211; Interim Reporting,&#8221; the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2023 and 2022, the Company recorded income tax expense of $<span id="xdx_90F_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20230701__20230930_zCAX1OUUoFGb" title="Income tax expense">1,670</span> in 2023 as compared
to $<span id="xdx_902_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20220701__20220930_zPLWglrOBq49" title="Income tax expense">1,409</span> in 2022. The 2023 provision is comprised of a current income tax component of $<span id="xdx_907_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_c20230701__20230930_zvgAdvdZjx8f" title="Income tax component - current">428</span> and a deferred income tax component of $<span id="xdx_90E_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zag9knJmBkIg" title="Income tax component - deferred">1,242</span>.
Obligations for any liability associated with the current income tax provision has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC Topic 740. The Company believes there are no uncertain tax positions in prior year tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC Topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2018.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company recorded a deferred tax asset of $<span id="xdx_902_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20230930_zEF2FWUVPxX8" title="Deferred tax asset">8,800</span>
and a deferred tax liability of $<span id="xdx_906_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20230930_ze3Cp7syDcac" title="Deferred tax liability">395</span>
as of September 30, 2023, primarily relating to Federal operating loss carryforwards, allowance for doubtful accounts and tax
credits. There is approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230930_zG6dbdffUY3b" title="Federal operating loss carryforwards"><span id="xdx_905_ecustom--FederalOperatingLosses_pn3n3_c20230701__20230930_zV95le90BkTl" title="Federal operating losses">3,198</span></span>
of Federal operating losses available to offset future taxable income through 2031. The net operating losses begin to expire in 2028
for federal tax and state income tax purposes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September, 2023, no such changes in ownership have occurred.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share
repurchases that occur after December 31, 2022 and introduces a 15% corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company is expecting
the IRA not to have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783988768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zTwiyT02uMoe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 &#8211; <span id="xdx_821_zl0CPIjTreQc">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to September 30, 2023 and through the date the condensed consolidated financial
statements were issued.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of October 31, 2023, the Company repurchased </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20231031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHkHVWivZNzj" title="Stock repurchase plan, shares">33</span>
shares of common stock at a cost of $<span id="xdx_90A_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20231031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTBvDEoxzEQb" title="Stock repurchase plan">471
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which
was authorized under the stock repurchase plan adopted in September 2022.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754780922192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zf8USUG2pr2i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_86B_zF4k5lZYbahl">Principles
of Consolidation</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenues</a></td>
<td class="text"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zjFRWqaa4ppj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_862_ztp9bSST0AKg">Revenues</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text"><p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zRu8GtWVUwmi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_864_zXRbla5Qq5p4">BUSINESS
COMBINATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zrStdWNG0D9j" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zotopoVYLNgf">Earnings
Per Share</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2023 and 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2023 and 2022, diluted EPS for
common shareholders includes <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20230930_z0iGwqA2jRg2" title="Shares included upon conversion of Class C Common"><span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zJxPWRVB75Rf" title="Shares included upon conversion of Class C Common">128</span></span> shares upon conversion of Class C Common.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,106</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,855</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,047</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,923</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share">0.64</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share">0.60</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share">0.17</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share">0.31</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share">0.29</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share">0.08</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock">128</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock">128</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0701">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share">6,536</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share">6,673</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share">0.59</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share">0.17</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share">0.29</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share">0.08</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zBwEnJBHhAF1">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>



















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_863_zBwEnJBHhAF1">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754790717536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earning per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,106</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,855</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,047</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,923</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share">0.64</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share">0.60</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share">0.17</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share">0.31</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share">0.29</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share">0.08</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding">6,408</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding">6,545</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock">128</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock">128</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"><span style="-sec-ix-hidden: xdx2ixbrl0701">&#8212;</span></span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share">6,536</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share">6,673</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share">383</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share">0.59</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share">0.17</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share">0.29</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share">0.08</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783990416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Financing receivable noncurrent allowance for credit loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zWq5k09emNHc" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"><span id="xdx_8BE_z1y9InVJZbHi" style="display: none">Financing receivable noncurrent allowance for credit loss</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zFuUZjzFtPhl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,291</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zNt4CVaWg8uc" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">199</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230930_zV0qVg2Q5OP7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,092</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLJMgdSNYhQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zDJnEYNqFq6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0741">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_pn3n3_c20230930_zwpZI3T8dKE9" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z5MRda6Hk1f4" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,924</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zP0Gg20G2nNl" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0747">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_pn3n3_c20230930_zn3Vo9lVCVqk" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,924</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zNDKUJgkeZfl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">49,882</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zes9eJCCR1E" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,764</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930_zVTo0kSdD6d3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,118</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztkuFc3YR5I6" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,829</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zuZGc3LF5kWh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,766</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930_zKfe0RZTt3Pg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,063</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zfIh7ricclI6" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,060</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrJISdlL9DPk" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">199</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630_zQrzXF3FHBC3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,861</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--MedicalReceivable_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zVWjq2dHhyR3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--MedicalReceivable_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zUHpP8oSxGEa" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0771">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--MedicalReceivable_pn3n3_c20230630_z3W0m3yBcSL" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,259</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zD1yvS2JZcK1" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z0bNuUhF6M4g" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,609</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630_zhr3HcVHF1pf" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,888</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLw7TfaAm5yl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,152</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zmjvqmqOy8fa" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630_zW0ICFokgpxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,162</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Schedule of facilities owned or managed</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zq88Lpxv1I8h" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 30%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_8B8_zkBh6jN57Y09" style="display: none">Schedule of facilities owned or managed</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="width: 17%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 12%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230930_zQBvQXslH9Ll" style="vertical-align: top; width: 25%; text-align: left" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">450</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230930_zUxelnUBC2W1" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">112</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20230930_zROFV8ZVydvk" style="border-bottom: Black 2.5pt double; vertical-align: top; text-align: left" title="Total"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">562</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock', window );">Schedule of patient fee revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_zxVyQdCFSCBa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BE_zJenYjEJlLPa" style="display: none">Schedule of patient fee revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Three Months Ended <br/>September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 67%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zYeGyRqOocj7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,173</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zgURSWDMaDFl" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">911</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zBYKRJlFSg2e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">271</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zoWD1QQb7Bga" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">238</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zAn1jjs8Ebh2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,138</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zpPXMG2Mnv1b" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,235</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z3iwOoMfpTC6" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,094</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z0fPfWvpZmTj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">692</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930_za6njTiOltb5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,676</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930_zikFvFnPoQ07" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,076</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Patient Fee Revenue Table Text Block</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfPatientFeeRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Facilities Owned Or Managed Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754790629744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee operating leases liability maturity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zJtpM52l2JI5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_8B9_zI7SinKVL1D3" style="display: none">Lessee operating leases liability maturity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Twelve
                                            Months Ending<span style="font-variant: normal">&#160;<br/>September 30,</span></span></p></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
                                            Lease<span style="font-variant: normal">&#160;<br/>Payments</span></span></p></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
                                            Lease</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payments</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 38%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBsqOcqp9ayk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,009</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zSBOfBlekqQ8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zk9MaZaYLVd9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,768</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTqB86RbVXl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zJ0BR2KdKIgj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,320</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlDKhUCwXbZ4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfLiGxKcAHg6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,865</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zq9FxaePDfKi" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">102</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zjOelamJoSKc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,526</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBmgPRARCHJe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfRrsrBua6H3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,471</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlo4KDWyauAe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--PresentValueDiscount_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zUYfxOlSm8Dh" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(10,161</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zjPsvMQdJS28" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(50</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zhs4OGrg9VGg" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,798</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FinanceLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zQqljvyyjNze" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">784</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754790588768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zElUGVYXOTee" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8BA_zAgah6TZlXw5" style="display: none">Schedule of inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_498_20230930_zk2cYdJ9i9n5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_499_20230630_zDwr2Agh67Rj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zpdRKa70pRvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,531</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,346</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_z14ihIR1LQz4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">293</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">224</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_mtIFGAWzdt0_zVgkMzY2k4l6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,824</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,570</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754789897008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zFOiTzJPcLF5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8BE_z87CRPHw7aga" style="display: none">Schedule of other intangible assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,468</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,452</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-compete</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,523</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630_zYISEkB4ydgf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,507</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230930_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,168</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630_z7UXWt5IJTH3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,075</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,355</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20230630_zoNV9uoHDR95" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,432</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754786829600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zAF61ffQMGIc" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span id="xdx_8BF_zOwmCgSmkskk" style="display: none">Schedule of other current liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_495_20230930_zLsxxZM3Espa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_490_20230630_zCZd4nMJg6ri" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2023</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zwUd3VTiwrlk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,827</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,413</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_z2m3DlJiBVGb" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">225</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">193</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzdop_z0ZU62Qz69Ej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0944">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzdop_zNqgGXEPBiva" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzdop_z5jN17Rzvpc1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzdop_zU755oafvnpl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">176</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">101</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzdop_zDMp3n3Elbag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_z36j2r9xAkb5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    general and administrative expenses</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">694</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">574</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zZ4FA4ElM3t" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,984</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,444</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754786827520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarized segment financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zZIG65ctMVI3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zEhaEFWdpf75" style="display: none">Schedule
    of summarized segment financial information</span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    <br/> Equipment</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    <br/> of Diagnostic <br/> Imaging <br/> Centers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2023</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 55%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHJJUM3abEY5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,056</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpNMaRqUO2uh" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,782</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20230930_zSYOLDvCoXP" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">25,838</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zQ2f6WTnmENj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">254</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyb499xmpPJ3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0987">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930_z4kbCKcoIzh8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">254</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zV7AeR6lAC77" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(738</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zcJauCxccFab" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,309</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930_zLyvhvaBxAFd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,571</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zzXioLSXFVQ6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">61</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPJOLg1o3BNb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,134</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930_z3YkNiVMql26" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,195</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_z6NPxTdabOi5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrWJgRRPSpo4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">63</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930_zEamsH9Hkezl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">79</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zRjbxIAP9QTj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,878</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zfc8GkVvSDF8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21,313</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20220701__20220930_zALiXFlYl3R2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,191</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_ziN2lGCyRkge" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zBbNgJRrkSyd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1017">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930_zMnJn1rIrynj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zJsyqubEYeT4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(802</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zsD8es7WMqYa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,713</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930_ztYbWRPzu2V8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,911</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zxDdIdvRDVA3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">72</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zVv2Q9YVWwX3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,046</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930_z8hX23re9786" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,118</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHB8D3KsxTCj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zeWHM6Zkznl4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930_zwg5Y5HbKbHd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">963</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754785154992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm', window );">The ownership interest of the original investors of HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestorsOwnershipInterest', window );">Investors ownership interest percentage</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Direct purchase of Noncontrolling Interests</a></td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Direct ownership interest percentage</a></td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of direct purchase of noncontrolling interests during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of hmca ownership size of imperial management services percent during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestorsOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of investors ownership interest during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestorsOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of ownership interest after reorganization for health management corporation of America of newly expanded hdm percent during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of ownership interest of original investors of hdm during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestOfOriginalInvestorsOfHdm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754780953248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 4,106<span></span>
</td>
<td class="nump">$ 2,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,408<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 3,855<span></span>
</td>
<td class="nump">$ 1,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,408<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 0.60<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,408<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">6,536<span></span>
</td>
<td class="nump">6,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConvertibleClassCStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the shares of convertible class c stock during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConvertibleClassCStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of net income loss available to common stockholder basic during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeLossAvailableToCommonStockholderBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of diluted earnings per share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754789905744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754778592864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">$ 4,092<span></span>
</td>
<td class="nump">$ 3,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">21,924<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">38,118<span></span>
</td>
<td class="nump">35,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">9,063<span></span>
</td>
<td class="nump">9,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">4,291<span></span>
</td>
<td class="nump">4,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">21,924<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">49,882<span></span>
</td>
<td class="nump">48,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">13,829<span></span>
</td>
<td class="nump">13,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember', window );">Doubtful [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">11,764<span></span>
</td>
<td class="nump">12,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">$ 4,766<span></span>
</td>
<td class="nump">$ 3,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of accounts receivable service and repair fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of management and other fees receivable related medical practices net allowances during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of medical receivable during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754778563888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueOneToTwoYears', window );">2025</a></td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2026</a></td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueOneToTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueOneToTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783573744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]</a></td>
<td class="nump">$ 8,676<span></span>
</td>
<td class="nump">$ 6,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]</a></td>
<td class="nump">5,138<span></span>
</td>
<td class="nump">4,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]</a></td>
<td class="nump">$ 2,094<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of patient fee revenue net of contractual allowances and discounts during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783581360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable - long term</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Percentage of net revenue derived from no-fault and personal injury protection claim</a></td>
<td class="nump">67.80%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage of consolidated net revenue from management fees charged to related party medical practices</a></td>
<td class="nump">11.60%<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of accounts receivable net long term during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781389392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">$ 6,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">5,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">5,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">3,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">3,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, after Year Five</a></td>
<td class="nump">21,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">[custom:PresentValueDiscount-0]</a></td>
<td class="num">(10,161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">35,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, to be Paid, Year Five</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, to be Paid, after Year Five</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">[custom:PresentValueDiscountFinancingLease-0]</a></td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 784<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of present value discount during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of present value discount financing lease during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783889056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,531<span></span>
</td>
<td class="nump">$ 2,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Total Inventories</a></td>
<td class="nump">$ 2,824<span></span>
</td>
<td class="nump">$ 2,570<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781402672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 20,523<span></span>
</td>
<td class="nump">$ 20,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">17,168<span></span>
</td>
<td class="nump">17,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets-net</a></td>
<td class="nump">3,355<span></span>
</td>
<td class="nump">3,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">5,468<span></span>
</td>
<td class="nump">5,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">4,150<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754783581360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781479056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 2,827<span></span>
</td>
<td class="nump">$ 4,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StateIncomeTaxesPayable', window );">State income taxes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other general and administrative expenses</a></td>
<td class="nump">694<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Current Liabilities</a></td>
<td class="nump">$ 3,984<span></span>
</td>
<td class="nump">$ 5,444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StateIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>the value of state income taxes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StateIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781361872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">$ 25,838<span></span>
</td>
<td class="nump">$ 23,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">6,571<span></span>
</td>
<td class="nump">3,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember', window );">Medical Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">2,056<span></span>
</td>
<td class="nump">1,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="num">(738)<span></span>
</td>
<td class="num">(802)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">23,782<span></span>
</td>
<td class="nump">21,313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">7,309<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of intersegment net revenues during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754780817216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754781410208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Number of shares repurchased, value</a></td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims', window );">Liability for individual claims</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth', window );">Reserve for self-funded</a></td>
<td class="nump">$ 176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of stop loss umbrella policy with 3 rd paryinsurer to limit maximum potential liability for individual claims during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754784036016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Income tax expense</a></td>
<td class="nump">$ 1,670<span></span>
</td>
<td class="nump">$ 1,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Income tax component - current</a></td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Income tax component - deferred</a></td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred tax liability</a></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal operating loss carryforwards</a></td>
<td class="nump">3,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FederalOperatingLosses', window );">Federal operating losses</a></td>
<td class="nump">$ 3,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FederalOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FederalOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480135/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139754878645920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase plan, shares | shares</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase plan | $</a></td>
<td class="nump">$ 471<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>fonar_10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20230930"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20230930.xsd" xlink:type="simple"/>
    <context id="From2023-07-01to2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-07_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember1033083781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember1033083828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="AsOf2023-10-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-07-01to2023-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-07-01to2023-09-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-07-01to2023-09-30">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-07-01to2023-09-30">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-07-01to2023-09-30">0000355019</dei:EntityCentralIndexKey>
    <FONR:AccountReceivableRelatedParties
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0068"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParty
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl0131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember"
      id="xdx2ixbrl0191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      id="xdx2ixbrl0193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0213"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-07-01to2023-09-30"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0438"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0486"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-07-012022-09-30"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0697"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0701"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0741"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0747"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0771"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl0863"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl0865"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StateIncomeTaxesPayable
      contextRef="AsOf2023-09-30"
      id="xdx2ixbrl0944"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl0987"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1017"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-07-01to2023-09-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2023-07-01to2023-09-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport contextRef="From2023-07-01to2023-09-30">false</dei:DocumentTransitionReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-01to2023-09-30">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2023-07-01to2023-09-30">000-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-07-01to2023-09-30">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-07-01to2023-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-07-01to2023-09-30">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-07-01to2023-09-30">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-07-01to2023-09-30">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-07-01to2023-09-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-07-01to2023-09-30">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-07-01to2023-09-30">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-07-01to2023-09-30">694-2929</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2023-07-01to2023-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-07-01to2023-09-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-07-01to2023-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-07-01to2023-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-07-01to2023-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2023-07-01to2023-09-30">false</dei:EntityShellCompany>
    <dei:Security12bTitle contextRef="From2023-07-01to2023-09-30">Common     Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-01to2023-09-30">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-01to2023-09-30">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-11-07_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6450882</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-11-07_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-11-07_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-11-07_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">51693000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">51280000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">33000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">33000</us-gaap:ShortTermInvestments>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">4092000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3861000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">90000</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">21924000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">21259000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">38118000</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">35888000</FONR:ManagementAndOtherFees>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">9063000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">9162000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">2824000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2570000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">1310000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1608000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">129147000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">125661000</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">500000</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">710000</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">8800000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">10042000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">21107000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">22146000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">33203000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">33069000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">680000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">729000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">3355000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3432000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">495000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">524000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">201556000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">200582000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">45000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">44000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">1040000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">1579000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">3984000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">5444000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">3944000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3832000</us-gaap:DeferredRevenueCurrent>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParty contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">82000</FONR:UnearnedRevenueOnServiceContractsRelatedParty>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">4295000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3905000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">219000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">218000</us-gaap:FinanceLeaseLiabilityCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">623000</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">602000</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">14232000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">15624000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">562000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">760000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">395000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">395000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">93000</FONR:AccountsPayableRelatedPartyNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">93000</FONR:AccountsPayableRelatedPartyNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">31503000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">32105000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">565000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">620000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">104000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">115000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilities contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">29000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">42000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">33251000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">34130000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">47483000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">49754000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6506000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6462000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6451000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6451000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30_custom_CommonStocksMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_custom_CommonStocksMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">182613000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">182613000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">-20085000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-24191000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2023-09-30" decimals="-3" unitRef="Shares">55000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2023-06-30" decimals="-3" unitRef="Shares">11000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">1230000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">516000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">161299000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">157907000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">-7226000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">-7079000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">154073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">150828000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">201556000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">200582000</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">8676000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">6076000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">164000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">30000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1864000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1820000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">12119000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">12250000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">2987000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2987000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">25838000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">23191000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">4427000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">3800000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">103000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">169000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">848000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">718000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">13000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">11000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">7024000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">6501000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1519000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1398000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">467000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">349000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">4866000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">6334000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">19267000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">19280000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">6571000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">3911000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">11000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">48000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">14000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">507000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">151000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">7030000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">4059000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1670000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1409000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">5360000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2650000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1254000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">603000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">4106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember"
      decimals="-3"
      unitRef="USD">3855000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember"
      decimals="-3"
      unitRef="USD">1923000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="-3"
      unitRef="USD">187000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="-3"
      unitRef="USD">92000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">64000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember"
      decimals="INF"
      unitRef="USDPShares">0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember"
      decimals="INF"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember"
      decimals="INF"
      unitRef="USDPShares">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember"
      decimals="INF"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember"
      decimals="-3"
      unitRef="Shares">6408000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_custom_CommonStockholdersMember"
      decimals="-3"
      unitRef="Shares">6536000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_custom_CommonStockholdersMember"
      decimals="-3"
      unitRef="Shares">6673000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember1033083781"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">182613000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-24191000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-516000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-7079000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">150828000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">4106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">4106000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012023-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">714000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">714000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1401000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1401000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1254000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1254000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember1033083828"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">182613000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-20085000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-1230000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-7226000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">154073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-33567000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-4054000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">146236000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">122000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">122000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1634000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1634000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">603000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">603000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-31520000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-797000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-5085000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">147130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">5360000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2650000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1195000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1118000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1024000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1061000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:ProvisionForBadDebts
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-68000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1398000</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1242000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1146000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">2837000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1407000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">5000</FONR:IncreaseDecreaseInNotesReceivable>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">11000</FONR:IncreaseDecreaseInNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">255000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">98000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-293000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">14000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-29000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-539000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-779000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-1463000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-1580000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <FONR:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-1322000</FONR:IncreaseDecreaseInOperatingLeaseLiabilities>
    <FONR:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-912000</FONR:IncreaseDecreaseInOperatingLeaseLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">54000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">52000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">20000</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">171000</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-12000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-16000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">2618000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2697000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">63000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">939000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">16000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">24000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-79000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-963000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">11000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">5000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">714000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">122000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1401000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1634000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">-2126000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-1761000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">413000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">-27000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">51280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48723000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">51693000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">48696000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zLcZBGEk3M46" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
1 &#x2013; &lt;span id="xdx_82B_zylxQw7N43Vd"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
&lt;span id="xdx_90B_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zpKfxXpuE70c" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"&gt;24.2&lt;/span&gt;% interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_901_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_z9lHTzIDwOI8" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"&gt;45.8&lt;/span&gt;% in HDM, and the original
investors in HDM retained a &lt;span id="xdx_90F_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z4G1MlJ27d2e" title="The ownership interest of the original investors of HDM"&gt;30.0&lt;/span&gt;% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $&lt;span id="xdx_903_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3n3_c20210701__20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zaFkCicpZPF4" title="Direct purchase of Noncontrolling Interests"&gt;546,000&lt;/span&gt;. Currently the Company has a direct ownership interest
of &lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zIE7y2yZfyXf" title="Direct ownership interest percentage"&gt;70.8&lt;/span&gt;% and the investors&#x2019; have a &lt;span id="xdx_900_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zyATQEzNmYEi" title="Investors ownership interest percentage"&gt;29.2&lt;/span&gt;% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#x201c;Health Management Company of America&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basis
of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2023, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2024. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2023 for the fiscal
year ended June 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. The Company must now take into account the severity, duration and recurrence
of new strains of the COVID-19 virus which adds a new dimension to the challenges and uncertainty facing our business and the world economy
in general. Although we are unable to predict if there will be additional consequences on our operations from the continuing global pandemic
of COVID-19, the Company believes with positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestOfOriginalInvestorsOfHdm
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.300</FONR:OwnershipInterestOfOriginalInvestorsOfHdm>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember"
      decimals="-3"
      unitRef="USD">546000000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FONR:InvestorsOwnershipInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.292</FONR:InvestorsOwnershipInterest>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zIMRMcyDwndc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
2 - &lt;span id="xdx_82B_z0Ur9KezDTSd"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zf8USUG2pr2i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_86B_zF4k5lZYbahl"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zjFRWqaa4ppj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_862_ztp9bSST0AKg"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgements employed in
the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zRu8GtWVUwmi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_864_zXRbla5Qq5p4"&gt;BUSINESS
COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zrStdWNG0D9j" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_863_zotopoVYLNgf"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 0.5in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2023 and 2022, diluted EPS for
common shareholders includes &lt;span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20230930_z0iGwqA2jRg2" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zJxPWRVB75Rf" title="Shares included upon conversion of Class C Common"&gt;128&lt;/span&gt;&lt;/span&gt; shares upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none"&gt;Schedule of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,106&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,855&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,047&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share"&gt;0.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share"&gt;0.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share"&gt;0.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0697"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0701"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share"&gt;6,536&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share"&gt;6,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share"&gt;0.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_863_zBwEnJBHhAF1"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zf8USUG2pr2i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_86B_zF4k5lZYbahl"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zjFRWqaa4ppj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_862_ztp9bSST0AKg"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgements employed in
the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zRu8GtWVUwmi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_864_zXRbla5Qq5p4"&gt;BUSINESS
COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zrStdWNG0D9j" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_863_zotopoVYLNgf"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 0.5in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2023 and 2022, diluted EPS for
common shareholders includes &lt;span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230701__20230930_z0iGwqA2jRg2" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zJxPWRVB75Rf" title="Shares included upon conversion of Class C Common"&gt;128&lt;/span&gt;&lt;/span&gt; shares upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none"&gt;Schedule of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,106&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,855&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,047&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share"&gt;0.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share"&gt;0.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share"&gt;0.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0697"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0701"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share"&gt;6,536&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share"&gt;6,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share"&gt;0.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_863_zBwEnJBHhAF1"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zmKTgkWnZz4j" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B8_zKK2aCcpJ6Hf" style="display: none"&gt;Schedule of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930_ze3XKAqZbRz8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,106&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNFdJk9eDRl5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,855&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKhGPS0kZOM2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930_ze9wJNdmEXo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,047&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVrfspx4W3A6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVw31bGP5H6h" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930_zFD2P079jFad" title="Basic Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziWfLGZsoIBa" title="Basic Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zf20jsaQ6oqh" title="Basic Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zh3HVNwlNb3h" title="Basic Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1pOsq59CU5f" title="Basic Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS0AYTaWjiL2" title="Basic Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930_zlzn5RsRJc1l" title="Basic income per common share"&gt;0.64&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zud0CqsMCx0l" title="Basic income per common share"&gt;0.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1lyAAzF2EMk" title="Basic income per common share"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930_zzpYSF1xb9z" title="Basic income per common share"&gt;0.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFTeN5cKM9ck" title="Basic income per common share"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2dUqVM0itT2" title="Basic income per common share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5Eba7toB3c7" title="Diluted Denominator: Weighted average shares outstanding"&gt;6,408&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zABNmwr1cjIh" title="Diluted Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8ZYGY157Hfi" title="Diluted Denominator: Weighted average shares outstanding"&gt;6,545&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6o8qLjgXRDh" title="Diluted Denominator: Weighted average shares outstanding"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv67wCRpjZe2" title="Convertible Class C Stock"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90F_ecustom--ConvertibleClassCStock_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzWnvtozHT3a" title="Convertible Class C Stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0697"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_905_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGWlTCo5SbM7" title="Convertible Class C Stock"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCkFUcho8ql9" title="Convertible Class C Stock"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0701"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_907_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQfs84VSTMF6" title="Total Denominator for Diluted Earnings Per Share"&gt;6,536&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfuGFpHRu2Jj" title="Total Denominator for Diluted Earnings Per Share"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_903_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqa7peXviSg" title="Total Denominator for Diluted Earnings Per Share"&gt;6,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_901_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuq15JOF0P1g" title="Total Denominator for Diluted Earnings Per Share"&gt;383&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgWI3CdD7XH7" title="Diluted Income per Common Share"&gt;0.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20230701__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znwwujfahen" title="Diluted Income per Common Share"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlLSWXiZg01h" title="Diluted Income per Common Share"&gt;0.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4kDiHHWwyg" title="Diluted Income per Common Share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">4106000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3855000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">64000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">2047000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1923000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">32000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="Shares">6408000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6408000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-01to2023-09-30"
      decimals="INF"
      unitRef="USDPShares">0.64</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.60</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.17</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="USDPShares">0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.08</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6408000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6536000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6673000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zl4UlNd4YRyf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_863_zBwEnJBHhAF1"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2023 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_809_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z76b1jhlAlJh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
3 &#x2013; &lt;span id="xdx_824_zx2kIfGqNB84"&gt;ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivables,
net is comprised of the following at September 30, 2023, and June 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zWq5k09emNHc" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span id="xdx_8BE_z1y9InVJZbHi" style="display: none"&gt;Financing receivable noncurrent allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zFuUZjzFtPhl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zNt4CVaWg8uc" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;199&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230930_zV0qVg2Q5OP7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLJMgdSNYhQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zDJnEYNqFq6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0741"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_pn3n3_c20230930_zwpZI3T8dKE9" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z5MRda6Hk1f4" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zP0Gg20G2nNl" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0747"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_pn3n3_c20230930_zn3Vo9lVCVqk" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zNDKUJgkeZfl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;49,882&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zes9eJCCR1E" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,764&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930_zVTo0kSdD6d3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;38,118&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztkuFc3YR5I6" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,829&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zuZGc3LF5kWh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,766&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930_zKfe0RZTt3Pg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,063&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zfIh7ricclI6" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrJISdlL9DPk" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;199&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630_zQrzXF3FHBC3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,861&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--MedicalReceivable_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zVWjq2dHhyR3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--MedicalReceivable_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zUHpP8oSxGEa" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0771"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--MedicalReceivable_pn3n3_c20230630_z3W0m3yBcSL" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zD1yvS2JZcK1" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;48,497&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z0bNuUhF6M4g" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630_zhr3HcVHF1pf" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,888&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLw7TfaAm5yl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,152&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zmjvqmqOy8fa" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,990&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630_zW0ICFokgpxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z8ll0KVc0Rx3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company's customers are concentrated in the healthcare industry.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long
Term Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long
term accounts receivable balances at September 30, 2023 and June 30, 2023 amounted to approximately $&lt;span id="xdx_90E_ecustom--AccountsReceivableNetLongTerm_iI_pn3n3_c20230930_zTIdAXXYEsa7" title="Accounts receivable - long term"&gt;500&lt;/span&gt; and $&lt;span id="xdx_90D_ecustom--AccountsReceivableNetLongTerm_iI_pn3n3_c20230630_z7Dt5zVHCTu5" title="Accounts receivable - long term"&gt;710&lt;/span&gt;, respectively. The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following two years as of September 30, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zq88Lpxv1I8h" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 30%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_8B8_zkBh6jN57Y09" style="display: none"&gt;Schedule of facilities owned or managed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230930_zQBvQXslH9Ll" style="vertical-align: top; width: 25%; text-align: left" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;450&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230930_zUxelnUBC2W1" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20230930_zROFV8ZVydvk" style="border-bottom: Black 2.5pt double; vertical-align: top; text-align: left" title="Total"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zDv3uF5HYa87" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
Receivables&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Payment
of the management fee receivables from the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner
their medical fees from the third-party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_90C_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230701__20230930_zVDje3lOgAP9" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;67.8&lt;/span&gt;%
and &lt;span id="xdx_909_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20220930_zBZQfnw072wc" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;69.0&lt;/span&gt;% of the PCs&#x2019; net revenues for the three months ended September 30, 2023 and 2022, respectively, were derived from no-fault
and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance
for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with
the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
revenues from management and other fees charged to the related PCs accounted for approximately &lt;span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230701__20230930_zq6fKDG6c1ec" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;11.6&lt;/span&gt;% and &lt;span id="xdx_907_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20220930_zqBgOeai7T1e" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;12.9&lt;/span&gt;% of the consolidated net
revenues for the three months ended September 30, 2023 and 2022, respectively.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tallahassee
Magnetic Resonance Imaging, Inc., Stand Up MRI of Boca Raton, Inc., and Stand Up MRI &amp;amp; Diagnostic Center, Inc. (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2023 and 2022
are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_zxVyQdCFSCBa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span id="xdx_8BE_zJenYjEJlLPa" style="display: none"&gt;Schedule of patient fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 67%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zYeGyRqOocj7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,173&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zgURSWDMaDFl" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;911&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zBYKRJlFSg2e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;271&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zoWD1QQb7Bga" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zAn1jjs8Ebh2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,138&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zpPXMG2Mnv1b" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,235&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z3iwOoMfpTC6" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,094&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z0fPfWvpZmTj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;692&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930_za6njTiOltb5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,676&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930_zikFvFnPoQ07" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,076&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z4fnd87NzEkl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zWq5k09emNHc" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span id="xdx_8BE_z1y9InVJZbHi" style="display: none"&gt;Financing receivable noncurrent allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zFuUZjzFtPhl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zNt4CVaWg8uc" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;199&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230930_zV0qVg2Q5OP7" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLJMgdSNYhQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zDJnEYNqFq6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0741"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableNetRelatedParty_pn3n3_c20230930_zwpZI3T8dKE9" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z5MRda6Hk1f4" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zP0Gg20G2nNl" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0747"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_pn3n3_c20230930_zn3Vo9lVCVqk" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,924&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zNDKUJgkeZfl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;49,882&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zes9eJCCR1E" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,764&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230930_zVTo0kSdD6d3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;38,118&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztkuFc3YR5I6" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,829&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zuZGc3LF5kWh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,766&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230930_zKfe0RZTt3Pg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,063&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zfIh7ricclI6" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrJISdlL9DPk" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;199&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableServiceAndRepairFees_pn3n3_c20230630_zQrzXF3FHBC3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,861&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--MedicalReceivable_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zVWjq2dHhyR3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--MedicalReceivable_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zUHpP8oSxGEa" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0771"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--MedicalReceivable_pn3n3_c20230630_z3W0m3yBcSL" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zD1yvS2JZcK1" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;48,497&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z0bNuUhF6M4g" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230630_zhr3HcVHF1pf" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,888&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zLw7TfaAm5yl" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,152&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zmjvqmqOy8fa" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,990&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230630_zW0ICFokgpxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4291000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">199000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">4092000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">90000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">90000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">21924000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">21924000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">49882000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">11764000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">38118000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">13829000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">4766000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">9063000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4060000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">199000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3861000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">21259000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">21259000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">48497000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">12609000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">35888000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">13152000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">3990000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">9162000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">500000</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">710000</FONR:AccountsReceivableNetLongTerm>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zq88Lpxv1I8h" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 30%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_8B8_zkBh6jN57Y09" style="display: none"&gt;Schedule of facilities owned or managed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 17%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230930_zQBvQXslH9Ll" style="vertical-align: top; width: 25%; text-align: left" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;450&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230930_zUxelnUBC2W1" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pn3n3_c20230930_zROFV8ZVydvk" style="border-bottom: Black 2.5pt double; vertical-align: top; text-align: left" title="Total"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <us-gaap:ContractReceivableDueOneToTwoYears contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">450000</us-gaap:ContractReceivableDueOneToTwoYears>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">112000</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">562000</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2023-07-01to2023-09-30"
      decimals="INF"
      unitRef="Pure">0.678</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="Pure">0.690</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2023-07-01to2023-09-30"
      decimals="INF"
      unitRef="Pure">0.116</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="Pure">0.129</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:ScheduleOfPatientFeeRevenueTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_zxVyQdCFSCBa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span id="xdx_8BE_zJenYjEJlLPa" style="display: none"&gt;Schedule of patient fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 67%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zYeGyRqOocj7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,173&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zgURSWDMaDFl" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 10%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;911&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zBYKRJlFSg2e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;271&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zoWD1QQb7Bga" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zAn1jjs8Ebh2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,138&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zpPXMG2Mnv1b" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,235&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z3iwOoMfpTC6" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,094&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherMember_z0fPfWvpZmTj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;692&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20230701__20230930_za6njTiOltb5" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,676&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_pn3n3_c20220701__20220930_zikFvFnPoQ07" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,076&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:ScheduleOfPatientFeeRevenueTableTextBlock>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-07-012023-09-30_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">1173000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">911000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-07-012023-09-30_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">271000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">238000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-07-012023-09-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">5138000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">4235000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-07-012023-09-30_custom_OtherMember"
      decimals="-3"
      unitRef="USD">2094000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_OtherMember"
      decimals="-3"
      unitRef="USD">692000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">8676000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">6076000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_804_eus-gaap--LesseeOperatingLeasesTextBlock_zuqeqDXcJ7q1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
4 &#x2013; &lt;span id="xdx_824_zcZbW4D6Jmwj"&gt;OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
July 2019, the Company adopted ASU 2016-02, &#x201c;Leases&#x201d; (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date, and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: -9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (ASC) 842 &#x2013;
&#x201c;Leases,&#x201d; as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zJtpM52l2JI5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_8B9_zI7SinKVL1D3" style="display: none"&gt;Lessee operating leases liability maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Twelve
                                            Months Ending&lt;span style="font-variant: normal"&gt;&#160;&lt;br/&gt;September 30,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
                                            Lease&lt;span style="font-variant: normal"&gt;&#160;&lt;br/&gt;Payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
                                            Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 38%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBsqOcqp9ayk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,009&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zSBOfBlekqQ8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zk9MaZaYLVd9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,768&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTqB86RbVXl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zJ0BR2KdKIgj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,320&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlDKhUCwXbZ4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfLiGxKcAHg6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,865&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zq9FxaePDfKi" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zjOelamJoSKc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,526&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBmgPRARCHJe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfRrsrBua6H3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,471&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlo4KDWyauAe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PresentValueDiscount_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zUYfxOlSm8Dh" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(10,161&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zjPsvMQdJS28" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zhs4OGrg9VGg" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,798&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinanceLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zQqljvyyjNze" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;784&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zJtpM52l2JI5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_8B9_zI7SinKVL1D3" style="display: none"&gt;Lessee operating leases liability maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Twelve
                                            Months Ending&lt;span style="font-variant: normal"&gt;&#160;&lt;br/&gt;September 30,&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
                                            Lease&lt;span style="font-variant: normal"&gt;&#160;&lt;br/&gt;Payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
                                            Lease&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 38%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBsqOcqp9ayk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,009&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 5%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zSBOfBlekqQ8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 24%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zk9MaZaYLVd9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,768&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTqB86RbVXl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zJ0BR2KdKIgj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,320&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlDKhUCwXbZ4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfLiGxKcAHg6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,865&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zq9FxaePDfKi" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zjOelamJoSKc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,526&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBmgPRARCHJe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zfRrsrBua6H3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,471&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zlo4KDWyauAe" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PresentValueDiscount_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zUYfxOlSm8Dh" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(10,161&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zjPsvMQdJS28" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zhs4OGrg9VGg" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,798&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinanceLeaseLiability_pn3n3_c20230930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zQqljvyyjNze" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;784&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">6009000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5768000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5320000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">3865000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">102000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">3526000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">21471000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">-10161000</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">-50000</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">35798000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="AsOf2023-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">784000</us-gaap:FinanceLeaseLiability>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zpnXhbCxq30b" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
5 - &lt;span id="xdx_82F_zUouiDw6VBu8"&gt;INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zElUGVYXOTee" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zAgah6TZlXw5" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20230930_zk2cYdJ9i9n5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230630_zDwr2Agh67Rj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zpdRKa70pRvb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,531&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,346&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_z14ihIR1LQz4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;293&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;224&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_mtIFGAWzdt0_zVgkMzY2k4l6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,824&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,570&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zElUGVYXOTee" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zAgah6TZlXw5" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20230930_zk2cYdJ9i9n5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230630_zDwr2Agh67Rj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_zpdRKa70pRvb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,531&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,346&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_z14ihIR1LQz4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;293&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;224&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_mtIFGAWzdt0_zVgkMzY2k4l6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,824&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,570&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">2531000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2346000</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">293000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">224000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">2824000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">2570000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zqYp6X1Avn79" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
6 &#x2013; &lt;span id="xdx_82C_zbba5GkoqrTl"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zFOiTzJPcLF5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BE_z87CRPHw7aga" style="display: none"&gt;Schedule of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,468&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,452&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,523&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630_zYISEkB4ydgf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,507&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230930_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,168&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630_z7UXWt5IJTH3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,075&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,355&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20230630_zoNV9uoHDR95" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,432&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of patents and copyrights for the three months ended September 30, 2023 and 2022 amounted to $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Amortization of Intangible Assets"&gt;43&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_z7ADYezpgPo3" title="Amortization of Intangible Assets"&gt;54&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of customer relationships for the three months ended September 30, 2023 and 2022 amounted to $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets"&gt;50&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsBMcHYK45Oa" title="Amortization of Intangible Assets"&gt;50&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_zFOiTzJPcLF5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BE_z87CRPHw7aga" style="display: none"&gt;Schedule of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,468&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,452&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230930_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,523&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20230630_zYISEkB4ydgf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,507&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230930_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,168&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20230630_z7UXWt5IJTH3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,075&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,355&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pn3n3_c20230630_zoNV9uoHDR95" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,432&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5468000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5452000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">20523000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">20507000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">17168000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">17075000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">3355000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">3432000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012023-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">43000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">54000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012023-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_809_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z7X5ojiVoag1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
7 &#x2013; &lt;span id="xdx_82C_zWsjdpbUbFqd"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zAF61ffQMGIc" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span id="xdx_8BF_zOwmCgSmkskk" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20230930_zLsxxZM3Espa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230630_zCZd4nMJg6ri" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zwUd3VTiwrlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,827&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,413&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_z2m3DlJiBVGb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;225&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;193&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzdop_z0ZU62Qz69Ej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzdop_zNqgGXEPBiva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzdop_z5jN17Rzvpc1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzdop_zU755oafvnpl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;176&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;101&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzdop_zDMp3n3Elbag" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_z36j2r9xAkb5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;694&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;574&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zZ4FA4ElM3t" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,984&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,444&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zAF61ffQMGIc" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span id="xdx_8BF_zOwmCgSmkskk" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20230930_zLsxxZM3Espa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20230630_zCZd4nMJg6ri" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzdop_zwUd3VTiwrlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,827&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,413&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzdop_z2m3DlJiBVGb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;225&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;193&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzdop_z0ZU62Qz69Ej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzdop_zNqgGXEPBiva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzdop_z5jN17Rzvpc1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;47&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzdop_zU755oafvnpl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;176&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;101&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzdop_zDMp3n3Elbag" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzdop_z36j2r9xAkb5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;694&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;574&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzdop_zZ4FA4ElM3t" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,984&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,444&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">2827000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">4413000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">225000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">193000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">48000</FONR:StateIncomeTaxesPayable>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">11000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">11000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">47000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">100000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">176000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">101000</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">4000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">4000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">694000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">574000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">3984000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">5444000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_zPzG0VQHf7W3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
8 - &lt;span id="xdx_822_z7fw4MW3tzOf"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#x2019;s 10-K as of June 30, 2023. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summarized
financial information concerning the Company's reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zZIG65ctMVI3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zEhaEFWdpf75" style="display: none"&gt;Schedule
    of summarized segment financial information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt; Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 55%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHJJUM3abEY5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,056&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpNMaRqUO2uh" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,782&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20230930_zSYOLDvCoXP" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;25,838&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zQ2f6WTnmENj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyb499xmpPJ3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0987"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930_z4kbCKcoIzh8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zV7AeR6lAC77" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(738&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zcJauCxccFab" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930_zLyvhvaBxAFd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zzXioLSXFVQ6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPJOLg1o3BNb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,134&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930_z3YkNiVMql26" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,195&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_z6NPxTdabOi5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrWJgRRPSpo4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930_zEamsH9Hkezl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zRjbxIAP9QTj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,878&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zfc8GkVvSDF8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,313&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20220701__20220930_zALiXFlYl3R2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,191&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_ziN2lGCyRkge" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zBbNgJRrkSyd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1017"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930_zMnJn1rIrynj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zJsyqubEYeT4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(802&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zsD8es7WMqYa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,713&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930_ztYbWRPzu2V8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,911&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zxDdIdvRDVA3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zVv2Q9YVWwX3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,046&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930_z8hX23re9786" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHB8D3KsxTCj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zeWHM6Zkznl4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930_zwg5Y5HbKbHd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;963&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2023-07-01to2023-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zZIG65ctMVI3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zEhaEFWdpf75" style="display: none"&gt;Schedule
    of summarized segment financial information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt; Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 55%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHJJUM3abEY5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,056&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpNMaRqUO2uh" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,782&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20230930_zSYOLDvCoXP" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;25,838&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zQ2f6WTnmENj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyb499xmpPJ3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0987"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pn3n3_c20230701__20230930_z4kbCKcoIzh8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zV7AeR6lAC77" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(738&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zcJauCxccFab" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20230701__20230930_zLyvhvaBxAFd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zzXioLSXFVQ6" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zPJOLg1o3BNb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,134&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20230701__20230930_z3YkNiVMql26" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,195&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_z6NPxTdabOi5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrWJgRRPSpo4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20230701__20230930_zEamsH9Hkezl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zRjbxIAP9QTj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,878&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zfc8GkVvSDF8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21,313&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20220701__20220930_zALiXFlYl3R2" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,191&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_ziN2lGCyRkge" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zBbNgJRrkSyd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1017"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20220930_zMnJn1rIrynj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zJsyqubEYeT4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(802&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zsD8es7WMqYa" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,713&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_c20220701__20220930_ztYbWRPzu2V8" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,911&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zxDdIdvRDVA3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zVv2Q9YVWwX3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,046&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20220701__20220930_z8hX23re9786" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_zHB8D3KsxTCj" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zeWHM6Zkznl4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20220701__20220930_zwg5Y5HbKbHd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;963&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">2056000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">23782000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">25838000</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">254000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">254000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-738000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">7309000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">6571000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">61000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1134000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1195000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012023-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">16000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-012023-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">63000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">79000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">1878000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">21313000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">23191000</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-802000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">4713000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">3911000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">72000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1046000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">24000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">939000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">963000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_809_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zscdwkucfBW8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
9 &#x2013; &lt;span id="xdx_82A_zJacSpFcxF8e"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the three months ended September 30, 2023 and September 30, 2022, the Company paid $&lt;span id="xdx_90A_eus-gaap--InterestPaidNet_pn3n3_c20230701__20230930_zN5BgU8b4D0d" title="Interest paid"&gt;48&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--InterestPaidNet_pn3n3_c20220701__20220930_z6wr6sgGQz14" title="Interest paid"&gt;15&lt;/span&gt; for interest, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the three months ended September 30, 2023 and September 30, 2022, the Company paid $&lt;span id="xdx_90B_eus-gaap--IncomeTaxesPaid_pn3n3_c20230701__20230930_z4vrgJW1fUlj" title="Income taxes paid"&gt;150&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--IncomeTaxesPaid_pn3n3_c20220701__20220930_zlotCbguAbs6" title="Income taxes paid"&gt;395&lt;/span&gt; for income taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">48000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">15000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">150000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">395000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zg3BCHiCbgUh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
10 &#x2013; &lt;span id="xdx_822_zlNQqUvQAwj5"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $&lt;span id="xdx_906_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn6n6_c20220926_zvNvX6GYAOZ3" title="Stock purchase plan"&gt;9&lt;/span&gt; million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the three months ended September 30, 2023 and
2022, the Company repurchased &lt;span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20230701__20230930_zBDlEazuNdHd" title="Number of shares repurchased"&gt;43&lt;/span&gt; and &lt;span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20220930_zyJqUgzP7RV7" title="Number of shares repurchased"&gt;9&lt;/span&gt; shares at a cost of $&lt;span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230701__20230930_zZlklHRUa9Q6" title="Number of shares repurchased, value"&gt;714&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20220701__20220930_zhMehpQdQVBf" title="Number of shares repurchased, value"&gt;122&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_900_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pn3n3_c20230701__20230930_zR4zl0QyZvre" title="Liability for individual claims"&gt;150&lt;/span&gt; per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of September 30, 2023 and June 30, 2023, the Company had approximately $&lt;span id="xdx_90A_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_iI_pn3n3_c20230930_z2HYkHqzGkEg" title="Reserve for self-funded"&gt;176&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_iI_pn3n3_c20230630_z675cYmLioef" title="Reserve for self-funded"&gt;101&lt;/span&gt;, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d; in the
condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="AsOf2022-09-26" decimals="-6" unitRef="USD">9000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="Shares">43000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="Shares">9000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">714000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">122000</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">150000</FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">176000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2023-06-30" decimals="-3" unitRef="USD">101000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zmIr6y0AlSi7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
11 - &lt;span id="xdx_827_zyet9be3q4K9"&gt;INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC 740-270, &#x201c;Income Taxes &#x2013; Interim Reporting,&#x201d; the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2023 and 2022, the Company recorded income tax expense of $&lt;span id="xdx_90F_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20230701__20230930_zCAX1OUUoFGb" title="Income tax expense"&gt;1,670&lt;/span&gt; in 2023 as compared
to $&lt;span id="xdx_902_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_pn3n3_c20220701__20220930_zPLWglrOBq49" title="Income tax expense"&gt;1,409&lt;/span&gt; in 2022. The 2023 provision is comprised of a current income tax component of $&lt;span id="xdx_907_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_c20230701__20230930_zvgAdvdZjx8f" title="Income tax component - current"&gt;428&lt;/span&gt; and a deferred income tax component of $&lt;span id="xdx_90E_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zag9knJmBkIg" title="Income tax component - deferred"&gt;1,242&lt;/span&gt;.
Obligations for any liability associated with the current income tax provision has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC Topic 740. The Company believes there are no uncertain tax positions in prior year tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC Topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#x201c;Interest expense, net&#x201d;. Penalties if incurred would be recognized as a component of &#x201c;Selling,
general and administrative&#x201d; expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2018.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company recorded a deferred tax asset of $&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3_c20230930_zEF2FWUVPxX8" title="Deferred tax asset"&gt;8,800&lt;/span&gt;
and a deferred tax liability of $&lt;span id="xdx_906_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pn3n3_c20230930_ze3Cp7syDcac" title="Deferred tax liability"&gt;395&lt;/span&gt;
as of September 30, 2023, primarily relating to Federal operating loss carryforwards, allowance for doubtful accounts and tax
credits. There is approximately $&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20230930_zG6dbdffUY3b" title="Federal operating loss carryforwards"&gt;&lt;span id="xdx_905_ecustom--FederalOperatingLosses_pn3n3_c20230701__20230930_zV95le90BkTl" title="Federal operating losses"&gt;3,198&lt;/span&gt;&lt;/span&gt;
of Federal operating losses available to offset future taxable income through 2031. The net operating losses begin to expire in 2028
for federal tax and state income tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September, 2023, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Inflation Reduction Act (&#x201c;IRA&#x201d;) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share
repurchases that occur after December 31, 2022 and introduces a 15% corporate alternative minimum tax (&#x201c;CAMT&#x201d;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company is expecting
the IRA not to have a material impact to the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1670000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2022-07-012022-09-30"
      decimals="-3"
      unitRef="USD">1409000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">428000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">1242000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">8800000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">395000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2023-09-30" decimals="-3" unitRef="USD">3198000</us-gaap:OperatingLossCarryforwards>
    <FONR:FederalOperatingLosses
      contextRef="From2023-07-01to2023-09-30"
      decimals="-3"
      unitRef="USD">3198000</FONR:FederalOperatingLosses>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-07-01to2023-09-30">&lt;p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zTwiyT02uMoe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
12 &#x2013; &lt;span id="xdx_821_zl0CPIjTreQc"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has evaluated events that occurred subsequent to September 30, 2023 and through the date the condensed consolidated financial
statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
of October 31, 2023, the Company repurchased &lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_903_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20231031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHkHVWivZNzj" title="Stock repurchase plan, shares"&gt;33&lt;/span&gt;
shares of common stock at a cost of $&lt;span id="xdx_90A_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20231031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTBvDEoxzEQb" title="Stock repurchase plan"&gt;471
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;which
was authorized under the stock repurchase plan adopted in September 2022.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="AsOf2023-10-31_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="Shares">33000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2023-10-31_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="USD">471000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>55
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M]<N%B-7LJ@W4[^=25L]O])<JME^B.?\_4$L#!!0    ( &AT;E>8ZI#5/@0
M ,46   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULM9C1CN(V%(9?Q4JK
M:E?:3F(#@9D"$@-4.]4NBY:9[475"P\8B":)J6U@MT]?.\DD\<0X@-(;B)-S
M3KYCY^<G[A\I>^%;0@3X'H4Q'SA;(79WKLN76Q)A?D-W))97UI1%6,@AV[A\
MQPA>)4E1Z"+/\]T(![$S["?GYFS8IWL1!C&9,\#W4839CWL2TN/ @<[KB:_!
M9BO4"7?8W^$-61#QM)LS.7+S*JL@(C$/: P860^<$;P;HZY*2"*^!>3(2\=
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M5RX62_=,TX&@NV3;\9D*0:/D<$OPBC 5(*^O*16O [63F>]<#_\#4$L#!!0
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M;,"M)SXN<<TDQP+XSKS7O;"![<7U]%]02P,$%     @ :'1N5XS&W_1P"@
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M5*Z]LR#D*JT)R*<AF X<SC;X!.42:Q5(U+;!YQNX'0,W50#39-..K*I3K-%
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M;3B+]DH>P.Z,6X!0<FTWD)T-?1BBM^XEN(;),<]VU4>C<!8=XF$KZC\%U[P
M2X./;4!P*0"KV4J@*';MFX73:40&CL+C"6D:3\/1:/ICZU=:Y:WAN3>0E51P
M,H;DJ][MW!EV_-;T7M,FXW :>2".)Q/R*QQ.Q@'%\A]"?S@9MNAC\\GH61RC
MH]G7..+3#^,X#0]GQ[15%$Z&;K<C(/O/X3@ZBIQ+L]G0X3B:1.PA%<$<U<2+
MS4M3MR.A#>-:H,H 8 $RI"UDX0HM%3RS:4P_RR*!N-[T68MD)P)S5R\!JO03
M&IY-8:LIT:B954Y1O6ECXS8T'1\;]["DU"JIL-IP(FF"A>@'KKIG+4HN:XQ
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M^\='/>*_M'VQJG0WIDME0;7N$=T'.4P"^'VEE&U>:(/V"OWL?U!+ P04
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MK:C= 8JOE+([QUW0#NO)'U!+ P04    " !H=&Y7@TL8PFP#  "O!P  &0
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M!-^KQLNXL: JCU I0?.!S.^#%0V>LA7H1,IYA@N> VH.B_6:>+D.^=)*=)O
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M][R.!QFN2%7H1[&YPVT];<N7BD*Y7]C4L:W8@[126K MV"A@E-=?\K[]'_8
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M<VAE971S+W-H965T,C N>&UL[5E;;]LZ$G[7KR!\#@Y:P'$<Y]HF#9"X23?
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MYI]A\?AEELX^+>&7%5L7J'\=!H:(;7B0-233FB1^@R2!!RG,3L,GD6/^<WQ
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M/FQ8MQ]/YG43-Z%RE7,%!5NB:W#6QE24=6-43[38V&9D(32V-G:XQEZ226.
MWY="Z/W$;-!TIX._ 5!+ P04    " !H=&Y7&)FHZ[<"  #R!0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R,RYX;6R-5&UOVC 0_IY?<4JKJI50\PJD+42"
MCFZ5V@X5MGTVR4&L.7%F&VC__6P'4B91M"_Q/?;=<\_9N1MLN?@M"T0%;R6K
MY- ME*IO/4]F!99$7O,:*WVRY*(D2D.Q\F0MD.0VJ&1>Z/L]KR2T<M.!W9N*
M=,#7BM$*IP+DNBR)>!\CX]NA&[C[C5>Z*I39\-)!358X0_6CG@J-O)8EIR56
MDO(*!"Z'[BBX'<?&WSK\I+B5!S:82A:<_S;@,1^ZOA&$##-E&(A>-GB/C!DB
M+>//CM-M4YK 0WO/_F!KU[4LB,1[SG[17!5#-W$AQR59,_7*M]]P5T_7\&6<
M2?N%;>,;1RYD:ZEXN0O6"DI:-2MYV]W#04#B?Q(0[@)"J[M)9%5^(8JD \&W
M((RW9C.&+=5&:W&T,H\R4T*?4AVGTN_3R>MH_OCR%2Y(6=_!P^/+Z.7>X*?)
M:#:9P>6<+!C*JX&G=#H3Y&4[ZG%#'7Y"'<$SKU0A85+EF/\;[VF9K=9PKW4<
MGB2<87T-D=^!T ^C$WQ16WMD^;J?U5ZC((I6*WB@%:DR8SVA?F)YK-B&*SK.
M97KG5M8DPZ&KFT.BV*";7IP%/?_NA-*X51J?8D^?4$I$X*U@9F4"HV1!&57O
M^I=0:Z&-8\I/<A]7_O\)G?D6V0:=C[<V[NW5.O9"/RYXAZ?D77>VDHY^RAC.
MH=?Q_1N]AG%LMKK0[?1[R1[V-(Q"?P_[$'627A<"/S0PT;"K?2[.DC ([YQY
M@7H\+14*"(-.W _:DZFIKU+.AK U0DYEQM>5@LO [P2] *[@LNO#E3/GBC#'
M5GQ0\#E$6M1-HHU^$L.Q5_4.^K!$L;+31H+-TK1DN]L.M%'3QQ_NS31\)F)%
M*WWAN-2A_G5?_\2BF3 -4+RV7;W@2L\(:Q9Z**,P#OI\R;G: Y.@'?/I7U!+
M P04    " !H=&Y7V=<L!'("  !/!0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R-"YX;6Q]5-%.VS 4?<]76-DT;1*0U"F%L382!:9U$JRB'3Q,>W"3V\;"
ML8/M4/C[73MIZ*2V+_&]]CW'YSH^'JZ5?C(%@"6OI9!F%!;65A=19+("2F9.
M5 425Y9*E\QBJE>1J32PW(-*$=$X'D0EXS),AWYNJM.AJJW@$J::F+HLF7X;
M@U#K4=@+-Q/W?%58-Q&EPXJM8 ;V=S75F$4=2\Y+D(8K230L1^%E[V+<=_6^
MX('#VFS%Q'6R4.K))9-\%,9.$ C(K&-@.+S %0CAB%#&<\L9=ELZX':\8?_N
M>\=>%LS E1*//+?%*#P/20Y+5@M[K]8_H.WGU/%E2AC_)>NF-J$AR6IC5=F"
M44')93.RU_8<M@#G\1X ;0'4ZVXV\BJOF67I4*LUT:X:V5S@6_5H%,>E^RDS
MJW&5(\ZFD[N'F[OYK_O)S8Q\GK.% /-E&%ED=NM1UK*,&Q:ZAR4AMTK:PI ;
MF4/^/SY"19TLNI$UI@<)9U"=D"0^(C2FR0&^I&LS\7RG^]J4+R"MTF_DFIM,
M*%-K('\N%\9JO!=_=W7<$":["9U7+DS%,AB%: 8#^@7"]-.'WB#^=D!NOY/;
M/\2>SM![>2V J"7AK70.9I?,@T2[9>YA#_#0+90+T($[^9^U!!<$TUIG!5[\
M/*B8MN:(9*JLE$28(4SFZ.>J$H@G'PD].DUZ?DSZ@^ 1_7C,Y7&E50;&$/HU
M(93V@[FR3 23]YT]XISV&X:SF.PZPFCKDI>@5][*!L74TC;WO9OM7HO+QB3O
MY<U3<\OTBDM#!"P1&I^<X;71C7V;Q*K*6V:A+!K0AP6^>*!= :XOE;*;Q&W0
MO:'I/U!+ P04    " !H=&Y7!;92YN<"   K!@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6R-5=]OTS 0?L]?806$0"I+FC3K&&VE=HPQM(UI+?"
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MJ$]E8-K6U"ZLKGT[F&M+=^6G)75S,,Z!SA=:V\W")=C^'T:_ 5!+ P04
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M=KK#9Q*D,<#_&R'T<6$"= _O^ =02P,$%     @ :'1N5TB\I59\ P  UPL
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MIB>LC7[^R;2-7U6]<:-@!<Z=E'/GAW9*I]($E:VKFEA0O7'=E$3W!W5)M](
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MV[E2=TJ=O8>K>XC8*K5 O!!U]]]?0 90(ZNNLR]"H/M+?TWR=9OZAO$OT0)
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M*-\><VT'@BV3DZ()$X(%R>T"Z!1X;"#?SYB4U'00'SYEAXW-_P%02P,$%
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MN\STU8;"%.C]+>?J)3#CUER6T2]02P,$%     @ :71N5SGMYIK9 P  6Q$
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MLQTZ5PXDN&:[U"SDX0-6>OJ6+Y:I+O[A4,5Z#L0[;616@2F#C(ORR;Y7/C0
MQ-,.\"N ?PKH/0'H5H#NSP)Z%:!7.%-**7R8,L-& R4/H&PTL=E&86:!)OE<
MV,^^-(K><L*943B9?+J?WRUA$4VBF\_A^&/T!F;1]&82?FR,03B?PBR<AW]$
MLVA^5W0_W7V(%O ^BII@>#5%PWBJ8<Z48O:COH:W<+^<PJL7K^$%< %W6[G3
M3"1ZX!J28!-QXRK=<9FN_T2Z79A)8;8:(I%@<HQW27JMWW_4/_;/$BXQOX"N
M]P9\S^^VY#/Y>;C? I^>A_^Y$T_-?J2F6W_-;L'7?X)O@3'R/5NEJ.%+N-)&
MT;[ZVF9SR=-MY[&UYEKG+,:A0\5$H]JC,WKY6R?PWK5Y]"O)IK^([,B_7NU?
M[QS[*(QCN1-&4T%[-)(6;RK%!@RJK,W(DC H"&V-W8_ZGC=P]TU_SD[Z7'_^
M.^%EY\>$1[+[M>S^6=FWJ&(4ALH\R#4(.FP4[E'LD"JHHAV<P%K)#(1\6]13
MH+T+.2HM!4MI0_^]4P^0*VFJ6AZGC+=Z56;1Z31R]RZ"RZL3NZHP[SCLZO>C
MWS%F>E;@_UPU06U?\ S[8BFT3'G"#/G6]++P,&."XNC<-+!&VJ7QEJD-!1I)
M<6F!R9DR#Y!APF.R-[=;F,?86BR#-D,[G>#$T/8P_]3#LRJ?ZZ';.),R)(WV
M;">]=G^5Y;D>K:\/87%JGHR/.]>3\A;P@Z:\D\S(.BXTI+@F2N_BDA:!*L_Y
MLF-D7IQ\*VGH'"V:6[H:H;(!]'XM:<U6'3M!?=D:_0M02P,$%     @ :71N
M5V)V,8Y\ P  3 X  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULM9=O
M;]HP$,:_BI5-TR;1)@Z00 =(_;M5ZCI4NDW3M!<&#K"6V)EMROKM9R<T88UC
ME:U[ W&2N_N=$S]//-AP\4.N !3ZE29,#KV54MF1[\O9"E(B#WD&3%]9<)$2
MI8=BZ<M, )GG06GBAT$0^2FAS!L-\G-C,1KPM4HH@[% <IVF1-R?0,(W0P][
M#R=NZ'*ES E_-,C($B:@/F5CH4=^F65.4V"2<H8$+(;>,3XZP7T3D-_QF<)&
M[APCT\J4\Q]F<#D?>H$A@@1FRJ0@^N\.3B%)3";-\7.;U"MKFL#=XX?L%WGS
MNIDID7#*DR]TKE9#K^>A.2S(.E$W?/,>M@UU3;X93V3^BS;%O;&N.%M+Q=-M
ML!ZGE!7_Y-=V(G8"PK A(-P&A#EW42BG/".*C :";Y P=^MLYB!O-8_6<)29
MIS)10E^E.DZ-/H[/;XYO+Z_?H5<DS=ZBB\OKX^M3,[XZ/YZ<3] !N@+=-1J3
M>_TPE$2OST 1FL@WZ"6B#-VN^%H2-I<#7VD>D]6?;6N?%+7#AMH3R Y1.VBA
M, C;Z-/D#+U^^>;/-+YNI^PI+'L*\[SMIIXR$$11MGR,_NT#I%,0WVVHSI1F
M;1S)C,Q@Z.F77X*X V_TZ@6.@K<.X'8)W'8"7X&4 "WT"+R%KBB9TH2J^Q92
M'$U-*W3>0E^!"/21@:V/HE*45S)+\FX4!4%_X-]9^#HE7^?Y^6XWW,975.KL
M\'7CJ&?GZY9\W?_ MQ)@G<%NG; =!G;"J"2,GI_P@J^%#3"J ;9[4=<.&)>
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M;^%^)O.R)^]HD=K*82HTUB&VN<!2$:29@,]G0NAMQR0HBL_^7U!+ P04
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ML3T'=\ZC:'5.1>M?T :_ %!+ P04    " !I=&Y7EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( &ET;E=[BZ]T_@,
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MSF;W._6.Z5J%^.QYK/'Y[Z0ZW>X-S\??EX^3G;?WCK.#?U&+7U!+ P04
M" !I=&Y7+M+XP*X!  #*&@  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-F<UN
MPC 0A%\%Y8J(L9W2'P&7MM>60U_ 338D(HDMVU!X^SKA1VI%HR(J=2ZQ$N_.
MC+W2=\GT;6?(#;9UU;A95'AO'AAS:4&U<K$VU(2=7-M:^?!JE\RH=*66Q,1X
M/&&I;CPU?N1;C6@^?:)<K2L_>-Z&SZ[4S2RR5+EH\+@O;+UFD3*F*E/EPS[;
M--DWE]'!(0Z=78TK2N.&H2!B9QW:G9\-#GVO&[*VS&BP4-:_J#I4L6W%G-]5
MY.)^B3,9=9Z7*64Z7=>A)7;&DLI<0>3K*MZ+#ON=?;AAVC_YU?Z=3)]AJ%Q8
M;5R8F*7+[8XC:;M')@B1]67_$4^.0?KJ\U$[[8RR7WJ'Z_W0=M7-P[%NN?Z.
MO\[XI']A#@&20X+D2$!RW(#DF(#DN 7)<0>2XQXD!Q^C!$$A*D=!*D=A*D>!
M*D>A*D?!*D?A*D<!*T<AJT AJT AJT AJT AJT AJT AJT AJT AJT AJT A
MJT0AJT0AJT0AJT0AJT0AJT0AJT0AJT0AJT0AJT0A:X)"U@2%K D*61,4LB;_
M2=9WK5=__7>E7>-:E<W1GW6_L.:?4$L! A0#%     @ :'1N5P=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !H=&Y76+84V>\    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !H=&Y7F5R<(Q &  "<)P  $P
M        @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &AT
M;E?6=4)Y6 8  %XD   8              " @0X(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !H=&Y7SU\_<"X)  !0,P  &
M        @(&<#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ :'1N5YCJD-4^!   Q18  !@              ("! !@  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( &AT;E?V@PR+N04  +X7   8
M              " @70<  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !H=&Y7^SGI2QH$   M$0  &               @(%C(@  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ :'1N5YBFI";*!
M,!D  !@              ("!LR8  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( &AT;E>Z^.A-T08  (T=   8              " @;,K
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !H=&Y7A!R]
MG:(&  #$#@  &               @(&Z,@  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ :'1N5XS&W_1P"@  K1D  !@
M ("!DCD  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( &AT
M;E<H$/76: D  $X7   9              " @3A$  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ :'1N5V ^A,E3!@  _PT  !D
M         ("!UTT  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !H=&Y7B]=^K*@"  "X!0  &0              @(%A5   >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( &AT;E>#2QC"; ,  *\'
M   9              " @4!7  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ :'1N5R*@Z(=+ P  \@8  !D              ("!XUH
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !H=&Y7N3"#
MLTP$  "^"0  &0              @(%E7@  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( &AT;E<8$D&;; (  ,D%   9
M  " @>AB  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M:'1N5PC,VN)^!0  J@L  !D              ("!BV4  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !H=&Y73X#3GZ,(  ##$P  &0
M            @(% :P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( &AT;E=-;[ACN (  .P%   9              " @1IT  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ :'1N5UG6&^'7"@
M+QX  !D              ("!"7<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !H=&Y7EZ].NB8#   )!P  &0              @($7
M@@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( &AT;E>A
MA;.V,@0  *D*   9              " @72%  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ :'1N5QB9J.NW @  \@4  !D
M     ("!W8D  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &AT;E=(O*56? ,  -<+   9              "
M@5R9  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ :'1N
M5Q<_?0ID!   ^1(  !D              ("!#YT  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !I=&Y7$<X3>X4"  #C!0  &0
M        @(&JH0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( &ET;E>\CUEH200  '@4   9              " @6:D  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ :71N5R%>FHI: @  . 4
M !D              ("!YJ@  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !I=&Y7.>WFFMD#  !;$0  &0              @(%WJP
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( &ET;E<$E(:@
M5 ,  '@)   9              " @8>O  !X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ :71N5V)V,8Y\ P  3 X  !D
M ("!$K,  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !I
M=&Y7OEP&#7\"  !2!@  &0              @('%M@  >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( &ET;E=JF<>"SP,  'X1   9
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M970T,2YX;6Q02P$"% ,4    " !I=&Y7T01J2G(#  !+#0  &0
M    @(%ERP  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M &ET;E?F,O=Q' ,  (@*   9              " @0[/  !X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ :71N5V!\!L!& @  Z@0  !D
M             ("!8=(  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    " !I=&Y7C;PZJ3T#  !.$P  #0              @ '>U   >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &ET;E>7BKL<P    !,"   +
M      "  4;8  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( &ET;E=[BZ]T_@,
M -@=   /              "  2_9  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " !I=&Y71QQ@N:0!  ";&@  &@              @ %:W0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !I=&Y7+M+XP*X!  #*
M&@  $P              @ $VWP  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    -  T ",.   5X0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>94</ContextCount>
  <ElementCount>233</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>29</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfIncome</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesTables</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingFinancingLeases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="fonar_10-q.htm">fonar_10-q.htm</File>
    <File>fonr-20230930.xsd</File>
    <File>fonr-20230930_cal.xml</File>
    <File>fonr-20230930_def.xml</File>
    <File>fonr-20230930_lab.xml</File>
    <File>fonr-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar_logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="436">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "fonar_10-q.htm": {
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "fonar_10-q.htm"
     ]
    },
    "schema": {
     "local": [
      "fonr-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "fonr-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 187,
   "keyCustom": 46,
   "axisStandard": 9,
   "axisCustom": 0,
   "memberStandard": 14,
   "memberCustom": 14,
   "hidden": {
    "total": 59,
    "http://fasb.org/us-gaap/2023": 44,
    "http://fonar.com/20230930": 10,
    "http://xbrl.sec.gov/dei/2023": 5
   },
   "contextCount": 94,
   "entityCount": 1,
   "segmentCount": 29,
   "elementCount": 346,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 436,
    "http://xbrl.sec.gov/dei/2023": 32
   },
   "report": {
    "R1": {
     "role": "http://fonar.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
     "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
     "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30_custom_CommonStockholdersMember",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
     "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "longName": "00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "longName": "00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "longName": "00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://fonar.com/role/OperatingFinancingLeases",
     "longName": "00000011 - Disclosure - OPERATING & FINANCING LEASES",
     "shortName": "OPERATING & FINANCING LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://fonar.com/role/Inventories",
     "longName": "00000012 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "longName": "00000013 - Disclosure - OTHER INTANGIBLE ASSETS",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "longName": "00000014 - Disclosure - OTHER CURRENT LIABILITIES",
     "shortName": "OTHER CURRENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "longName": "00000015 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "longName": "00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "longName": "00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://fonar.com/role/IncomeTaxes",
     "longName": "00000018 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://fonar.com/role/SubsequentEvents",
     "longName": "00000019 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "longName": "00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://fonar.com/role/OperatingFinancingLeasesTables",
     "longName": "00000023 - Disclosure - OPERATING & FINANCING LEASES (Tables)",
     "shortName": "OPERATING & FINANCING LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://fonar.com/role/InventoriesTables",
     "longName": "00000024 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "longName": "00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "longName": "00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "longName": "00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "longName": "00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_NoncontrollingInterestMember",
      "name": "FONR:OwnershipInterestOfOriginalInvestorsOfHdm",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_NoncontrollingInterestMember",
      "name": "FONR:OwnershipInterestOfOriginalInvestorsOfHdm",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "longName": "00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "FONR:AccountsReceivableServiceAndRepairFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "FONR:AccountsReceivableNetRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1",
     "longName": "00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "longName": "00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "longName": "00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "FONR:AccountsReceivableNetLongTerm",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "longName": "00000035 - Disclosure - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "longName": "00000036 - Disclosure - INVENTORIES - Inventories (Details)",
     "shortName": "INVENTORIES - Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "longName": "00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Other intagible assets net of amoritization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "longName": "00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-07-012023-09-30_custom_PatentsAndCopyrightsMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30_custom_PatentsAndCopyrightsMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "longName": "00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
     "longName": "00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "FONR:IntersegmentNetRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "longName": "00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2022-09-26",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-09-26",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000043 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-01to2023-09-30",
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2023-10-31_us-gaap_SubsequentEventMember",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-10-31_us-gaap_SubsequentEventMember",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-q.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r203",
      "r284",
      "r394",
      "r404",
      "r460",
      "r461"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of Treasury Stock",
        "label": "Number of shares repurchased, value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r61",
      "r62",
      "r92",
      "r317",
      "r376",
      "r382",
      "r414"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Revenues \u2013 Net",
        "label": "Net revenues from external customers",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r141",
      "r175",
      "r176",
      "r181",
      "r185",
      "r186",
      "r192",
      "r194",
      "r195",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r264",
      "r286",
      "r463"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other intangible assets",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock repurchase plan, shares",
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "FONR_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "OtherMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other current liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Of Diagnostic Imaging Centers [Member]",
        "documentation": "Management of Diagnostic Imaging Centers - Member - Custom element"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r68",
      "r69",
      "r70"
     ]
    },
    "FONR_FinancingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "FinancingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountReceivableRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "AccountReceivableRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - related party",
        "documentation": "It represents the amount of accounts receivable service related parties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares repurchased",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r61",
      "r62",
      "r92",
      "r312",
      "r376",
      "r382"
     ]
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liability",
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "AccountsReceivableServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - net",
        "verboseLabel": "Accounts receivable",
        "documentation": "It represents the amount of accounts receivable service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "documentation": "Information by major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest and penalty",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r178"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r37",
      "r77"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NetIncomeLossAvailableToCommonStockholderBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "NetIncomeLossAvailableToCommonStockholderBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Numerator: Net income available to common stockholders",
        "documentation": "This represents the amount of net income loss available to common stockholder basic during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ConvertibleClassCStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ConvertibleClassCStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Class C Stock",
        "documentation": "This represents the shares of convertible class c stock during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r233",
      "r235",
      "r236",
      "r237",
      "r241",
      "r245",
      "r246",
      "r247",
      "r314"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earning per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "FONR_CommonStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CommonStockholdersMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability - current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "FONR_UnearnedRevenueOnServiceContractsRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "UnearnedRevenueOnServiceContractsRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts \u2013 related party",
        "documentation": "This represents the amount of unearned revenue on service contracts related party during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CustomerDeposits",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits",
        "documentation": "This represents the amount of customer deposits during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "FONR_AccountsPayableRelatedPartyNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "AccountsPayableRelatedPartyNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related medical practices",
        "documentation": "This represents the amount of accounts payable related party noncurrent during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401"
     ]
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue \u2013 net of contractual allowances and discounts",
        "documentation": "This represents the amount of patient fee revenue net of contractual allowances and discounts during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ProductSalesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ProductSalesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net",
        "documentation": "This represents the amount of product sales net during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r409",
      "r410",
      "r411",
      "r412",
      "r484",
      "r488"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r227",
      "r451",
      "r452",
      "r453",
      "r488"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401"
     ]
    },
    "FONR_ServiceAndRepairFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ServiceAndRepairFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net",
        "documentation": "This represents the amount of service and repair fees net during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees - related parties \u2013 net",
        "documentation": "This represents the amount of service and repair fees related parties net during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "periodStartLabel": "Balance - June 30, 2022",
        "periodEndLabel": "Balance \u2013 September 30, 2022",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r50",
      "r111",
      "r112",
      "r129",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r200",
      "r201",
      "r227",
      "r229",
      "r230",
      "r231",
      "r239",
      "r240",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r266",
      "r270",
      "r277",
      "r304",
      "r305",
      "r315",
      "r338",
      "r354",
      "r377",
      "r378",
      "r384",
      "r414",
      "r449",
      "r457",
      "r474",
      "r488"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ManagementAndOtherFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net",
        "documentation": "This represents the value of management and other fees net during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r360"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r360"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees - related medical practices \u2013 net",
        "documentation": "This represents the value of management and other fees related medical practices net during the period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToProductSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CostsRelatedToProductSales",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales",
        "documentation": "This represents the value of costs related to product sales during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax liability",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r279"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related medical practices",
        "documentation": "This represents the amount of costs related to management and other fees related medical practices during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CostsRelatedToServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees",
        "documentation": "This represents the amount of costs related to service and repair fees during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees - related parties",
        "documentation": "This represents the amount of costs related to service and repair fees related parties during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CostsRelatedToManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees",
        "documentation": "This represents the amount of costs related to management and other fees during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ProvisionForBadDebts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ProvisionForBadDebts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Recovery) Provision for bad debts",
        "documentation": "This represents the amount of provision for bad debts during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_InvestorsOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "InvestorsOwnershipInterest",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors ownership interest percentage",
        "documentation": "This represents the rate of investors ownership interest during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Customer deposits",
        "documentation": "This represents the amount of increase decrease in customer advance during period.",
        "label": "IncreaseDecreaseInCustomerAdvance"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "IncreaseDecreaseInNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventorySupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInventorySupplies",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased parts, components and supplies",
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24"
     ]
    },
    "FONR_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financing lease liabilities",
        "documentation": "This represents the amount of increase decrease in financing liabilities during period.",
        "label": "IncreaseDecreaseInFinancingLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing receivable noncurrent allowance for credit loss",
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r458"
     ]
    },
    "FONR_DisclosureOperatingFinancingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "DisclosureOperatingFinancingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Financing Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of facilities owned or managed",
        "documentation": "Total Facilities Owned Or Managed Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ScheduleOfPatientFeeRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ScheduleOfPatientFeeRevenueTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of patient fee revenue",
        "documentation": "Schedule Of Patient Fee Revenue Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "HmcaOwnershipSizeOfImperialManagementServicesPercent",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of Imperial Management Services after reorganization of newly expanded HDM",
        "documentation": "This represents the rate of hmca ownership size of imperial management services percent during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM",
        "documentation": "This represents the rate of ownership interest after reorganization for health management corporation of America of newly expanded hdm percent during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OwnershipInterestOfOriginalInvestorsOfHdm": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "OwnershipInterestOfOriginalInvestorsOfHdm",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of the original investors of HDM",
        "documentation": "This represents the rate of ownership interest of original investors of hdm during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING &amp; FINANCING LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct purchase of Noncontrolling Interests",
        "documentation": "This represents the amount of direct purchase of noncontrolling interests during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r317",
      "r451",
      "r452",
      "r453",
      "r473",
      "r488"
     ]
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PatientFeeRevenueNetOfContractualAllowancesAndDiscount]",
        "documentation": "This represents the amount of patient fee revenue net of contractual allowances and discounts during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Denominator for Diluted Earnings Per Share",
        "documentation": "Weighted average number of diluted earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountsReceivableNetRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "AccountsReceivableNetRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - Related party",
        "documentation": "Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNonRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ManagementAndOtherFeesNonRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r291",
      "r404"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of net revenue derived from no-fault and personal injury protection claim",
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of consolidated net revenue from management fees charged to related party medical practices",
        "documentation": "Percentage of consolidated net revenue from management fees."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PresentValueDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PresentValueDiscount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PresentValueDiscount-0]",
        "documentation": "This represents the amount of present value discount during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r15",
      "r111",
      "r128",
      "r129",
      "r130",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r167",
      "r200",
      "r201",
      "r227",
      "r229",
      "r230",
      "r231",
      "r239",
      "r240",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r277",
      "r303",
      "r304",
      "r305",
      "r317",
      "r376"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r429",
      "r430"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r200",
      "r201",
      "r229",
      "r230",
      "r231",
      "r239",
      "r240",
      "r255",
      "r257",
      "r258",
      "r260",
      "r261",
      "r303",
      "r305",
      "r317",
      "r488"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r167",
      "r281",
      "r308",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r355",
      "r358",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r408"
     ]
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PresentValueDiscountFinancingLease",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PresentValueDiscountFinancingLease-0]",
        "documentation": "This represents the amount of present value discount financing lease during period."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_StateIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "StateIncomeTaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State income taxes payable",
        "documentation": "the value of state income taxes payable."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicalEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "MedicalEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "FONR_IntersegmentNetRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "IntersegmentNetRevenues",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment net revenues",
        "documentation": "This represents the amount of intersegment net revenues during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment - net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r287",
      "r296",
      "r404"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts, medical and management fee receivable(s)",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r111",
      "r128",
      "r129",
      "r130",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155",
      "r167",
      "r200",
      "r201",
      "r227",
      "r229",
      "r230",
      "r231",
      "r239",
      "r240",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r277",
      "r303",
      "r304",
      "r305",
      "r317",
      "r376"
     ]
    },
    "FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for individual claims",
        "documentation": "This represents the amount of stop loss umbrella policy with 3 rd paryinsurer to limit maximum potential liability for individual claims during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PatentsAndCopyrightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "PatentsAndCopyrightsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents and copyrights",
        "documentation": "Patents and copyrights - Member - Custom elements"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FederalOperatingLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "FederalOperatingLosses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal operating losses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Loss) Income from operations",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r75",
      "r86",
      "r148",
      "r149",
      "r150",
      "r151",
      "r162",
      "r165"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other general and administrative expenses",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r38"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic income per common share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r101",
      "r103",
      "r133",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r158",
      "r163",
      "r164",
      "r263",
      "r285",
      "r481"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r32",
      "r36"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BUSINESS COMBINATION",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicareMedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "MedicareMedicaidMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Medicaid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r167",
      "r281",
      "r308",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r355",
      "r358",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r408"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "auth_ref": [
      "r196",
      "r197",
      "r198"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CommercialInsuranceManagedCareMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Insurance Managed Care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentOperatingActivitiesDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r292",
      "r404"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Before Provision for Income Taxes and Noncontrolling Interests",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r72",
      "r102",
      "r174",
      "r182",
      "r187",
      "r190",
      "r286",
      "r297",
      "r393"
     ]
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "WorkersCompensationPersonalInjuryMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers Compensation Personal Injury [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r336"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r62",
      "r336",
      "r354",
      "r488",
      "r489"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Activities [Axis]",
        "documentation": "Information by continuing and discontinuing operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r122",
      "r123",
      "r124",
      "r141",
      "r158",
      "r159",
      "r163",
      "r165",
      "r168",
      "r169",
      "r199",
      "r213",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r264",
      "r309",
      "r310",
      "r311",
      "r312",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r336",
      "r357",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r436",
      "r448",
      "r454"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "FONR_OperatingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "OperatingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost \u2013 55 shares of common stock at September 30, 2023 and 11 shares of common stock at June 30, 2023",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r39",
      "r40"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve for self-funded",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r483"
     ]
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue on service contracts",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales tax payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r92",
      "r293",
      "r306",
      "r307",
      "r313",
      "r337",
      "r404"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r207"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in capital in excess of par value",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r404",
      "r486"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncompete Agreements [Member]",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r282"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax expense",
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DoubtfulMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DoubtfulMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Doubtful [Member]",
        "documentation": "A category of financing receivables that have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r459"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r119",
      "r141",
      "r174",
      "r183",
      "r188",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r249",
      "r253",
      "r264",
      "r290",
      "r348",
      "r404",
      "r415",
      "r463",
      "r464",
      "r476"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r222"
     ]
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r58",
      "r59",
      "r60",
      "r141",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r250",
      "r253",
      "r254",
      "r264",
      "r463",
      "r476",
      "r477"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfConvertiblePreferredStock",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury stock",
        "label": "Payments for Repurchase of Convertible Preferred Stock",
        "documentation": "The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r336"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r336",
      "r354",
      "r488",
      "r489"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Costs and Expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r470",
      "r471",
      "r472"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r222"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r22"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTS AND EXPENSES"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income \u2013 Attributable to FONAR",
        "label": "Net Income (Loss) Attributable to Parent",
        "verboseLabel": "Net income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r86",
      "r104",
      "r113",
      "r126",
      "r127",
      "r130",
      "r141",
      "r146",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r155",
      "r162",
      "r174",
      "r182",
      "r187",
      "r190",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r263",
      "r264",
      "r300",
      "r356",
      "r374",
      "r375",
      "r393",
      "r413",
      "r463"
     ]
    },
    "FONR_CommonStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "CommonStocksMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period",
        "periodEndLabel": "Cash and Cash Equivalents - End of Period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r84",
      "r139"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT AND RELATED INFORMATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r180",
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r387",
      "r390"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85",
      "r86"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r141",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r250",
      "r253",
      "r254",
      "r264",
      "r335",
      "r392",
      "r415",
      "r463",
      "r476",
      "r477"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r211",
      "r212",
      "r386",
      "r462"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summarized segment financial information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r30"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax component - deferred",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r468",
      "r469"
     ]
    },
    "FONR_ControllingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ControllingInterestMember",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Controlling Interest [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income",
        "label": "Net income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r126",
      "r127",
      "r135",
      "r141",
      "r146",
      "r154",
      "r155",
      "r174",
      "r182",
      "r187",
      "r190",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r248",
      "r251",
      "r252",
      "r263",
      "r264",
      "r286",
      "r298",
      "r316",
      "r356",
      "r374",
      "r375",
      "r393",
      "r402",
      "r403",
      "r414",
      "r445",
      "r463"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued salaries, commissions and payroll taxes",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r388"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r451",
      "r452",
      "r473",
      "r484",
      "r488"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax \u2013 net",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r93",
      "r108",
      "r243",
      "r244",
      "r450"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders' Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r98",
      "r295",
      "r404",
      "r449",
      "r457",
      "r474"
     ]
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self-funded health insurance reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r232",
      "r480"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest Expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r105",
      "r131",
      "r177",
      "r272",
      "r361",
      "r413",
      "r487"
     ]
    },
    "us-gaap_SupplementalIncomeStatementElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalIncomeStatementElementsAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Income Statement Elements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income - Noncontrolling Interests",
        "label": "Income - Non controlling interests",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r94",
      "r126",
      "r127",
      "r154",
      "r155",
      "r299",
      "r445"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury stock, shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "FONR_ClassANonVotingPreferredStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ClassANonVotingPreferredStockholdersMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ClassANonVotingPreferredStockMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stock [Member]",
        "documentation": "Class A Non Voting Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Basic Shares Outstanding",
        "verboseLabel": "Basic Denominator: Weighted average shares outstanding",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r165"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r276"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability - current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax asset",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r467"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income From Operations",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r280"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "totalLabel": "Other Current Liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r404"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee operating leases liability maturity",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r475"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r279"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings and capital lease obligations",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r279"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r279"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct ownership interest percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r122",
      "r123",
      "r124",
      "r141",
      "r158",
      "r159",
      "r163",
      "r165",
      "r168",
      "r169",
      "r199",
      "r213",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r264",
      "r309",
      "r310",
      "r311",
      "r312",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r336",
      "r357",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r436",
      "r448",
      "r454"
     ]
    },
    "us-gaap_CommonClassCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassCMember",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class C [Member]",
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r118",
      "r289",
      "r415"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r65",
      "r66",
      "r89",
      "r338",
      "r354",
      "r377",
      "r378",
      "r404",
      "r415",
      "r449",
      "r457",
      "r474",
      "r488"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r279"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractReceivableDueTwoToThreeYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_ContractReceivableDueOneToTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractReceivableDueOneToTwoYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCostOfOperatingRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to patient fee revenue",
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax asset",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Diluted Shares Outstanding - Common Stockholders",
        "verboseLabel": "Diluted Denominator: Weighted average shares outstanding",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r165"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r125",
      "r141",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r249",
      "r253",
      "r264",
      "r404",
      "r463",
      "r464",
      "r476"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of patents",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r115",
      "r141",
      "r199",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r250",
      "r253",
      "r254",
      "r264",
      "r404",
      "r463",
      "r476",
      "r477"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long-term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Diluted Income per Common Share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r158",
      "r163",
      "r164",
      "r165",
      "r166",
      "r262",
      "r263",
      "r285",
      "r301",
      "r391"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock repurchase plan",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "totalLabel": "Total Inventories",
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale."
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax component - current",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r450",
      "r469"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock purchase plan",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r282",
      "r283"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CURRENT LIABILITIES",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interests",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r97",
      "r141",
      "r199",
      "r213",
      "r215",
      "r216",
      "r217",
      "r220",
      "r221",
      "r264",
      "r294",
      "r338"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt, less current portion",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r137",
      "r138"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r443"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r288",
      "r331",
      "r332",
      "r415",
      "r485"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Net Income Per Common Share Available to Common Stockholders",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r156",
      "r158",
      "r163",
      "r164",
      "r165",
      "r166",
      "r262",
      "r263",
      "r285",
      "r301",
      "r391"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use Asset - operating lease",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r87",
      "r88"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions - Non controlling",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r389"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets - net",
        "verboseLabel": "Other intangible assets-net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r34"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for Income Taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r154",
      "r155",
      "r179",
      "r234",
      "r242",
      "r302"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r404"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use Asset - financing lease",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r140"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "AccountsReceivableNetLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - long term",
        "documentation": "This represents the amount of accounts receivable net long term during period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of right-of-use assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - related medical practices - net",
        "verboseLabel": "Management and other fees receivable from related medical practices (\"PC's\")",
        "documentation": "This represents the amount of management and other fees receivable related medical practices net allowances during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Increase (Decrease) in Cash and Cash Equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r84"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross other intangible assets",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r283"
     ]
    },
    "FONR_MedicalReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "MedicalReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivable - net",
        "verboseLabel": "Medical Receivables",
        "documentation": "This represents the amount of medical receivable during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares included upon conversion of Class C Common",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r161",
      "r165"
     ]
    },
    "FONR_ManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230930",
     "localname": "ManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - net",
        "documentation": "This represents the amount of management and other fees during period."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480135/944-740-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-29"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.13)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//230/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//310-10/tableOfContent"
  },
  "r457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r475": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r477": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r478": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r480": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000355019-23-000054-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-23-000054-xbrl.zip
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M1*SR,?.O_9*^O/\^]I'&[5%(\_[G;8XT8.]&.^^_S?#'<3U$8@M1]<;]$LT
MEI.#'J!'&2P$[$0&,#+OPA; .CH:F:Y0+,52DZS5-,XHZ"FJ*M0\ZH]U@C,^
MYA#U\I"2++U 11,0\XU%1IUG>R52-BU29@MVQ]&H-0N1]&VJ:Q/I.8KVG72S
M8$A=5@PAD?!2B+-">UF>]+3^Q$4EY?R&RAWD!8X5ES3[0J1_ <5N1&9W(#*
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M7J/Z[-O_^_C_N0CTQP\_[XNM3J5U^QNT*LU&JP/NZ^5*"R IZB!) 70*-%J
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M:%HT%7!#W=K^$X>A&;!W!K^&>T"BUX@B^AYOJ?WW#$T\_GO,\KSU]^[*PE1
M-$5]^@)ZLL)#)<G)HLB.58B&97XR<CI?-<5ZPPM4\+-$:_P]6=/DD97Z^:KQ
MUH7F(XW?T74BRST#3)@JBP(?8JQG2 ;>LZP@QU,O-M%744JX$Z<R*\F\BX ^
M\7]_R'>9O])K?L%@G6H,.A7[2Y=@,D:^',>JOCC1215R>/5#@V-%?L$X7W6\
M/(SD[!L/119OB-PFZ1J_G#-?E;;]P9$!0V$%#!UV6C.7"HRMZYN<-CG=&'#?
MQ>OK,N.;GG8AX.P;32>9=#9-IW(>Y@_]/V5O^32U1U*$?<39S'DZ&*6M ]1X
MN:P &7<3 4\315!Y@=,C4Z3)O_84Y $9%PEV=.NWV+J4_',<](;$JMIYZ[Q]
M;KR],AJ+\@P''#;>K$(&U.7S?V(&APW,/I%9?$O(0=.R37&:5CR=048\G %N
M-K-%GE>@JIK_W H2I)VU:K$V:MZEV,JP6E@DKHQ' //FA/4!X,> Q@&)JG7U
MZT E5KT4N&,5;J*"LB*\N!G0%5_-"R]*Z&-#Z<BODC,GKJ6_U$A^IJ3OM"LG
M\#.P,L1/\9L+2_K.OMVA.1=$T6WLB3?Y#\9IQ+K.;RA-Y,0@=>[B76DWY33\
M-9L^,8SKL/4'X7%;CPK/RW(>RMFW.GP%OV7E>1?WRA*UA<O]*3@U&A_%<>4$
MG::,9D;\(XS=W7*Z+WU/O4A:*^>N.8S' /0<8'C%_HK,"I58<^32)^*OF0,T
M';8^&"L(]L(8W0RGD)MH2"^BKY$+ M73=L;0Y!JOQE-,W*RHS<\F-^M"3YE\
MBVBN9YFB^U\D9AH4X7@H2]8"0P('0.($<Q"@()Y%FHJ'EV_,KA7.8MM=1)>Y
M:TON:3JF(/?\U/-CS<'^/B0DV13]CXO>>T-RUB09=XL3FWC(FX+NN_;WNRI5
M@TI&]('L]7>>?<L6TDFFP!1BG \--U?NV_,/''5-PO7R.*70FP%NB)"-7_ ,
MA#[ :ZRVI+"@ A:\0E%,/DO(N04J9%6$ ![]H$ZPI+$JX&%?D(R<<6LB0I"F
M,MCJX2>UD;E3]+IJ4.2T<_ ;?>@^=E'4#;K=[KGO?(\F&L*<+4G6T#=_)X*"
M9D23@;[NJNC5 BH83Q1U@B]$/Z"IT1,@= K'!HN_]!H6<_;PE!$A-BE]FJB:
MT)\%-)>O0ZAG]=8F]#/]#Q@B$<.SR -6%!=3:9_C'C0O0,]<G=:5Z;0)8V7*
M#5EI@,A <XQ_QS5)@$<_(Y.)KQTKD(.Z :49H%<QJ. S>B * 8$ZX89 '<IX
M9<BJPM"&K+9._"NKOH6B?K,YB'^0^I!X\)GYY^,'/,H>"B+1!;TG- 9\@WXM
MN@N383Y(;Q^D4Z%3R:H:*%" 9V?J^1MC65F)C4H314$W&X4SZ(DX*)VHSH:S
M6O]QD[EI/Y2>WT1'YF/ XCG >)!OT9$SG6???N.*9&<O8:E18R$#IRNN&,0(
MOR-!TQ#DD5?*:8HLX9A&G &(XIL9T(^X93D]!BRS&@NJAH)>D>;E,^P:&QO7
MCQ],ZXH\X(FQZ1NTDQTD0RGF?&%X!7WE=HQ7;CT+]6[RC)QNV21S(:9(KVQ;
M/ER,'0_=1+JS" ZG-W<T_#$K/#SY)EK.[]\D6JM^^)X@0N+Y\0.1SPC(I^[-
MBH@L"%B.0_*IL%C(,':Q*RLY?HO+.Y,./ZB(1O3!-&98JG"?.U::)3Y^0 *%
MGH:L%>;   P4^54;6K^?(TL,#:]9L%;O')[O2J?KBW5KNO;2CQ^L'RWWG&9Z
M2<;R"2Q'P'#//Y=T%B('_Y]+<.O\?H1B=/':EQC;;X3_ZDU9GU)"MPQD9>8L
M\]0C]?B:9IJI)[AN=O6[@76[;QEL8V>8/@3.?+93'GN%]K-O=2= ;##."+/&
ME'W\\';.NNML*ZVP3;_S:J*B"$MU\59:[%.[/)V4M-_Y=;;I=P/K]B#+ZAVH
M/?OVZ,*4+J@XBX:N(]?XD5[AAW7CM7Y?R;C-F2\#]M=]L\$Q^=(12K8W4(LU
M;"&73G\Y3MZ$& D/1D(=0B0X%BH_.V0Y7-7H/V::PT$CYE=%&[]C(X(;G=KS
MBS)_IEN#-Y*M$[A 5.!(MA.+-> &=1<+4,2G2'89MF/S@6$*E;7(8!'T,Y][
M]NS-98RK(=$36.X9F8>)Q..GR,HEDEA!@_L7>*2HT-9I.UA8%PN D$41$H?[
M=WE9VLY%9V6;R8?',87%;S$H56>CGBP29KD1C0O35]$%+0N$U  2$SW)9NF*
M_19>=Q' XQ0_6/N&3 TY0R99ESMG8_I0GTQOVS>OU1O6AXS"^CN-W4YXIQ-F
M35N3N><$^)]SBJ)HA D%O+#B)%KEQ,>9,VN+ARGN;5W0G2<L_4-^O6G=5BK7
M?M2>K+S0:.U#IF,1HUMPMAQ9]QTWF>MT^8>L/624H7]A.'KKVQHR)YJ0ZBNV
MRT6WU@MFM0D[%G#ETAWR\J$6<GU#C-S3):F1=M67\1MV:\T]I,CN&6U:@#S1
M<%L>/:]M64/3!386J?]7-7PO?&T?QW1(32-:= W-JM:UG"BKT/I#1*]3-3#6
ML\6<[B[C[;Q!KX8&B9U8./W[^_:9@^M!2U[]<YJ.CL^9*GQ:A9#>N?Q \AI+
MB3+H8C50EU^,OEXY:UOZ@<5\AV\MQTM?NA0;SUQX6:;;=1PS[O=<;-XK;[!!
MYX+1B<LV=5VA9EAPFJ9R7:NS'#+U5O=#W"Y3?\18EO"R.N[%9KO.]FRCXUIW
MWGI^8;]SM#BNO%D6M\\',&@!-F(6KD)55ZGHTC?KWAN&<K;B62Q;YM'(N5@V
M!U^G=S6]A>P&+VL\Y 3$^3-@?E#_/:O5JV< =\W2'VXU-,LFTADJD<\SEJ=A
M$7Y83;*7H,H'-0:N@$,X$@T)L1Q=Q=C)GZ3.Z74[&(3@%/P3')W%C;Y^MZ/0
MZ!=<65(S??R5>_Q3*7<Z;S9I1$9L[!0?)#=T.NNOQ/@L&"4B&!MK-$(0C)(E
M&%>MY[M.K:?=<T*T!:/D@V"D\DPB0Z?B:4Z*H*G /E3TRA\B.$ZK>3X+CM&4
M&\F-?NI'798>9%PVL)B&%;_L[O:A.:C6LZ7)<X0$R>PK[F$$APD6G4JD4_G=
M!"O:VUN<(_C_)).@*D"1OP1-=@"_@+;>*YE#838-DDE++GCAQ7JO06E2D\>7
M((LI-;^PHLJL7IN^S S8,P'KF8*]AK(A(["2.<!4N*HZ1/XJCW&*%-^Q'IBG
M4I^6O,/3_?:*]">7Z;(QUV+K%X!;O5ZB ;(]@?L"</[18'U=QORVWW-AW:3_
MX/+RE'.L;J<8 ]0"I]6@=WU6>PIDGY,]B&0&T3/6H>!MIL>KP+@T-B<LFT2N
MO-$^.CQH V)1SD(:PZ?>##X.NP["I5UO:?7Q@ZVG%<!=@-OW5^U:N59LU2KM
MXPTL]#?ZU"65O#=(R-;JY<IC'.IUMJ7?/1M9#Z/Q:EU]2KY?K6:A#V14L]CJ
MF#UY #(UM7JQ7JH5;P%R\QJM.[/37@CQA.?Q.K>\M:(/ZR8]]G#P80[FUG7%
M@1T.H:+5(Y-).5'B.M<.'M9!\HHB&^,=]#GR(R16XM#E8!'R."^U!#BW^&%)
M59A#8V$KJ"6<#1.2HMPGQ"F2_^52;;,^4^MMEPOX-:OU!'3N/*\W;3;50IXY
M= WK*PN&"H[#_L\5*Z+)A>TAA!I>F<%DJ)!'H:>DBXU>(V]>!/2K5"3O;3C6
MC!4EJ],Q^'POL1,>C9G_1]_*\'TB05L?9-938YB"_XMS+JRW%,#BQ>["=A!!
M*?]0YBN8? ,0;L8X@@O-X(JAI>[ Z_3&78N]H!WT, CNC%UM%;TIN /$,*S>
M?,W8D>>*LY!1%0B4#"JR<5-;OB&MI!<2J37)6/OTB#3S+ESZ;]Q'0+<[%;E3
MUV(E5AU61?G5*ZC0Y0!?KQ(T[4Y%WC]7.&8JK"YK4.W("X]ZB2J\+0?]AC>$
MN"#0R0U_9\ I[*B&]HBA>,B9K7<O <(45$1!@HX9;'\0<5<N&N$68,[!\K32
M_U5!65"YB7X AZXUBA(KSE1!5S]+*&"L&/N0\34MJ$Y$0T.9IZ,B +T#7##4
M$35*V(C!N!!E?'B@:B(G=8X/X<+K?:S>F@)# 7TA6G_;[@#%GCS1S.)JT!+4
MY_< CQU]YGUR+V&C  F^ILBB6I3XIB)SD+?A(7T.K)]U+"PO()-]"KK EGO%
MR==&YZ;2.F;B-<8SO.-$KGF';]8@?!7Q6SA@15UV];X_EG33YT#_!=A^(G)]
M%+D.%0[86%=93I.5!1**Y[H)!^;7! 4G(_OW*FST30%7EP'"O61K(M!F16-7
ME)G7LK4(Q%;_WM@193WD/8!CQ_C0+Q41*C+*L,_B(&_I^UO?@/LQ+A:$DF#T
M!#7!0";^9+3"'7IEF^U#G/RV/'W\'3"^M =Z)SWKQQ+TZ !!5F!-,NIN$2$F
M&C+GH*$W1;+]=-(X>%_27YD.A9ZPT/S9<V!]<]*3S!3V*=>(ZR2WT2-9S4CF
M+#^?^ 1[F]JP]??;FFO7HDF_JP[7)GFU+#[HVJ?%]HIM&Q<8LG'AL(T+>F7^
M/KL7&+)](>HUPU&D-,2= ^&</+Y:O6C27FK4RY5ZNU+&(ZVW&[>U<K%3*8.K
MXFVQ7JJ ]DVETHG%0#\71_A@8_7C!YS0,5OF"!+0AO)$15^I"=PZ#J+GC*%B
M_ Y8XY98G/K]^;Y>O"_7T.3X3^Z[$>IBNQT3.!^RN<+:N9NB*EV:IKMC*26E
MNO/[]EUSQL+:O8)\A<D(C6&F7W>Y+)(!2;#0"&"#0@ V-.[32\G7[1QAU34Y
M^RT>,;-R^QNR/ /OK9.U1I4U]^E"UM;+KLR\UAY2S^RTP.^^]V;3SJJ]>.%A
M&%%G;LE@;A8S=W*?G93OZ9\E*AT#YAJA2WC=2!SCYN Z)2#YQU__>Y8Z<Y)Y
MGQI5FT6IQFM35.*DAH=WHSB/+/Q>-ANS+@X;T@+L5^? ^MUWT1V:_EEO2/?>
MF?%?5WPN=#7NQ+MH1%)45:BIYH%(Q1X^"8'3NL+5V>XNAC+H?6:H=())Y1-,
M)O./)V_#H?GMH=T<C;$8[S:&=QF:.G(99U@;T_QH=N/Y94$-C,Q.=&?'6:'D
M;0H%[VXI2CS^!Y>6O+ BWFM0907E ;>+6JXR=P6*KIFAV(@MEN;5UDMW_BO[
M5/L[2W5ZK^(>*L@MRK%:Q68_O?4&0]O)@5EB4(83,AS>!027'-JP=]F3DVMM
M[PVA0^VN--$.7#^0RO_QB5TT$T 77>>^6J:$7'H6$)<66PX'^+CVS4IB;P1)
M#M3]DD4#K?MV^>Q;ADYD"QNZTAW(6/_G?.L>?R(G1$YL<I+U34Z8/!5O.=EN
MMMOX%-@.5$8UZ06JFKY!T-E"5UNC-O5'O7_(9L,*$D(RT#H/DB@.,]N7"$M6
M'#;;$5(UD=3)X2H6)Z@';&M3_MO9"$XD@7E<8>Z3J8PES)UMXU476HUXBQRG
MKXJW( >1&](3(7K8B\!!Y)VTX!@Y)%4(78QE:EJ84-_[CZ]<VL=P]F@6TF*%
M09&R8 A( FGMO"6B/6*I/?#I:)?>$!^PS4PGJ,*&,S@BJT\(\-\K\/VRHHE\
MEHXA\)T-*?W&D"Z9VX+XN#6^R2IXKYFS!1V_B..'GS_E1RU_8N'F!F.J&(S!
MIRQH,Z)=3DN[N.$_8'M:\#^'%<$))7 /&>[VF_&1KDEAFAP*/%*>EP!9 $:8
M]A21HK)Y/((\0S/6$(SQ^#^J,(U;96G<[B ^JU1<"K>S.6M4OO.5T<.4^I,[
MA8#0'#6)!T] DMT-UQML!VRJ&#I18-+$7!&01Q'D/H5Y".1,IA!#D#N;PK+-
M%"XZ4:*P66\JX)X@S?.][P,Y/4B-F1,+[Y9<6!;]R'J'A3[B!C&6)ZM''-$?
M] )C/D'3&T["BZPR(4A_+TCW*SN:2>3S<43Z]@@2LW.=FV^21::;TM0'SD&U
M#K6B*,JO>"NSBXW]SE[?7\M_>E5J>!(QYPZ&U4JDC@RN@;'%-F)T3T\5'28[
M0:=?$U0VCN411"J(5 1GS0L).AO'17YG8YZU%=3BJBM)DY5959 $=0CY:UGF
M<<?U7[+R7)/TSJJJB\$NS6@EG<]7_U#[)(F]!L7!6VJ+!WHCT94I)7N\]J[K
M\P:LH#.TB;SW!"W9-'C"@/(K&YK(Y#PO4!]+OQ=L^KVIX'H@OC(=X^.6+ .[
MLIW:6;F_SNF[O[]NTD-A$&@TYG@ZK?_;K4T^& 1!@QNJ+2;C#%X 5N=,)/;J
MFX_<97]^T!*_"RW!:P0/V [8OM")%.U9'3@B/<S9(_ ]%?CZ9,WH1);RG*,\
M$GP/:I+K(<;PW]00QR^PEQ&W_/W-SH[-@; WVUFXLYKISB*_=C[G!MWY+5LL
MY[/WJ=?KDW!K.[)FE;69XS=["1$7( XN0*B^*E-(T.E<Q,T]@6J<H>J77\ID
M$EGOFXN(9TI\G]/T?<CL1'EVG#W3XJ8M^76HW<K2 /<[6$N[&NYIL\!4Z?MJ
M(3T\B1J8#7L'1<0&@)O8$, 'M"?8AK6@>[11$5H3(1 *%4(^N7PY[WGT*/0A
M*\,^1)XPWV&GAF-L?5&3.'FTOJG.T.VO8TJ9/_T0ZD7ZQ/806(.W^I%A%@"-
MG1JK:40Z_8K!MJ N8"V?3^2)GG_?2/(KOJ<25-IS/5TTRBCD,5+5LZ;(ZF6*
MN-7G&)<L(@OIJ.R%_CA;R%'EV?PD.FI9XU^6LD.+ XXEZD0T#U@6=H=:\!N:
M:<ISAIBH^)/#D5]5<DR"3F>C@R/7K< +_=Y K&(UI#5O(:O"%IZ<1O]>A;IQ
M=%3POUGQKM!,7?=+O1/SYO71)^5^<J)"V_$D2,_+%I<008A-1%;]DM6-\ N\
MZ6^"H3QO^2%*__2 Y%M;W025]=PIXEA:G[)I_:H@X=U#GG6^P-:@,BM?T;W^
M*3CU[HJ^KS.&*'K?Y7,#X@)6\UGOAT,0'7]J&/(K2<]$7KW3-O6.-PB]"J+H
MJ,MORK7'3$6\K=VF8KUYT1HDD2^_Y,OB:."-PYDH>4L$,@%"QB?]&S'(;$^K
MU"2-E09"3S3,$]ZS7YERX@1KP8W:N=B7>^.:D/O#^'F^XM$\;7UGC[4Z:K'$
MW&M(\N=^[Q/>CKF@4RJ)5"83'3DE<#H2G'P[:2&=BOQJJ7U#CFTCHZ-VGPFW
MF7[NL7S7@F$?X/VV1CQ4[4^VE\=GQX,-Q4&' @7/UH)LRR$@W1&D?ATPZ[V3
M3APWY+C%#&07SO$]-+(+A\S.CNYH[LW^\/6-X88K>IVN/+X.?MS)\+BN:*!;
MP]_]EG"W\^6C9<M#\349BDYD,IZ+LXB_2>#I"9Y^E0Y25"*3]YSM.+:G>:'A
M;5+H\\</7\?6"T:L,A"DI":/+P'U!9A_6B12_I(S7GNY\3@/W6<-LA ]^+^#
MA>J_)1GG452\":BOR"/ 3G@!MS0W2TG04U2-U?1^Z.IYU*B/)D_;$'[\P'*<
M/$(/F>%J'$G6H HT&<N@P6W\2=<&K%=F^S&P51GCT&N@<N8CXP!US@C2>H(N
M?6[DXGQ[S?H+T%LS@A0$EA"U_TDF056 (G\)FNP ?@%M^'<")0Y>@A1()BTC
MQ LO3GHDBZE=TR19G1NZ!D)S((JF,OSW#"EB_#>B@+/^WFLPR.4U+!!R=T5V
MK")2K4]?P*O :T/,=>H3IL(UY$;D.ZKDI1(WGY1*?5IR;U7-6U>D/SDC#S,4
MV#EL\?8+Z,S&B.RBPO8$[@NH(XMF\+\N8Z:G[#==6'?A7]Q(2'URM+MVNK%U
ML"S#UPLTH0YSVU,@^YSL060P$4%C'1#>YGO-S%P:BL9Z_WCUC?;1Z4S2@1:@
M"HB@%@Z TFJC7FQ]_%!JM)J-5K%3:]1!L5X&[?NK=JU<*[9JE78<AE%JU,N5
M>KM2QD.IMQNWM7*Q4RF#J^)ML5ZJ@/9-I=*)Q4@^%T=FHPF\-TT=L@JRDX($
MM*$\4=%7:@+ *0?1<\90,7X'K''+/[$8WWV]>%^NH<GQG]QW([6WM>)5[;;6
M0=+Y\8,NKYU&Z<=-X[9<:;7U4W]S7T#EYWVM\SL>3-[#].OO*B&N]A3A8*N/
M2=B2:C<N"B"!&M1#\5CQ5WILZI##\P6);:2)X*B'5%&*2IS0N+Y/)+@^)#-8
M/BI2PDTFN7![EVR.+[.!$S.$%0M6_-<%E<M%@Y1MT>!60!&#*&@"M)H>%GNJ
MAM-17>'*IZ4"VW1XMBONZPG^+1U8K61M/+@,24N%M6SD^K9@5L2.,+@3&,*I
MSL]VY6,VW2K#GN9X2LMM:5Y(%[OSQ^?QCZ9T77Z<[[-\N:AY>)OGR&0_.>F:
MD"KF+ 4TEA5](4+NZ_T"D[A?(. 14USGSK,>-<>9_Q0LEG:EAW9@NY^K2X<1
MQS@GOP)<='*0A*"+\3;7XD5M=GW&'Y&'DY$'OS8=;2[[B]KL>K2V]C8 5M_+
M)CO#"96-!O=I<%UCIKWOKYS@?Q!P]#Z]Z.$Z"PZ=X(CHD(BJVI#+-AS1'?C!
M:%1Z<[^!$YK12! 14=Y$&^V^G:.6R6W>EQO1&74TC;GUG5QO4V'.MO%^<'-=
M*,SDQE_6IV#TN!MV%X>"BDL&$%UQ.KK"!=R!;PXNY(-PJ2,YI9$@(J*\B3C<
M_=HVED@'$D$>QS:6',X :,$7*$TVAXW#3K'Z]^Y/4QT53BALO)<@JTB0!XK!
M H PIT+E1>"@#BH\V\1BGI *<89\\ 8SGAJ$H/T]H=VW9A_Y+<T^(CJCCO:R
MO#P,S3(6)C<;4MNP%"7+4+2@B#<Q-%E%FSE;40A'W."A7;Z]]6NU,]JF$^A%
MB?07=)'.&D0)X@U1,?%7,?IY6SM)1-"'^\12YQ#X1Q[^]IN3*N22PC0Y%'BD
M7R\!LA&,,.TI(D6G:#P&I.T8:Q#&B&+#;D?S5W0]8L**PV<;P\;^E9K[V?SS
MO=HYI;"QL7J,Q"*].@/)1<K5K/PAPAXK8=_A;()U 0B^V^Z6)ELG-+.1("*B
MO(D'ZGT+)@M4+%'O:$UIEZ,[O-G2[]<_AHWT]]Y+\2GNP6-U]7@.8D"C0%:X
M!S^$;#X9.I;U#03Q[P_Q?C4BHO-Q1/RV+&Q)_Q<J93B656&]/[-E*W^(U3N!
M^34J<<]AQ)W';,YL,03!PN#(X9,<WM9*\W';ME-&!Y[!DQUPSG9=?H(^M8O9
M?#*C;P"-K,$APD2$R2>3GJ6"6.0X:@O"53M_M7'_^EH#7-/6(Z,_KV6FW;F<
M3W/,CRPC]X);7 VS]2UPV,5.U!%11YNWUX5=#4QC-_ETU!(1JMB1'26A\FL_
M3B:1W7):19R$RFL'I3UB\3!.MR#=2&(PN!,8PJG.CZ.K7W!V]>NRQ/G1K6HW
M=]X_[8';&R1Q?P/2>RK.@SN!(9SJ_+@M$+AM:UIJE+6E@OI<_%OOSG^_WDPF
M?QO7#3Y[0B5J9&=3I,@*?:_'$O4!Q_^9+"F\)G"//MQ]BLQSV5AVA=E:W&WQ
MLR9Q\@AVV"E4BQ*_ON-ZFRTMYV[R\^>K[^/V/N7>D2I1LQ@"!)TC0&.GRS(U
MHDE.3Y-X17[0FX5)E3>1@OA*@5]UW_&4 K=%;:MX;:VYEWU[Y#;32M$_JW/J
MM2H]#TXH3"VCR%23%]N#1Y#'XP%C?<XYTJWJ%%2,7BGC"?D!F]9"$*5HD9S:
M2! 14=[$!_8^V=)XPG[?[<C;[*A"L?GQ_!Y.\OFXAZC+;<AO'I-\8=&MR\>=
M?5O?:&5UYI"@AD\G<-MU1?10W/70EGV<X06V=")#Q5(5$>2_4^3[%<PR"?J$
M=C%?;=O%O,T$9VH/\NCQ82I5]]G('-50UGU/LT=32S1-[#7-%G$(?"DVEDJ&
M@/Y=@MZO/5',Z2S(,BXGZ&TSJ%*U]CLU[TT>?@[C'M/>KIR2ET O5U5B,4]7
M>3C#/.@]2Q1IQTRP'G&L^[65B(ZE4[@]_;NV-.UL&2OE4F52O&\V)Z=TVIUQ
MN$]L#O4AFQ6/>4I*T(VU2%^MZ**-",F!0N+7$;2QK)%WM,'5;?OVUKMT&)9X
MT:7C=EZ99+A"Z5K(G$:7#L<=?Z2E %% 7EL*A+<"FT)>+'TR706(7,6.[(C)
ME5_KN^D$G0HB"TVZ=>R+XGAO<3[I_=MD?J(].$>O/^OL]:_[^KJ+CUS]8KLR
M?[G/=^?-N\%]/4OU&WGN1+Q]#SY^Y%R,:'D.1W,(@CZA)9=(YW<H<(R UTR0
M&B^D^I6.*B1RF1V60(_KAUYH>.L$^H3_^SK>V8L>L<I 0$12^#^_ 3[^%@FJ
M_EN2\:J3"OF/'_J*/ +LA!?PCKJ^496(GJ)JK 9'*!I2SZ-&?31YVH;PXP>6
MX^01>L@,%W9*L@95O%^1L[B-/^G*@HTWLQ%=_TDF056 (G\)FNP ?@%M^'<"
M)0Y>@C1()M%E /W/5UYXL=YLT)74Y/$ER&*58'YAJ8FL3JLNO8"#HFBJD7_/
MD [#?R,*..OOO0:#?$9#@R-_463'*B+5^O0%O J\-L3\I3YA*ER#642^HS);
MJC_S2:G4IR7WL'YZ>T7ZT^JC.(0 J)Q]PPP%=@Y;O/T".K,Q(KNH(-W/?0%U
M9!$,_M=ES/2T_:8+ZR[\BQL)J4^.=LM.-]:KEE;]>H$FU&%N>PIDGY,]B&P-
M(FBL \+;?(]7X7%I0-9Z_WCUC?;1Z4S2@>:'E#A/1!355 "45AOU8NOCAU*C
MU6RTBIU:HPZ*]3)HWU^U:^5:L56KM.,PC%*C7J[4VY4R'DJ]W;BME8N=2AE<
M%6^+]5(%M&\JE4XL1O*Y.-+W@2*#(B&1';(*,B2"!+2A/%'15VH"P"D'T7/&
M4#%^!ZQQRS^Q&-]]O7A?KJ')B06YCD?S1IC>VUKQJG9;ZR"Y_?A!E^1.H_3C
MIG%;KK3:^O:2W!=0^7E?Z_P&G_'IVX(T@7R,IF*=TCV<!OU=)41:3Q$.]A>P
M>=J: #^SK)COJR:'>JXV=/RO0:,!CI5&M-%=/;.8BB8'?ZU'L$$N2_D"Y#;2
MWG#4@XI!?XI* !RT$XX'QO'O$PDNF?VUIX"+;SK/P7\=\@@>!-KKBM::T.^]
M@NNE8#3O0^JZ)+*J:I!=1+=)R1=9;QLP5JPF=ZHFHUG]'^,M5MJ_0%5L:?^F
M=7$;7]MDE8;2QE$N_\"*$]B$2AM[+5VAUAT+8ZK+X8F@"BFJVUT\HFU%Q3I!
MC;[^I.)44+O=Q?%^^)=B798>=!)77WJGRU=W_J>GW'1H>9A*,6= $S3,D^;J
M6!*(CPIXP:19S%L.*W/HL+*!#"M5:V;_C"?:XTO!V[ VIA.]#6Q33MRDONN!
M>'OFL5:O+E*/U&KJL:F_4PV6]&RPI)]3%.541..63-7_64[;%[".QIPK&HU7
M%B<H2E"$.>1U%.IK;4%*5_-[OMZ'C<I=,>\.0S.$81>TO96RPM[C"D:\RDK[
M[Q,]F=%7@]W&M0-6UT?FFW@=DO/?1^B\#F1G8?-C(.F,TS+;9@%\,[& U<#"
M9UNX:P#'Y]BQ6'R3>".PJ2W KJGJ)"QA35WGY''E)3=X&6X%M:#3]590RUO&
MTYAHJH;X@H@(9U \];U\/<FD^L.GK8.2E\2]'9F[_[)IIH)1/\QXRM6XAZL[
MC=U[IK:IU TS%<R@KEN9-E_NM/O/O1UG:F==9,Q5S!6J;8)B/I+-TW$4LQ#(
M=!QE)"G:DX';S02N&41#Q^CVSB:91I3HT30>EML(,(UQY*TT_[/.F(4&SV==
M-;@>VRRU]HAM5^8WHUZ@AK9?S-//_>GC+>T:2)O!YD$L]:5VQGYS4H5<4I@F
MAP+/0_0"Q%M&F/84D:(+-(9&GJ$9"QN.R?X]LW'!%[T0,?(B1J4]Q2@8+ZB6
M^_G]Q^O=;VW@&C''3HQ2\1:C@W*^B[KCN"5Z%Z S2'?)ZKH+C]]979?76'(S
M2]?2TT(_4Q3%O?*XU=#RN%L&\B.GMG]]S]=@=4-L%V;FUGQ4-Q:Y6C^)/?<Y
M.9L./CF[!5M_Q%3U^?EO[THY+!WKONCA6SIVRTCZ4C;[ [9XE=X@[F$F8#<#
M+](IU^!)SV1S8299G</11>_4=307=\SL\9+/8EGHRU4Y]ZCE?^^?SLOOD\[S
M?235G_5^FVURTO#YL&RKNU^Q94[\4C#7;'-2^O%<ZK#[)\.W)?<WSXE?(^F5
M;]B7_NO#K;1K!CR(O*IG98,#"JQP7F6%5Z%T[-Q==(GWD#V-)-U>$Z8A$(\(
MAT$G24EF9I>\U3(]X^XU^Y3EW*8^F9O"M5R;/>'(XR02,L@)BG="ADB/9^D)
M/+FY17JN4K^4FPZCO=3HDY&>]YS.]+.$U:R2SV0_';&<51Z-9,D80]LYQ4G9
M1,BX/-C\INT=EA0->DI&EI^JG=G2A3<N\Y#9+!U$_^Z*P('^I\GH]V2>;ST_
MI#S0O]&3]# "3R[\&RK]364>0&;65S)]+S&M.,/)_Q2F X[N9])WZ1X.N)]9
M%QQY2%[F]QN +X) -;\SPT:J>/.R _U>@;97OM(!8,$G*_<@>IM4^$%T/I&A
MG'JOA58-6MX$S0-+03?!4AG1C=?:5>GIL;\9EXM,UV[3NT->**"IS:*IS;K-
MI#XUZW/![#X7OJB(WW_5'GS\F:FUTD>8BS#$+)M(9UV;&"^2]VLR9+AH;H*$
MGCN&Z#DO4)R]%:OTIJGTHR)YTWS6"[79+-_[6:,SF^=SA]SKID$<5\K2[DUA
M':5LH\;SHP1YT]3DZ_Q+.97K/)>WN!,!3TU(0K=A:NS+9!ZMUXK,'1KUFJ%@
M_E.$,C76)FZ'Z#3@I$W*62C\KNI</EFU)(+],VIUA(;:'S*.$K%OKL;B)>/<
M42; 3FCK_/-4*O^&,WX<GK.Q1UH< $J$^A"A=O$G_:XQ=1!J_B6E_KB]?4ZI
MPCL3ZBP1ZJA7MH;9L. *F+ W,KV?:0J\Z&WX%HV2_GF;_LT=)?VK7W"U2!MQ
M#?%J_%2I0&<)WIC_=8E^ L[_K@Z@"FM_I]-!@:%ST4H V\F,<@;X$#I]3P%7
MPTT!KT+IZ;YS_]B?CMN,&Y0\Y( W)G?\SP&OCJ"?^<7GQJ_I8LEM->=(6>!5
MD,4E#>P_U0P38KGJ%W#N<<7Q3>IQ3/EL9]B;^6/YY?7ZZO[98^YQETR;,^7^
MR)1<5W[=Y#5Z7AWL1SF]2R+*=\;7E,?)S][SU4#:POB-1;.9/<?@SQ0\M=E?
M15ANS5)T<-FTG5<2]M .E*-%W5.E[9QN/S;!^Z628T!U&+RFTTZ+3$%LMC<W
MUZ]M<2";[0/-X;@XOGX7HCIIUX(Z@VRCW7I6"KXF<8Y519<A-:CO16I<W%F_
M"U"=I.;UZ==/Z7?J3E/9TY :4GOJ8_O4,'./I;7<(Y/QD'N\.E[NL;1H=?C0
M81^K[/<4[U:/LB'WZ))G"2/WN!A KM&K]JF?S%" $<P]EF*2>]R33M]SC\4C
MY!X74*K\?;Y]>KSC"FUN_]SCQB@]H-SC8@13D7NZ^S$=5QD^@KG'4BQSC[Y2
M'?)6^9W$R]\*U%5@W@^>U72+*?*O6]+Z;@D\%UL96)'?*OG2/?<R["A/HU];
M-,/&!-[&,?A;<[I*?AM66N*?NVMF6V']7HG? .KXUK1:KG--3?)R(3>,6NKQ
MF"KM@%3>,<G>+V4:<4:'0G;*\<S8H'I]&H$-23^&EDAQ*98.,/VXT+#ST7B:
M_JED7GXXV[>X)5)R)/WX7J3&Q:4-,/VXD)J_##?]\>.9+;6=]U7%3FI.*/UH
M 22]4N%7Y'D!VT!6;+("7Y-*[%C06-$!)_->1R[,:\-1+?UTMGLR,R;5DY@+
MZ"T&F9S!#'S8)#YA4D7^='^9JR'Z*<AB^G +K%W$8%,4X4<U=9Y)9!W;U4==
ML1"XOR>X9]\[W)WMJ'V=MP4U5I @7V$5"9DDM<AQD]%$Q,L09=@7.$%S,JG,
M8 X'OYY_T[^&>YC44SA>T<8G@WC>X!;1-G'2-I\WJYOMPN&[H571V-!WZRJ(
MH1)4/A-U#?0/03]!_R%VUPW]Z01=\'\+7Z#HWQ["=A3(JA-E9L]RU!?=A87N
M2+7,[>.HUWM,*0^WOXX6P*Z86(?SJ<.RNQ;3;(==)' ZFY-5S;5Q>,F-ZV::
M2<_*.ZTWSC.EQO1GOGE3>UXVXK>>L+IDM<UU=7UO<+':8JG:U7 LEMOZB A;
MNLM]?6#3%AC/K,5)N_F<RU_W5:'T-*'#9NWA<<&BCMR]58<[:WU<8PG[K'CS
MD8&<#Q^TG0V$Z!#L\%L[$71Z!T5F3NW5? =JU!Q0(DU$FGS/'F5HUWYV,9(E
M9W?6WJ)39^A0%A$JU,K?B:#-ND)GD3K23%\6YY!JS>+\\2[?G0]?"T(KK3W]
MQD=1OLLT4D?66-$@NRI+K )*LC*6%1:C1/=F<U]48.>L^24P.$SB[3C%VYL5
MTUOY"=K,9Y&A+Q2B'E:359SWBW2_%G RN42!<JK7CCK2G<VNO5+F3D O0"RL
M(?ZA>'-MN69A:L7[FX>^/+AN_N7??0[)X'-=EC#H%%D4%V>@"R8351)'D#AB
MLQ);E[NP5H)R"88YA8"""!41JKV%RN\%IER"ROGO"$<E2L]NC-)K$B=.,)U-
M6<'#+FJ:(O0F&ML384=>M9)+)V,ELK>\C!%[6T1Q_LL]<CBFW+18N/J3Z?53
MD8OM'2<FV.C>SO?_]25Z)_KP!/3AKH'2/L(:=!HADT;:T__JN#"TIS_1,Y%#
M(H<'R*%O20XJD6?RIR*'VQ<<;@6V)XB")D"U*/%;EA^6CHF2>JS/_Q3O?_Z$
MT<R$,.>9X/T1&_/TNHXP_!-]8$?2C/J[ 2]/D( >3SG^SRYZT0>2@U>-VX0P
M8.>#H>A$)A-\/L24R5BX'T3,B)CY[%LP%)7(Y%W/@HN?F"V\BPO=94.?/W[X
M.MZ9_A&K# 1$)(7_\UOHQM&@ZK\E&2_(J'BC2U^11X!%CJ\&>= 7)%;BT*WH
MR>:V:_4\:M1'DZ=M"#]^8#E.'J&'S'!'#DGO,:C)6(X-;N-/>EC$NC+;OJG;
M<8-W1(;K2!6BZS_))*@*4.0O09,=(.W;AG\G4.+@)<B 9-*R.;SP8KW9H"NI
MR>-+D,6JPOS"4B!9G59=I@$'1=%4,'K?._PWHH"S_MYK,"@F,(P(B@=$=JPB
M4JU/RS.!* H?I>7>.A.1[ZCDEAK4?%(J]6G)O54=:UV17CN B(,XW,0;P@<0
MV#EL\?8+Z,S&B.RB@DP*]P74D:$Q^%^7,=,S]ILNK+OP+VXDI)S/E;+3C?6M
MI6N_7J )=9C;G@+9YV0/(FN%"!KK@/ VW^-5>%P:D+7>/UY]HWUT.I-TH/DA
M)<X3$47U%0"EU4:]V/KXH=1H-1NM8J?6J(-BO0S:]U?M6KE6;-4J[3@,8[F_
MH28A]0P7'47.+&>GU*B7*_5VI8P'6V\W;FOE8J>"1MI!_]Q5ZITV:%1!K5YJ
MW%7B,.+/Q9$\0=8$&22)7[2/DX VE"<J^DI-Z$TDT',6'7 !:]SR3RS&=U\O
MWI=K:(K>D.O-3EC9IQ1%=VDZ9::4YKU2Z?JY4_O1NT6F9#)" YGIUR%-:V$&
M),$"+6 K6("-TMU;S7@U2YZZ.ML27&OFQ_[G,B1$[\*<U2.'1;*ND.GJNWUR
MB&_=Y9:JOZ_J]?>^)% \O1BETZ3O_]XK_#9F\5[&>"\WRG7&+]_SO;N>Y_<:
M8<(N[++/6U(5YF@BZ"#6 VRO"G?Y8<'RW(*+V[+Z =B:ED%0YZ:"_J]5J8"[
M1KUSTP85)&U(NBI-)%U7E1;>9>4AJUQ=:8CP J4)"K-[JH;#W*YPY4.:^+#Q
MMBH/E?J]S8!& @"IXP%@P\:Y=\D,QEO7#^OPV2:K">C-50A-M->AUNB7\)(5
M0OR$%8NB*+^B>%//-I4%E=/-?5= &M6J+6W-;S-L=_[RD'OFM.NKVK ?3)F'
M:;PR68>#5L-KKJ7SRZ"M#R%0#+8M-AQ+4#,V>BXX"-@%"_7U%=YBH@ML0SR#
M.;B3:]WRKN$?0(RBD=;EGC!?S:56%7EDY%)S28K69%^7+_*);,[SXL61CA$G
MR(PV,AD#F<8GGW"935 1Q>5VVZ;(_(33VFA@*N*JD\VZK\\S*>I!_>/K7HBC
M&2=CP&9###QLNUE:F[/ 13A,S12FP*ZB*D0306?37@4Q#-X3  4'H" TN?=&
M#L?2W9FE[D:WO@@<1":O!<>LH"#[Z*;#M7E^D!X_":FK@#H0'DN=FSQ8'ANJ
MZ*S 80=1[/[+I0ODPE3PB3Q1\>\-2D&H>@0D)O+:OKQ9V[>@WE^PR2JXU,E%
M]\MMJOIC])*"Z?P)^.\;%7X2_:5S!+=OUXMUB0D(0V[?X#!$@^"]AI]8@U-$
M51"V(4J8<C8,Z:5AN&,E=J OH"/N-;0AW!0(%,:</*7@J#I/GU8@L.3"TC3(
MF!DD% A&8EUA%V8PP"1HVO-.=*+_3P5-@<0##%)ID0\(2MOTOFDT[R"/57I3
M'P;G:@[&+^HO]KK!I!\&@<8&1VQ?M,4P+$.&D<$R,+9XML%H'*=\8H^2B6-O
M43ZZ"G&7AS!CE$0A[[F?VM%W\A-0GQBH PF18@!I9Q-ZY5"^V!4ZB[WOAFD<
ML;7;:JDQ5X:WW?G?N<KTKTJ(8_LL@>\5-6VWF$PN^'WO%G\6IK!.3&&TM<;R
M.!ICYL*T<IE$/N4Y<T+,' &L9\ &8L%2NQR3%"D35E@Y^UG5<-E;93K&&V%]
MKL3WFM:CSIF,( 5BCDJ-=J=M$(2WR%4>FWB'D%MU?] [2;9M70F_ZX7KR_V0
MV?W?'O+0R42?UD1O/XM5CX:P]FOT&V.(#X&0!J8164EUE8J5^?T-[,X+S^W:
MK'&5^UX)://%L=8^=!-@4&,ELS09O4BOFK;OP"#):K^\E0W@"]'C3B?2C.<@
MG"Q_G!2B BE_3>2IR"^!V&JB=,5G)L,ZLKUHV-D"/$W^B.F>/'NH<R=0"N6B
M]@TN&'L;B'CZDH5UQUF8B]V4YZ[!1-6?#)8"6>K.1JAFPEG)5]R4O%.AF+.R
M9^3[J?*]4A\\GMB>!V>]KQJ,6:^))5(;@-0Z@3#,?=#I"-4G$DR%C*D@+$*.
MCA"B7'/>WBW":NFPLWWX];>9IU_N9M7??G8VCX51>+M1@HAT2"*]BLPPPP<2
M/1" !1A3>%Y)/98!R;H9$.<:*V>CD:E(T]N7FV;UZL3V3SC;C]&"-6MULT2<
M Q!G9R"&:"-R"8HAFZO?,ZZ":8^4H2)O'5Q7%7:JP'4V&NJ/3%XN_!Z62_3)
M1AJNEF)1.NJZSX+(?&@R[P+;4/MW9,B./0*WL'I\I J13VS1*_L15,@JW!"W
M,80O4)3'F*5F::>S<?GY/&S>7F>?"LKS:44D%B^6V_;X)4N($/M7=[T!<F'6
M,F5))=-[150@M4SI"+D9KC''\J1YJ)]^>PTEJ+ B8EV1'PF2@&OY->$%;C0!
M/XKEL5IL_^Y,LZ>ZB]MD3\*@<F!P23<*[ J?R%Z?..SU\0;V4 MI\UG/'9S)
MSC6"9I_0'$RZ+97RG,2-U+:VU(9M;=CR+?=H6Z9OI-IV:>?XWW_+&6E\\[#/
M@GZ,=VGKO-*-H<4MHCCBH#C6,1YF&JZ08+P'7,3B$>#N#-Q $GH(MGG/.U0B
M9=SL;4>,PS)O957%O,('F0C2!%%J;OR1)?5*/]>UAL^[@JH5.UM_&K<;_[_#
M3J%:F2)? R%$D%AE5M/@2*W+DGZ\DJR[)M:-1ANPI1E=&D^KW4GOYJX[?VI(
MW-6-]K,$3Z%CL,$G@QS,;K#D,LGY^*41CHGH$,UF-I')16@IFT#VE" ;S([.
M0O0K\YCU7?V(<;*U!];@L)7_7+%3F:JBMBH_M/2?S&DM?>E,,*@QAD^D?@>I
MM]^<5"&7%*;)H<"C.;L$"'",,.TI(I7*Y#!A>89F+,H,,CT32W1ZY'3Z9NU!
MBJ'M^RMMT<B*@>L*=3- X(5%@DW7MS?<_.8J_^-1IO=IH!*]N, 8MD&0.7@B
MBMY?]GF;?[4"JS!7<XY5\_,/@4^H\ E$=Q^K /X?#VH[NZ*V7Q![<&F%8>1P
M;F?%/?XI:;G<G+EIUICHK(<$J,XM=FQPG$D^.9+Y9 <HAV@N,A19""' #12X
M@1BJ3#R;UU;V6@C9.<WV=IT#&\41V[R==XJP.[^]+P_ZPTZZHSV=1#"S7.0P
M6 ::BOPBJ!BSZ$_3' *=A7JIP"K7P"([25S8\!/,.X,[W#VA43H5FR R1H@,
MPNRE$U0F\I7=F3<V#C'3C&2OH 3[@K:69K/,$MUJ<#>/T]M)89^U][@%;0L;
M99"Y;JB($QP-)WAKJL81X:'N*LWF(E46M)X))-"-/W2#V:&:ICQ;L_"!NST+
MB30XXA=V*>P!EVG-1FR]=CN7*JWNG/V14S,/PO=6?I]NG+'8HX2"?Y)ZC)X&
MV*P EO@-,^.82&4C9:Y(SO%D$!O,88]9[T<C1RK9:&^N@/3S,@ N:IHB]"8:
MVQ-A1W9+(=:-X&QAQ5Y2-RFNF:Z-Y @=!!F600-)KTE#HCFBZ>WN+ &AAG!,
M)E+;%DD(]YY '<A.7.\G=D0EM'.UESBZ&VD+0SB3,S,X>GCNU_?I.K1_.,><
M9XYG_ZQ.=G:0X=YWU4:]V/(XL?H CJ0O]'<#7IX@NGU'U__LHBW<*0G>?UZ!
M=:@])FAJ[QX3=MP?*>PCR(T^<H,)_JCTW@52H>'6;LZ.$Y@=U3057UA!M.Q1
M21Z-$'C:FLP]#V41@=AK@$9D/ 09UV^V7*["RIFVJRX7A^T/E4-.65?_5$A1
MW>ZR8YC&:GK'S9+(JFJCKT]W<2JHW>ZRDS$&@AT'=W#4@TIW_KNIRG=T9?!P
MP_MF+Y?6TB2@Z_9^?XZJS&3<M5*TE!,1N"@)G'N,@P6.60@<XZ? E>!UMG\W
MF/+EIP#,? @"1R<*S(9P-EH"YQS<%NW]%B?CL:C/)BL:W%Y,;\7X7BWV< LO
M3NL*5]WYX.EN]'SW>WCS(RH],7K60WA!'8OL#+-,0B^QC\QR#Q9C ];@OE[T
MEA5U%@>]5</9KMY<R;;]0J<'1HD:XE7:O$JL]4 1KP$D'V2\N18T%=B'B@)Y
MXFO&P_25 _0U\2]%! X#&PMH.!G#[XQ8%G+T7'L5@_0^/5/DAWG,;XB1HV4<
MB4A&220+ 7JC.XCDK"8K8V[Z_%Q+!^F?ABF2!28N$GF0FQ'3Q10'WZ)$,E>Q
M4EU%_[T)6_]?C 3]@I*EHUX>ZS7FITBI\U00;H-Y;_?MJ_U8"]Y0VQ M941D
M+#XRMI=[L%'&;E_NF)0VON]- \E3!2ICJ?=A\..75[AB58$SB$2@L3R )E06
M!G_(*F01*\9JRKZIO\(J$IH/%<VO/J_Z['?'PI@*<D5+NQ7&O1OZS_ )G@%-
MT/"H]#<?!+EM.M!QK*$NDM7JU85&I%8U8E,G"8V!.M^TW2!:JI'(=93DNNI=
MK@-:.%-_/?"3BO1KT!(C*==!K<5YDVMFP^;!:,GU>\AQE 5QHD&>>#HGK!$W
M>3KF_ ?NZUS]?+VGBY6AP#PM=*+Y[E"UHOG."/H[FUJ$1$LO$NF.DG27=I'N
M@#R>)E]EF5]3X7X46>$F3@_)\VS.\^ 6<Q9J;8@UH&IMI%E=]B%J,;)J,1=P
M>F=C2OK/ZQ7U@V?%R2CK;P2X-LA,X)[=QF%6F9RBEG^FIC?"4?7^+BFL@]/Y
M7A1^D#YI* .@SFFGXJ M)BQ:EHSHXRCIXTUNJA]IN8V*ZL?KKQNJE?\CC3.!
MZN-\X+[XQF$B\:W<C@<C5HFJ/@Y@>35<?7RD 5#GE-,)(;'2QX&D4X\://R"
M6%%:V=,B&@T[@,!0+,;,@<9$4S446>#:\T4,0;*GAW?O.-Z.1VO6S?FN3["L
M(R6M3[AMODVKIO<7##"SFDL/?Q>KC^TF0V]3=#M1'H5]DY;ZRR;2COHODGJ.
MB&_DQ+?D@_@&E#I]:CU\EUJ45E&W5J\=+KXA[\)<BF\F'9N=ST$G0"/HL5@Q
M@H//DB3>2OS4';U=W9E3_D9W!.^OI%Z>?^:G=ZF__675FT7DWHC<4W6Z<2%:
MOD\FM:$)4[24)U$&D5,&'D(7#\H@(.^'>I#OY:E0^_'Z'"]E<#1/*IN+94N+
M4ZV?VY0"LB\H;TH'D27E&*G3]+$R01LS_]* OTF)J<*@QKOK4;?$Y.:*P9 =
MR(W#O.[<-L:O]]EZ.7-T<W%0UBRH367>%CR"\8:#'E,J[V3Y8K4$0O1YY/1Y
M\5BIP8V*[NGG'3U6VRGM:H-?'+8^#V!=?C2<J6/J[^OK\7,!!Z51XZ_/PQ_3
M">CS181SH7=61Y\_?O@ZMEXP8I6!("4U>7P)J"_ _-,BDO*7G+'^<OOKC0?2
MU)8G680ABO!_P3-N_"VB=+8A_/B!Y3AYA!XRP_I%DC6D<309"PR/#]OC\2?]
MT @6JZ2^(+$2AYZ)7FEJ0/7<>;C_229!58 B?PF:2$:_@#;\.X$2!R]!%B23
MEJGFA1<G^&3Q<-< E-4=!J.E/P=%T90"O8@$_XW>SUE_[\41%)8;]AF%Y"([
M5A&IUJ<OX%7@M2&>-NH3IL(UPD?D.T[44GK-)Z52G]PZ'EI7I#^M/HJ#^'R,
MLV^8H<#.88NW7T!G-D9D%Q6V)W!?0!VI38/_=1DS/6N_Z<*Z"__B1D+JDZ-+
MLMZ!T5((7R_0A#K,;4^!['.RIQ]=? G&.B"\S?>:=KG$DK!\_WCUC?;1Z4S2
M@>:_\%D3<9AGUE/ !2)//YL"E!JM9J-5[-0:=5"LET'[_JI=*]>*K5JE'; J
M\6<T"Q>L-&2E 51K4N7O1-!F9Y85*S7JY4J]72E__( ^MANWM7*Q4T$C[:!_
M[BKU3ALTJJ!T4ZQ?5]J@5@>5G_>USN\X#/YS<21/D"Y$ZE1"(F0X;H($M*$\
M4=%7:@+ *0?1<\90,7X'K''+/[$8WWV]>%^NH=GRG]PX&%M?F!@?2JNR\O&#
M-H2@,U0@!'?H]J$**D8,TD8PUKUBD*(2 .=#/ SI@J8SGXX^+N<9\.916,%E
MBLIU:3IMAHES)3\O/"#/_KF 3UF:C- @9OJ%E[:.SBALLW0?V$7U 9O<K?DT
M^FA+B#D]13C8G?%]T<(SEMU7-XPU"^J<R@B2FY_D\34KM_M'ZQNJS( >5YX+
M>N7Y$C7IJZ)#]L PD"C>',N2WLX<9Q#6$@AZI&_E#_K:7;_.C:2[Z\PZ'G:C
MWQ*G@_CJ@271G*CEK%SM/"M%!$\<J;-BDQ7XFE1BQX+&BM8,E2=B(_T@UW[\
MXLD,^3%#S,XSU((:*TB0M[8Y+*;F;TM6,X7.#RY'IL:/J<GL/#4=% :J$V6F
M*S5#OUFS,Q@)G5\/N;NLPI'9\6-VJCO/CO-9G OQ><[6_MXQW,]*EDR0/YIM
MGOTNWM_4?CY*E7X,>&ID?[<ZBC9_,,"E-,]C"O<P8.08XZ_U%8!-BWZVPW@/
MFO"#!F)H8(-X72437@?&:^PM&J0+$N ,IQ%_Q'DA505R'S%/ 2^L.(%D%@*;
MA2+'3483D5U4L)5A7^ $C; \,)9;/A]1,V%PNV[I\]+2DP.6*^>VD84PW@>8
MRTBA;S_A+E5V+!6TG7IGJ^PPW/6:Q(D3S/:FK.#,@_UL\X[L[+1WA79W7I1G
MO4GQ>ZWY^+3'@7@>MG9YYK:9;4Q3G]P2? <VM1)9B8,&?5:9\?>)!-^FJ/<$
MOCD YE/P)6N[TD1_<O+; VFKLBMI6>?%X\/6&3=6!ODC/:L%0T6UT3?*/K-O
MRX1LZ5F:2J6H?"J7I_TXK,SK<=X1@(L_<1H1,2)B:R*V,=?NRXF 3")+;]A?
M1$2-B%J@HO8Y,K+FO&JREY"IB#WHNW5I8]()NA GN_8/D3,B9W[+F>L2F)^B
MEJ$W[* G<D;D[/3E;--BII^BEDM0N0W-SHFP$6$[U3C-CP@L0R7RS(96=Y&3
MGRU]'Q:)WI5SN5:/!9V_%!YJU9LKZ9>ME"*"19>'+418ATD;I9"'36B$5$TD
M _I@-@V;-R=5R"6%:7(H\#Q$+T#P9H1I3Q&I-)/#(\@S-&,-P1B/_Z.*"*L)
M$",*Q#P!(@%BD$ ,["Q['Q-OJ[Y5.D%3_J<!(CC;1!:BJ911A$"4,@%B!(!(
M$R 2($;?.]#DI7_PCAT YWS*U7J17 N.)PHW9%7(ER<*3FNA)\K\ RZA[@KU
M+B]TY_GK7DK(R-PDE3MR"5PH29>FR1"#3+D/K-4F],"#ZVZ)4HFH=4L3ZT:
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M@(ZD'/5W UZ>(! <3S^ZM:(+BN2XMZ@K>.G6GV?RD>S6[R+/L?!BB*@243U
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M;0PCS3"#]&G#=<RV"4>((0R=H O^5Y9&<(Z)!,1> H+I\DK3^1CB?WNKUT6
M<8O;[+;PE#;Z*/8HJBK4[+RN3,>X2M'-(L/:4Z\EMY7O$A_QJ"0HXVQGUN+
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MF^BBKFE(/H]@/Q@[>SI5*_F-,7%->D'62E8$J&X*AL=4J=&Z4RNISE,4@N'
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MV#W4 23XHN*M5+=[*XO=<V0%U5A!73"$K*#&<HV.S$Z49\=93UW9]%0+CLU
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M5JEY?M:J485:M5BJ-DM%_%>S=ELIYEKPH5RIYJJ%2NZ6:K;@B[M2M;4;+8I
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M5G%L5=C<T]-S2:'3GW1[Y47LC('G;)D5[1B!QY4.DY&5YXB$P@N4*^Y(.7)
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MYI7E,7^?G\V4@J*IOD;+M*!.["/U$"5ILJ+!E]A!,QYPS "[(284(XN*8MZ
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M*!)\NR[5WG,EP(]S9I?T  '%5JZ+8 UZ"<SXH^-.'3%0 ;Q1ET=]O!R/Y1!
M?(S.F<]4!OMV$+(YV38T@^ND+=9BJ#\?*2SAWV_C@LNK4.HK4<"CAK<_3Y7L
MMO7]*=Z/29*EM=UG^-_"7XNY&12[9O8I=U+\S_\VSLO-LZK6*=W^V^"^/T*4
M&TR#Z#U0)WBFH&->:I>U0BZUFRDPUX+;+[Q@ 0L09"83*Y28^]5"-<.48$)8
M,ZHK@GH(ZX<-"#O"GTP'4RRFWAM2/1%[".DP. -E8H>46Q<*IK@_)1&PNN.
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MUI"7#<C ($+R!-!DA;^]Y#4("FIP'V#:F,N WH?.)Z_AJ!@OM-CP,RP'G =
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M;>LI9'8 '!8K9"TAS4DHT7/[5J V)I)GGB*T*N9X"MS4HI )JQ 4?&Z/5QG
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M-=NS;^ K/ AF97-_<E-QU^8K&ST._ZQ]@>W*-04X[7R[PX\7GC4!914!&YB
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MUA/$EF1P!Y:GIX\II04Z](N9'"2U$<#49)LBP/_WB-SF:W)[JQ)%IR"=0LM
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M$P*?$)L8?@)2YA*K"=!F4[8KKS24X%GV/FJI]K/JZS9[Y W7@;?'^!MY]R6
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M\;U4-.ZJ9JMU]-LC-UYF.<.76YHW( GJ!W4#-^D7'<N?>"Q_"?+_4$L#!!0
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MD[^IF2%5]EO<:HH;]O(A7%8_'N.E35W1 O_N03;A[^(],-NJBB\GJ-+N[UE
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M?";#3L0 QAGD*]'/VFJD[$_A3U*]^N0C6XL4\W*YI\9,@FAM$,]F5C1B)&C
MG%./&AGV+?NNGO\3)\A ;AH;BCK*\"&Q3;[#D'V)_5_[@PHP?D57%@/CP"A5
MB;Z(RY(159T0-TAW"E9GEF@?HR$G(Y]_\_946-&2EGA7Y1+@77C53SK@N)A,
M$&..8[BZ0B"M_CPQ-R)?<;S.M'0KD;*=_X'&9T',1A\DAXJ4V!DQ302,<R\8
M&IB[::-.M^0U%Y7/8]Y_70MOT9;J:4&L,X6A"-E$!U*-3$/Y0\3&[I]RTQGD
MS*UAN PG92)SO"/;*FJ'KV6M^Y7!(5/B83OPHWG?J2?W;MUJ4_I><Y/C9'I?
M'(%]A! K#HM(57[F$;D9D"8?N9**+5)<'E$+K3S_Y079*O:(H82*DW<Z3_!=
M-V8A7]=J'YVJ*&*X)RS]1$Z7%9QM8.('29W82?3Q[$2BT*(%5G9]P 9YLA@=
M.3O $"JEUH/#I51L51&I/ZL[T+Q.?N=^Z->)DQVY@K?!FM$[X(^\18^9-^<-
M_G0TCKVZ^TA_T4@:+1C;V-<\F>M0L![  J37]7:>UG\XPA%Q04O;*LPRUT!6
MKK,2FYJ.:T]&\Y(B\#!1.[)0S4DJ?O6KM]AC<.7!1]14W* LQC&A'__)9$B0
MH C+'6?<T%0]8G\PTO>(7[XZ\J>7.3!FCV]7SF7.G<5<?CZ,3V4JW>K]:4<K
M-CH!>=B]M_-3.[+^UD\[(_+8@!X+X.F90C&%)@1! A7N+AKG$EGT3=M0O3=-
M1MWPVIJ'8L67[8&H<;'9<:FN>N(7)ZDKL:K3DX3I&9E/0?IN0D\55K#=Q+X'
M48ET [^E2JL4=!]V3Z4PW93!21:NQ0K:7XG.LRX?&E/E'RK0:S^<R1Q@T\Z4
MJ@(O84E5VBHP:MB3U2!^+R2M'$E\PG!?(_LV-"\5W ;)_I3$P"4>VY07I)6<
M;\R9HFT$A@#%_&IB$S81C&QW$GWC;NJ>TI7K!RDI-5>SDV7J%<7<\?Q:CG<\
M_8V.0'::\UST'[J-QOP^39=7.57B+%6,["P&_+G\[3W,RBK+W\]ZI'Q)UC]Y
ML<GF?;Q)?][ G-G,;/#NEIF_CA55P&+8]\>LFXV:IZV]8,!?>@+$&4*_AZN!
MB0>>E%'I\O4G6I+<VW8@0?^45$EOY$Y1"T%_"SDNARH^!^8MT0;6UW(7A8.,
M,[V_NFTI'FC_MJ!2V54BJF;&77CIY3%$'?ZC">U4[@KH3$=!?Y+U8A2];](B
M#6,?:.ESB(6WGI:\?TG<L3IK8.&V0,I3 Y,]IDL23@M]P9@I, NSEVER+K>A
MS)I>[,E=LJ!<-<0"1MKT9BL[MJBE<]2[M-?(1?T^)"7> /+28Q-BGH#Z70*6
MV\A'L3N'_$V8TO'XE(+<U^\+M+59P),,2'@[<[XZ&K4N^P>&79B5Z;^)TA>/
M&B!Y8[0\26M6&G#E"[;Y[#K0SG-M(,AYI/9XS!N#U2M\7&P81YMC8=W?%FQ5
M<05C8A*"!K\JWQ_W/?#M@)2G!.ECZB,YPITYD5QAG"&BM^REX^+-MQY9A"VS
MXN2-ZK2@-#Q#)6!%961J*P9)RH +Q^0"2(09DEN\.HT^Q<\XO1L,,R/$B08A
M^OB^?KT!0YBEO<IA 75[ICIW#JD\W^R1AAMYY(W X9H,!F.$G%/ENF/Y&>S8
M;0F37=M*(U-KT7#M^-?X8DXQ71_]-UVJ9[I;92UV7+:B^(-!F[=VA:946.]!
M5'*--AOYMX@V;Q^>9*_( @1O.@2:-VKX5]@O2HKV'GN%IA397(_"F^GNOY'G
M9+N5+1?T8V$F6$7DRY5PN?SD&.3OC\T!,MIS*MXZ?_T[#Z&:LVD!>N75OQ)#
MF[W=V*XOAP WC6Y1\TTX P<:(:#_$UDX--CP:3:J9B2CHK#,=8S_N_GMO].S
M5B-M$%_D]Y>!6"=%1Q=-MW8_7#?5:&0:G0KCW3$\X6VZ.LDJY@'>77'8O'YB
MR'=HAG&6F)=!ISRZ6/X!# ,8+]%>TWQ[F,@C]'],I>YP,V#.&FH-MW74>HH+
MOMK- ER\AZ-M15-M*S]-7"%?^\CU*97YVT6+PU*+?9$+F/9CF@A.NSQD-*)[
MZGK:'"S?<3A7K;2#2HQY<K*XBZ12*BTA*2U[>5MQF8G5X5F,7\16/=U M*^M
M)*U# TC!9RS@T^XVA5_Q;)4YK ; $?$X^FV&R=$.[6.+##A$EXOGD+6T*(:O
MB'?!+19P&$_) 3^F7BJX_ *D+&*A.,%Q).%],[)TJZZ3+GJ7!?R5Q&><EKIB
M+221M[T*NW)G@PX&RY_T(VN \U_D=@Z5S.L5XGHN'H"#PM.$C&^5(9=V^X--
MSC :XF N;GP#3!3>XIC1^_=L_*EZ&O+X(3:CPZS=-IUNA,_FGS\^OB;<3S)R
MEE>Z)B)YX5O6P\M'56C'Z4%0+5:TF@O=,RY-VGH!B7O8%H2#P3L1K\"<A74C
ML9'6QM#X9\]:]<TN52UM#3X+//$+$UUNTA!B7F,;@^!D7,UU2S^Q[IMS>[&?
M?7+DC\21:Y:6PT'W#NHY!%F]2K_7ZQMSX46*L49./#ZGJK-;2XG,?X&TI?8%
MQ<_9(606DZDZ)2'16Y#@D>2 T>V<4X)$FJFP1Y_.3N(8A^#T;.@A,-.1KA6&
M+U?ST7R!/]2='G;]3I8GY+&]N3Q2VQXR0+\*UMY"$K[B?Y1&GR1%-J%>0((]
M(N+YQ6028\W#[Q<Q\ZU)\?.=N>'*93@V0+R78(\N20WBS&8!4YO;L;?Y=*YX
M">:;G?5[6(2*0A85WC::1+N]>"W%D^0H:YY<'M_P2R>7!3P<=O$G<4#<I3#M
MD*'I$351[+0UJDLE.:WJ[8G3BKB?'A4>=5_/L?V.LJ"MFLO\PNFR@,A!]& ]
MAA:0O[TS.@[KB& (). G2FCB\^GLR"VV74GW%[Z"+^518']%<(0[.0/+J:>W
MBLJ5[WSZWB=?T8.9W41J-=*<WSM]/X2SBB@,[@X(+OO:A:+QFAE.QVL_W^T#
M&F0!%,REJRQ@KS=R6Q)#"\&LQ 0B2"9V+(#!!6ORZ:#M72$/(KUX[[B.[^?
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M!2P+,YT@4[%A:<:CA>",@]%'#&?-38"V"6H%9S=8>(:#&$E%"FN;(/IGRKZ
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MT95D :!*IK. N:8X.H%Y&\[0$#= \5(Y2:\7L@B1VIJH* #Q\N9UFXGY>BV
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MPDB'@_JG9?5G L(,,M'8KO[.M F-DH-A1S)VG9;4GP4Q8I"#QC;MZ=8RLL.
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MYC*6TR"IU(=3I8S[N[O>_'<.W1A]FHR&HWYOLNCT^OWI_60QFGSJS!B;_='
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M^HQV;*PWD77TU!J8/II+S&_8+V-M]63)4*2JIA)E9&^GS]((8J_D1=T!6]2
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M 7#)I!M >+''?\YFCTQ_DP2X8M2$F]K8%UVAYM2L[",C9:(FV T?')HA>LS
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MERR_S?'>H\LMSR]"R8:BW<3C@*=K8XLH=GJ>NR7^H?^"W.!CX96$O'.J;2H
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MU1,XWQO''F'/.[E/Z(0X=*D%$9.$LM6A]K2%IY]A48K[X*P*M(R/0UEP7%,
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M.5 \48!3#TD:>;],63WC)&%'?8+4'%!DPJ[9H@8\Y(LH"8HQ2GA*SG -5*G
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MIO1+D'/+"07,/BD&0H!8(4>FH$4EC+@THN)>B+$D\38@;ZLX-#05HJ!;:JB
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MBR=[L^/TG1U0.L2MAO9CE&'Q_ #DXXB=U@] 0?T$1N^0;WL,^2VU;/FN\Q@
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MWO&==4P__V7,!R*[(R0GHU.KV:\TH/9X*_9I'-([U^=3/O]A2/ABKN5')]=
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MN7[$NU]Z^*-^<$-6E)'L,7^J>O9K(IX+FMQ_X0!RWES?8:_Q?7QU4 ")2?'
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MV1JK +R'G(H.]'X7AT:Z)9R2A9L0XB^[&[%;^3W^5=YO])+81H.3D5@1;0H
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M,DNC#PR2%8-0\<#S8!A^7ST,>U^G4W'@&@ZZ-X/A8(ZVA*6>2\)4&[^0<3S
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MGJ7_(O[? Z^*_^7_ U!+ 0(4 Q0    ( &ET;E=HXY++A!$! "_1#  .
M          "  0    !F;VYA<E\Q,"UQ+FAT;5!+ 0(4 Q0    ( &ET;E=T
M+K&T.0@  !)2   4              "  ; 1 0!F;VYA<E]E>&AI8FET+3,Q
M+FAT;5!+ 0(4 Q0    ( &ET;E?Q=4$)X@0  +XC   4              "
M 1L: 0!F;VYA<E]E>&AI8FET+3,R+FAT;5!+ 0(4 Q0    ( &ET;E>-79IP
M]S4  &@X   .              "  2\? 0!F;VYA<E]L;V=O+FIP9U!+ 0(4
M Q0    ( &ET;E?CQ@5B=@X  -*5   1              "  5)5 0!F;VYR
M+3(P,C,P.3,P+GAS9%!+ 0(4 Q0    ( &ET;E<+&[!PL!,  )S^   5
M          "  ?=C 0!F;VYR+3(P,C,P.3,P7V-A;"YX;6Q02P$"% ,4
M" !I=&Y7-.24"U C  #!)0( %0              @ ':=P$ 9F]N<BTR,#(S
M,#DS,%]D968N>&UL4$L! A0#%     @ :71N5V5*=<($2@  B/8# !4
M         ( !79L! &9O;G(M,C R,S Y,S!?;&%B+GAM;%!+ 0(4 Q0    (
M &ET;E<H#NR;M#$  #85 P 5              "  93E 0!F;VYR+3(P,C,P
A.3,P7W!R92YX;6Q02P4&      D "0!' @  >Q<"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
